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Abstract 
7-diethylaminocoumarins are famous fluorescent dyes due to their low pH-dependence, 
high quantum yields, strong intensity of fluorescence and photostability. They are widely 
used in multi-coloured fluorescence investigation.  
Within the scope of this thesis the synthesis of fluorescent dyes based on 7-
diethylaminocoumarin moiety was developed and their application was studied. Further-
more, various labelling methods were developed by attaching coumarins to amino acids and 
peptides by bioorthogonal reactions for the biomolecular imaging. The fluorescent tags were 
attached to the C-terminus, N-terminus and an amino acid backbone. It was found that the 
triflate derivative of coumarin is a good coupling partner for various transition metal- 
catalyzed cross-couplings, like for instance Sonogashira, Suzuki-Miyaura and Stille coupling. 
The amino acid backbone was labelled through Pd-catalyzed allylic alkylation. Furthermore, 
Michael acceptors based on the coumarin moiety were developed. The labelling reactions 
proceeded smoothly, under mild conditions, furnishing molecules with fluorescent tags in 
good to excellent yields. All compounds were characterized by fluorescent spectroscopy in 
the group of Prof. Jung. 
 
Kurzfassung 
7-Diethylaminocumarine sind bekannte Fluoreszenzfarbstoffe aufgrund ihrer niedrigen 
pH-Abhängigkeit, hohe Quantenausbeuten, Fluoreszenz  starken Intensität und 
Photostabilität. Sie werden in der mehrfarbigen Fluoreszenzspektroskopie verwendet. 
Im Rahmen dieser Arbeit wurde die Synthese von fluoreszierenden Farbstoffen auf Basis 
von 7-Diethylaminocumarin Einheit entwickelt und deren Anwendung untersucht. Weiterhin 
wurden verschiedene Labels in bioorthogonalen Reaktionen zum Fluoreszenzmarkierung von 
verschiedenen Aminosäuren und Peptiden untersucht. Die Fluoreszenz-Markierungen 
gelangen sowohl an C-Terminus, als auch an N-Terminus und an der -Position der 
Aminosäuren. Es wurde festgestellt, dass die Triflatderivat von Cumarin ein guter 
Kupplungspartner für die verschiedenen Übergangsmetall-katalysierten Kreuzkupplungen 
darstellt, so zum Beispiel für Sonogashira-, Suzuki-Miyaura- und Stille-Kupplung. Das 
Aminosäure-Rückgrat wurde durch Pd-katalysierte allylische Alkylierung markiert. Außerdem 
wurde ein Michael-Akzeptor ausgehend aus Cumarin entwickelt. Die Labelingsreaktionen 
verliefen glatt und unter milden Bedingungen, die Verbindungen mit Fluoreszenzmarker 
konnten in guten bis ausgezeichneten Ausbeuten isoliert werden. Alle Verbindungen wurden 
Fluoreszenzspektroskopisch in der Gruppe von Prof. Jung charakterisiert. 
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Preface 
 
 
 
Fluorescence spectroscopy is a unique analytical technique in detection and 
analysis of various biochemical and biophysical properties as well as morphology of 
cells and tissues. The recent development of fluorescent microscope allows by 
fluorescent labeling of biomolecules, observing and recording the progress of 
molecular or cellular processes for biochemical, biological, diagnostic or therapeutic 
application. This biomolecular imaging made it possible to study mechanisms of the 
process and identify the targets; therefore the starting points for drug development 
can be found. [12, 19] 
Fluorescent dyes are the most important participants in fluorescence 
spectroscopy. There are known various fluorescent probes with different 
characteristics [9], like for instance coumarin, fluorescein, BODIPYs, Alexa dyes and 
others. Therefore based on the experiment requirements a specific fluorescent tag 
can be chosen. Fluorescent dyes based on the 7-aminocoumarin moiety are popular 
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due to their low pH-dependence and high quantum yields. They became also target 
of this research. 
The most commonly labelled molecules are usually antibodies, proteins, amino 
acids and peptides. Among the labelling methods for biomolecules chemical as well 
as enzymatic labelling protocols are widely used.[56] The targets for fluorescent tags 
are usually N- or C-termini, and also the backbone of the protein.[19] Among the 
methods, which were used in this work for bioorthogonal labelling, are Pd-catalyzed 
cross-coupling reactions (Suzuki-Miyaura, Sonogashira), Buchwald-Hartwig 
amination with and without CO-insertion, Pd-catalyzed allylic alkylations and Michael 
additions. The methods developed in this work are shown in Figure 1.1 and Figure 
1.2. 
 
Figure 1.1:  Bioorthogonal labelling methods developed in scope of this work. 
 
Figure 1.2: Bioorthogonal labelling through Michael addition. 
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Introduction 
 
 
The term fluorescence derives from the name of the mineral fluorite (calcium 
difluoride)[1] (Figure 2.1).[2] This phenomenon was first described by Monardes in 
1565, which he observed in a Mexican medicinal wood; in Europe it was known as 
Lignum nephriticum. The compound which causes this fluorescence is matlaline – an 
oxidation product of one of the flavonoids found in this wood.[3] For many centuries 
the fluorescence remained a mystery for science. 
At the beginning of 19th century, Edward D. Clarke[4] and René Just Haüy[5] noticed 
fluorescence in minerals fluorites. The phenomenon was also observed in 
chlorophyll[6]  and in quinine.[7] 
 In 1852 George Gabriel Stokes described the ability of fluorspar and uranium 
glass to change from light invisible to human eye into blue light. He named this 
phenomenon fluorescence: "I am almost inclined to coin a word, and call the 
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appearance fluorescence, from fluor-spar, as the analogous term opalescence is 
derived from the name of a mineral".[8]  Some samples of fluorite contain traces of 
europium, which acts as the fluorescent activator to emit blue light. 
In nature there are a lot of species, like fishes, butterflies, parrots, plants, corals, 
etc., which contain fluorescenting substances and therefore exhibit these 
phenomena. 
 
 
 
 
 
Figure 2.1:  Fluorescing fluorite from Boltsburn Mine, Weardale,  
  North Pennines, County Durham, England, UK.
[2]
 
A fluorophore is a molecule that is capable of fluorescing. Typical fluorophores 
usually contain aromatic and heterocyclic ring. In Figure 2.2[9] are shown some 
examples of these compounds. Fluorophores allow scientist to detect and visualize 
different components of complex biomolecules, study the mechanisms of chemical 
and biological processes, even in case of low concentrations.  
 
 
 
 
 
 
 
 
 
 
 
 
    Figure 2.2:  Some typical fluorescenting compounds.
[9]
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One of the well-known fluorophores is quinine, which can be found in tonic 
water. A slight blue fluorescence can be observed if tonic water is lit by sunlight at a 
specific angle. This phenomenon of quinine solution was first described by Sir John 
Fridrich Herschel. Quinine is still widely used as a fluorophore in fluorescent 
spectroscopy, as well as a drug due to its antipyretic (fever-reducing), antimalarial, 
analgesic (painkilling), and anti-inflammatory activities. It was widely used during the 
World War II. Furthermore quinine fluorophore inspired the development of the first 
spectrofluorometers.[9]  
2.1 Basics of Fluorescence 
Some molecules are capable of being excited by absorption of light energy to a 
higher energy state – excited state. These energy states are not stable and energy 
cannot be sustained for a long period; it decreases by emission of light. This process 
is called photoluminiscence. Photoluminiscence is an ability of a substance to glow, 
which is caused by transfer of the electrons of the molecule from an excited state to 
its ground state, if the excitation is carried out by absorption of photons of 
electromagnetic radiation in the optical range. Depending on the nature of the 
energy levels involved in the formation of the radiation, photoluminescence is 
divided into fluorescence and phosphorescence. The fluorescence results from the 
optical transition between the two levels of the same multiplicity (usually between 
the first excited S1 and singlet ground state S0 of a molecule) and is characterized by 
a high probability of spontaneous transition - short lifetime  of electronically excited 
singlet state. Phosphorescence unlike fluorescence is due to optical transitions 
between the levels of different multiplicity (typically between the lowest excited 
triplet T1 and singlet ground S1 state of the molecule), and has a very low probability 
of transition (long lifetime of the triplet excited state T1).
[10] 
In its ground state, a fluorophore molecule has a relatively low energy and is in its 
stable configuration, it does not fluoresce. If light of an external source hits the 
molecule, the fluorophore can absorb the energy light, thus getting a higher energy 
level – excited state. This process is called excitation. The fluorophore can reach 
different excited states, depending on the energy of the external light source. Since 
the high energy level cannot be maintained for a long time, the molecule goes to a 
lower energy level. The time during which the molecule is in excited configuration is 
called an excited lifetime, and it lasts for a very short time (10-15 to 10-9 seconds). 
Then the molecule rearranges from metastable to the ground state, the excess 
energy is emitted in a form of light. This light has a lower energy and longer 
wavelength then the absorbed light. This means that the colour of the light emitted 
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differs from the one absorbed. This entire absorption-emission process can continue 
repeatedly.[11] 
In general, the excited molecules lose their excess energy not only through 
radiative transitions, but also through nonradiative processes. Nonradiative 
transitions between electronic states of the same multiplicity are called internal 
conversion, and between states of different multiplicity - intersystem crossing 
The scheme of intramolecular processes occurring after the optical excitation of 
molecules is shown in Figure 2.3. It is called the Jablonski Diagram. 
 
Figure 2.3: Jablonski Diagram.[
2]
 
The entire process can be summarized as follows: 
1. The fluorophore is excited by absorption of the light energy; 
2. Excited lifetime, fluorophore reminds in the excited state; 
3. The fluorophore returns to its ground state emitting light (fluorescence). 
Molecules which undergo such electronic transitions and result in fluorescence 
are called fluorescent probes, fluorochromes, or dyes. Fluorochromes which are 
covalently bonded to macromolecule, like a nucleinic acid, lipid, enzyme, serving as a 
marker are called fluorophores. Fluorophores can be intrinsic and extrinsic. Intrinsic 
fluorophores are naturally occurring compounds like aromatic amino acids, 
neurotransmitters, flavins, quinine, pophyrins, nicotinamide adenine dinucleotide 
(NADH), adenosine triphosphate (ATP), etc. Extrinsic fluorophores are synthetic dyes, 
like fluorescein, rhodamine, ethidium bromide, etc. There are as well fluorescent 
proteins, which are “genetically” attached to the target protein.[12] 
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Properties of excited molecules 
Lifetime and quantum yield 
Once a molecule (fluorophore) absorbs light (photons) it is important to know the 
most crucial processes that can take place. Fluorescence lifetime and quantum yield 
are two the most important features. The fluorescence quantum yield () is the ratio 
of photons absorbed to photons emitted by fluorescence. The molecules that 
possess large quantum yields have the brightest emissions. The quantum yield for 
some process x can be found from the following formula:[10] 
 
k
kx
  =x  

  
In other words it is a rate of some process x divided by the sum of all rates. For 
instance, if quantum yield of some fluorescence is  = 0.70, it means that once a 
photon is absorbed by a fluorophore, 70% of the molecules will irradiate the 
absorbed energy in form of fluorescence. On the other hand, quantum yield for 
intersystem crossing ISC, which results the degradation of the fluorophore, should 
be as small as possible. The lifetime of fluorescence defines the time during which a 
molecule is in its excited state. 
Stokes Shift 
As it was mentioned above the energy of the light that fluorophore absorbes 
differs from the energy of the emitted light. This results in difference between 
absorption and emission spectra. Stokes shift is the difference between positions of 
maxima of the absorption and emission spectra. It is named after Irish physicist 
George G. Stokes.[13] If the energy emitted is more than the energy absorbed then 
the difference is called the anti-Stokes shift (Figure 2.4).[14] 
This feature is especially interesting in case of polar fluorophores in polar 
solvents. One of the examples is the indole group of tryptophan residue in proteins, 
[9] which is a sensitive fluorophore towards the environment. Due to this feature the 
location of tryptophan residue in protein can be determined. If the residue is 
shielded and thus has less interaction with an environment (aqueous phase), the 
emission spectra is observed in shorter wavelength. The unfolding of the tryptophan 
residue results in exposure of the indole residue and subsequently the emission 
spectra is shifted toward the longer wavelength. 
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Figure 2.4: Stokes Shift. 
Another interesting example is 6-(p-toluidinyl)naphthalene-2-sulfonate (TNS),[9] 
which reveals very weak fluorescence if water is used as a solvent but a strong 
fluorescence can be observed once it is bounded to a biomolecule, like 
apomyoglobin protein. This biomolecule possesses a hydrophobic pocket that binds 
the heme group as well as other nonpolar molecules. If to a solution of TNS is added 
apomyoglobin, strong fluorescence can be observed and the emission spectrum is 
shifted towards shorter wavelengths (Figure 2.5). Therefore by studying the emission 
spectra of solvent-sensitive fluorophores the binding sites of the biomolecules can 
be determined. 
 
 
 
 
 
 
 
 
 
Figure 2.5: Emission spectra of TNS in water, bound to apomyoglobin, 
and bound to lipid vesicles. 
Quenching of fluorescence and photobleaching 
Besides emission of light, a molecule can lose its energy by interaction with a 
quencher.[15]  A quencher is a molecule that by some sort of interaction with an 
excited fluorophore decreases the fluorescence. Molecular oxygen, iodide ions and 
acrylamide[16] are typical examples of chemical quenchers. The chloride ion causes 
quenching of quinine fluorescence.[17] As mentioned before, many fluorophores have 
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aromatic and heterocyclic rings, which by interaction with each other via van der 
Waal forces, form nonfluorescenting complexes.[9] Fluorescence quenching is mostly 
an undesirable process which results in reduction of fluorescence intensity and thus 
giving incorrect measurements data.  
Another undesirable process is photobleaching (or fading) of fluorescence. This 
dynamic process takes place when a fluorophore loses its ability to fluoresce due to 
photon-induced chemical destruction and covalent modification caused by excitation 
light.[18] As shown in the Jablonski Diagram, Figure 2.3, the fluorophore molecule 
after being excited go from ground singlet state to excited singlet state. By radiative 
(fluorescence) or non-radiative (internal-conversion) decay they return to the 
ground state. On the other hand non-radiative intersystem crossing to a triplet state 
may take place. During these transitions, fluorophores may interact with other 
molecules from the environment and create irreversible covalent complexes. The 
lifetime of a triplet state is relatively longer, thus allowing the molecules to undergo 
different modification. Those photobleached molecules are unable to participate in 
the excitation-emission cycle. The rate of photobleaching depends on the structure 
of the fluorophore and the environment.  
The phenomena of photobleaching are widely used in fluorescence 
spectroscopes. The most widely used technic is known as fluorescence recovery after 
photobleaching (FRAP), based on work by Peters et al. This is a method of 
determining the kinetics of diffusion in living cells using fluorescence 
spectroscope.[12]  
2.2 Fluorescence spectroscopy 
A fluorescence spectroscope is an electromagnetic spectroscope which analyses 
fluorescence properties of a sample. A fluorescent spectroscope uses a source of 
light, usually ultraviolet light, to excite the electrons in molecules of certain 
compounds. Devices that measure fluorescence are called fluorometers.[9] 
In general there are two types of instruments: 
 Filter fluorometers, where filters are used for isolation of the incident and 
fluorescent light. 
 Spectrofluorometers, where diffraction grating monochromators are used for 
isolation of the incident and fluorescent light. 
The basic principle of both instruments is shown on the scheme in Figure 2.6.  A 
fluorimeter consists of the light source, which hits the sample. These may be lasers, 
LED lamps, xenon arc lamp or mercury-vapor lamps. Dissadvantage of the laser 
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lamps is that it does not allow the change of the wavelength by much. The 
advantage of a xenon arc is that it has a continuous emission spectrum, high 
intensity in the range from 300-800 nm. The light goes through a filter or a 
monochromator, in order to decrease the amount of the light with different 
wavelengths. Then it hits the sample causing the fluorescence of some of the 
molecules. The light in form of fluorescence goes further through the second filter or 
monochromator before it reaches the detector. The detector is placed at a 90° angle 
in order to avoid interference of the excited light. In the end the results are 
presented in graphical form. 
 
Figure 2.6: A basic scheme of a fluorimeter. 
Application of fluorescent technologies in Life Sciences grew significantlly in the 
last decades. The reason for this is that in comparison with other measuring 
methods, like radioactive methods, it is much cheaper, faster, more flexible and 
more precise.[19,15] The fields where fluorescence spectroscopy can be applied are 
vast. It can be used for solution of many problems in lifesciences, especially chemical 
and biological sciences. Fluorescence technologies can give information about 
different reaction mechanisms, a wide range of molecular processes, conformational 
changes, etc. The progress in fluorescent technogies made it inexpensive and unique 
for diverse analytics. 
New fluorescence technologies 
Developments in fundamental physics and particularly in spectroscopy have 
enabled the expansion of luminescent labeling and detection in the life sciences. 
Nowadays instrumentation devised in laboratories is becoming also commercially 
available.[20] 
The Nobel Prize in Chemistry 2014 was awarded jointly to Eric Betzig, Stefan W. 
Hell and William E. Moerner "for the development of super-resolved fluorescence 
microscopy".[21]  
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In 1873 E. Abbe published an equation according to which the microscope would 
not be able to observe things smaller than half the wavelength of light, apr. 0.2 
micrometres (Figure 2.7). Therefore according to this view the observation of a 
single protein, the size of which is few nanometers, would not be possible.   
By studying absorption and fluorescence of molecules, usually millions of 
molecules are observed at the same time. As a result the experiments represent an 
average molecule. Scientist working in this field have always dreamt of a microscope 
able to measure a single molecule, thus giving more understanding of different 
processes, like for example, the development of a disease.[21] The first experiment 
was carried out in 1989 by W. E. Moerner; he measured the light absorption of a 
single molecule. This gave stimulus to many chemists to start investigation of single 
molecules. 
 
Figure 2.7: Abbe’s diffraction limit. 
 
Super-resolution fluorescence microscope is a type of light microscope. The 
application of fluorescent molecules made it possible to take a light microscope to 
another level. The principle is the following: all fluorescent molecules are being 
excited by a light source; meanwhile a laser-beam quenches fluorescence from all 
fluorophores except those in a nanometre-sized volume. Only this volume is then 
recorded. By moving along the sample and continuously measuring light levels, it is 
possible to get a high-resolution image. The smaller the volume taken the better the 
image can be achieved. Therefore half-wavelength limit no longer applies.  
2.3 Fluorescent dyes 
As mentioned above, fluorophores are devided into naturally occurring and 
synthetic. Among the major characteristics that should be considered when choosing 
a fluorescent dye are absorbtion coefficient and quantum yield, emission spectra (in 
order to avoid mistakes because of autofluorescence), solubility, reactivity and 
labelling technic. Molecular Probes Handbook of Fluorescent Probes and Research 
Products[11] gives a very good information about many synthetic dyes.[12] An “ideal” 
fluorophore should possess further characteristics:[12] 
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 reacts only with the target molecule, cell, etc; 
 be non-toxic; 
 be bright; 
 not be photobleachable; 
 be dissociable; 
 be small 
Organic fluorophores are the first fluorescent compounds that have been used in 
biological research. Today they are the most commonly used fluorescent labels due 
to their flexible design and the small size, which allows binding of the fluorophore to 
a macromolecule without loss of functionality, as well as the specific labeling of 
certain molecular positions. Among other advantages are their low price, good 
availability and the presence of established methods for conjugating the dyes to 
biomolecules. Organic fluorophores are, for instance, classical chromophores for 
fluorescence resonance energy transfer measurements (FRET). FRET measurements 
can be regarded as spectroscopic ruler, with which the distance between two 
fluorescently labeled, functional groups (donor and acceptor) can be determined. 
The organic fluorescent dyes have polymethine, xanthene or coumarin ring. 
 
Figure 2.8 Basic structures of organic fluorophores. 
Coumarin dyes 
Coumarins or 2H-chromen-2-ones (Figure 2.9) are a class of heterocyclic organic 
compounds which are widely spread and exhibit different biological activities against 
cancer, HIV, as well as anticoagulant, spasmolytic and antibacterial activities.[22,23] Its 
name derives from tonka bean, coumarou, from which it was first isolated in 1820. It 
also occurs naturally in vanilla grass, woodruff, mullein, lavender, strawberries, 
apricots, cinnamon and has a peculiar flavour which reminds vanilla.[23] 
 
Figure 2.9: Structure of coumarin. 
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Besides their pharmacological properties, coumarins exhibit fluorescence ability 
as well.[19] They belong to the group of blue fluorophores, i.e. they absorb light at the 
abs = 354-423 nm range and emission occurs at the em = 420-590 nm range. Simple, 
unsubstituted coumarin does not reavel fluorescence properties, it is necessary to 
create a “push-pull” – system using different substituents. A fluorescenting coumarin 
should possess electron-donating groups in positions 6 and 7 (R7 and R6 – 
substituents with +M-effect), and electron-withdrawing groups in position 3 and 4 
(R3 and R4 – substituents with -M-effect). Fluorescence properties of coumarin 
changes drastically with different substituents and expansion of the coumarin ring: 
[24]  
 electron-donating groups in position 6 and electron-withdrawing groups in 
position 3 influence the emission of fluorophore; 
 electron-donating groups in position 7 and electron-withdrawing groups in 
position 2 influrence the fluorescence intensity; 
 electron-withdrawing substituents in position 4 cause the shifting of emission 
maxima.[15] 
Due to blue fluorescence of coumarin it is easy to distinguish its light from green, 
yellow and red; it is widely used in multi-coloured fluorescence investigation, for 
instance, immunfluorescence, nucleinic acid and protein-microassays. Furthermore 
because of its fixed trans-conformation of a carbon-carbon double bond due to a 
lactone structure, it helps to avoid the trans-cis transformation under UV-irradiation, 
which results in strong intensity of fluorescence, high quantum yield and 
photostabilitity of coumarin derivatives.[25] Among the coumarin derivatives the 
most important are 7-aminocoumarins (Figure 2.10) as well as 7-
hydroxycoumarin,[19] which is  widely used in fluorescence spectroscopy.[26] 
 
Figure 2.10: 7-aminocoumarins. 
Application of 7-hydroxycoumarin and its derivatives is limited because of its pH 
dependence. It exhibits fluorescence maximum at pH 10 or higher, and only in its 
anionic form.[27,28] Therefore, for investigation of enzymes which reveal their 
catalytic activity at pH 7 or lower, 7-hydroxycoumarin, in these conditions neutral 
and nonfluorescent, cannot be applied.[15]  
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In comparison with 7-hydroxycoumarin and Pacific blue (6,8-difluoro-7-
hydroxycoumarin), 7-aminocoumarin reveals low pH-dependence, it is active at a 
wide range of pH; 7-aminocoumarins exhibit high fluorescence intensity and 
excellent fluorescent quantum yield. It is an excellent dye candidate for fluorescent 
investigation; on the other hand, its synthesis is not as trivial and requires a novel 
synthetic route.  
Synthesis of coumarins 
Because of all the properties mentioned above, a lot of synthetic routes have 
been developed to obtain coumarin and its derivatives,[23] like Pechmann,[19] Perkin, 
[29] Reformatsky[30] and Wittig[31] reactions. The most widely used one is the 
Pechmann condensation reaction (Scheme 2.1) of phenols with β-ketoesters 
furnishing the 4-substituted coumarins. Depending on the reagents different 
catalysts can be used, for instance, sulphuric acid, aluminium chloride, phosphorus 
pentoxide, as well as Lewis acids.[32] Kazmaier et al. reported on Ti-catalyzed 
Pechmann condensation reaction,[33] which was applied for the synthesis of 7-
aminocoumarins giving the desired fluorescent dyes in high yields. 
 
Scheme 2.1: Pechmann condensation reaction. 
 
In recent works Trost et al. developed a Pd-catalyzed C-C bond formation giving 4- 
substituted coumarins via the intermolecular reaction of propiolic acids with 
phenols.[34,35] Fujiwara and coworkers synthesized coumarins by Pd-catalyzed inter- 
and intramolecular hydroarylation of aryl propiolates (Scheme 2.2),[32] though this 
methodology cannot be used in the synthesis of 3-substituted fluorescent dye. 
 
Scheme 2.2: Pd-catalyzed synthesis of coumarin. 
Larock et al. synthesized coumarin through Pd-catalyzed annulation of internal 
alkynes by O-iodophenols in the presence of CO (Scheme 2.3).[36,37] The disadvantage 
of this method is the formation of regioisomers due to application of unsymmetrical 
alkyne. 
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Scheme 2.3: Pd-catalyzed synthesis of coumarin according to Larock. 
Fluorescein  dyes 
Fluorescein which was synthesized for the first time by Bayer in 1871 via the 
Friedel-Crafts reaction between phthalic anhydride and resorcinol in the presence of 
zinc chloride, is a polycyclic fluorophore which has long absorbtion maxima abs = 
480-600 nm range and emission wavelength at em = 510-615 nm range.
[9,19]  
 
Figure 2.11: Fluorescein. 
The most important reactive derivatives are isothiocyanates, iodoacetamides, and 
maleimides. Iodoacetamides and maleimides are used as labels for sulfhydryl groups, 
whereas isothiocyantes and sulfuril chlorides are good labels for amines.[9] 
Fluorescein markers are widely used for labelling antibodies. Fluorescein labelled 
proteins can be purchased directly and there is a wide application of these proteins 
in fluorescence spectroscopy and immunoassays. 
Fluorescein and its derivatives are characterized by high absorption and high 
quantum yield (ϕ = 0.92) at pH > 8,[16] good solubility in water, as well as fluorescein 
excitation maximum at 494 nm, which is close to the 488 nm spectral line of the 
argon laser, making it a good fluorophore in confocal laser-scanning microscopy and 
flow cytometry.[8]   
 Nevertheless fluorescein and its derivatives have some negative aspects, like 
photobleachining, pH-sensitivity, a relatively broad fluorescene emission spectrum 
(which makes them bad candidate in multicolour fluorescent investigation), self-
quenching by conjugation with biopolymers, low photostability.[8,33]  
 There are many known fluorescein derivatives, for instance, fluorescein 
isothiocyanate, or FITC. This dye reacts with amino group of proteins forming a 
thiourea linkage.[39] 
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Rhodamine dyes 
Rhodamines are organic heterocyclic compounds, which belong to the family of 
fluorine dyes. The most important represantives are rhodamine 6G, rhodamine B, 
rhodamine 123 and texas red (Figure 2.12).[8] 
 
Figure 2.12: Rhodamin dyes. 
Rhodamine and its derivatives are usually characterized by high absorption at the 
abs = 470-557 nm range and emission is observed at the em = 510-615 nm range.
[19] 
These fluorophores have been reported in different fluorescent studies.[8] The 
molecule of rhodamine consists of the xanthen nucleus bearing amino-groups in 3- 
and 6-position, and a benzoic acid in 9-position. By alkylation of amino groups, as 
well as of xanthen nucleus, different rhodamine derivatives can be obtained, 
therefore expanding its application in spectroscopy. The expansion of the xanthen 
skeleton results in bathochromic shifting of absorption spectrum.[15] Usually 
rhodamines are stable at a wide pH-range (from 4 to 10), are relatively photostable 
and quenching effect is not as strong as for fluorescein and its derivatives.[15,19] The 
disadvantage of rhodamine dyes is their poor water-solubility.[39] 
Since the development of BODIPY- and Alexa-fluorescent dyes, the application of 
rhodamines has been significantly reduced.   
Alexa dyes 
The Alexa fluor dyes, which were developed by Molecular Probes Inc,[11] are a 
new series of flurescent dyes which are often used as fluorescent markers in Life 
Sciences. Their emission and excitation spectra are similar to already known dyes, 
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like Lucifer Yellow, fluorescein, rhodamine, etc. But unlike other fluorophores they 
exhibit high photostability and low pH-dependence, and are characterized by strong 
fluorescence and high quantum yield,[38] on the other hand they are more expensive. 
Alexa-dyes were synthesized through sulfonation of coumarin, rhodamine, 
xanthene and cyanine dyes (Scheme 2.4). The sulfonation reduces the tendency of 
molecules to self-quench, which can be explained by negative charge and 
hydrophilicy.[19]  
 
Scheme 2.4: Synthesis of Alexa-dyes. 
 
The name comes from Alex Haugland.[2] Each Alexa-dye is labelled by a number 
that corresponds its absorption maximum.[15] By modification of coumarin 
derivatives the blue Alexa-dye (Alexa 350) is obtained, rhodamine and fluorescein 
give green fluorophores (Alexa 488 and Alexa 430), as well as from rhodamine a red 
fluorophore can be obtained.[8,15] 
BODIPYs 
Another interesting class of fluorescent markers are BODIPY-dyes (patented by 
Molecular Probes). The name comes from abbreviation of BOron-DIPYrromethenes, 
which in IUPAC-system is known as 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene.[39] 
 
 Figure 2.13: Structure of BODIPY-fluorophore.
[34]
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The first synthesis of these dyes was performed by Treibs and Kreuzer in 1968 but 
only after 1980 they found their wide range of application. They can be obtained by 
condensation of acyl chlorides with pyrroles with subsequent complexation with 
BF3·OEt2 in the presence of a base.
[40] Depending on its structure, BODIPY-
fluorophores exhibit the absorption in the range 504-544 nm, and emission in the 
range 510-675 nm. Because of their intensive green fluorescence, BODIPY markers 
are good substituents of fluorescein and rhodamine dyes.[19]  
BODIPY dyes are characterized by high fluorescence quantum yield (ϕ  1.0) 
regardless of the solvent (even in water), excellent thermal and photochemical 
stability, the fluorescence intensity does not depend on pH-value of the 
environment. They show narrow emission band widths (an advantage in multicolour 
analysis), high molar absorption coefficients, good solubility, and chemical 
rebustness. BODIPY dye molecule is neutral,  they are widely used as reagents for 
detection of amine-derivatives in HPLC and capillary electrophoresis because of their 
high peak intensity.[8,40] 
These dyes have been applied as markers for proteins and DNA. Though they have 
also some disadvantageous characteristics. One example is that most of them emit 
at less than 600 nm.[41] Through expansion of the chromophore molecule, for 
instance, annelation of the phenyl ring, results in the bathchromic shift and 
emmision maximum is observed at 630 nm. The disadvantage of such big structures 
is a high lipophilicity and therefore they cannot be applied to all the systems.[15] 
Squaraine dyes 
Squaraine dyes are a class of organic fluorophores characterized by intense 
fluorescence in the red and near infrared region (abs = 630-670 nm, em = 650-700 
nm). They exhibit intense and sharp absorption spectra in the visible and near-
infrared range, as well as sharp and intense fluorescence. These fluorophores are 
characterized by photoconductivity. Due to their photophysical properties they are 
widely used in detection of biomolecules. Squaraine dyes are unique four-membered 
aromatic systems derived from squaric acid. 
 
 
Figure 2.14: Structure of squarylium dye. 
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By modification of this dye on the aromatic ring or on the N-atom different 
derivatives can be obtained. The conjugates with protein show higher quantum 
yields, longer lifetimes and better photostability compared to polymethines. 
Squaraines dyes can be excited by a red laser as well as by blue light.[8] 
Cyanines 
Cyanine dyes are another class of fluorescent compounds which have been widely 
used since their discovery. They are being applied in genetic analysis, DNA 
sequencing, in vivo imaging and proteomics.[8] The first total synthesis of this 
compound was reported by Hammer et al. in 1930.[15] 
The name derives from the Greek word “kyanos” which means a shade of blue-
green. The molecule of cyanine is built out of two aromatic or heterocyclic rings 
which are linked by a polymethine chain with conjugated carbon-carbon double 
bonds. 
Cyanine fluorophores exhibit emission spectra at the range between 600 and 900 
nm and absorption close to infrared areas (em > 550 nm). The addition of a vinyl 
group gives further bathochromic shift. These dyes are the main source in long-
wavelength spectroscopy.[8] Cyanines are widely used to increase the sensitivity 
range of photographic emulsions, they are used in CD-R and DVD-R media.[2] 
 
Figure 2.15: Basic structure of cyanine dye. 
A major advandage of cyanine fluorophores is their large emission wavelengths, 
and the possibility to control emission spectra by extension or by shortening the 
polymethine chain. Due to this feature interfering autofluorescence of the tissue can 
be avoided. In addition, several different fluorescent fluorophores can be used and 
detected separately, which allows tracking of multiple effects simultaneously.[19] 
Cyanine dyes possess also sharp and intense absorbtion bands; they show high 
stability towards pH (4.0-9.0). Fluorescent quantum yield is in the ϕ = 0.09 – 0.52 
range. Low quantum yield can be explained by thermo- and photoinduced cis-trans-
isomerisation.[8,15] Furthermore cyanine dyes have short lifetime and in aqueous 
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solution they build aggregates, which causes low fluorescent intensity. Despite these 
disadvantages, cyanine fluorophores are still widely used in biological imaging.[15,19] 
2.4 Green fluorescent protein 
The green fluorescent protein (GFP) is a protein which consists of 238 amino acid 
residues and is characterized by bright green fluorescence when exposed to high 
frequency light. It was isolated for the first time from the jellyfish Aequorea Victoria 
(Figure 2.16). Its major excitation peak is observed at 395 nm and minor at 475 nm. 
Emission occurs at 509 nm, which is in the lower green segment of the visible 
spectrum. The fluorescent quantum yield is 0.79.[42,43] 
  
Figure 2.16: Structure of the ‘Aequorea victoria’ green fluorescent protein.
[44]
 
The GFP gene is extensively applied as a reporter of expression.[45] The use of 
genetically encoded fluorescent proteins has grown tremendously in modern 
biological research in recent years. Only thirty years after the isolation by 
Shimomura (1962) the GFP found its value in biotechnology as a marker of gene 
expression and protein targeting in intact cells and organisms.[43] The 2008 Nobel 
Prize in Chemistry was awarded to Martin Chalfie, Osamu Shimomura and Roger 
Y.Tsien for the discovery and development of the green fluorescent protein.[21]  
Modified forms of GFP were used to produce biosensors. The GFP gene can be 
introduced into organisms and maintained in their genome through breeding, 
injection with a viral vector, or cell transformation. The GFP has been already 
introduced so far in many bacteria, yeast and other fungi, fish, plants, flies, as well as 
mammalian cells, including human.[43] 
The biggest advantage of GFP is its heredity, i.e it can be transferred with 
genetically encoded protein. Furthermore, it is easy to visualize and detect GFP just 
by shining light (Figure 2.17). Also, GFP is a relatively small and inert molecule, so it 
does not have any significant impact on the target molecule. If GFP is used with a 
monomer it is able to diffuse readily throughout cells.[46] It is worth mentioning that 
GFP does not have any toxic effect on the living cells while illuminated. 
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GFP can also be expressed in a wide range of structures making morphological 
distinction possible. In this case, the gene for the production of GFP is introduced 
into the genome in the region of the DNA which is responsible for the target 
proteins; consequently the gene’s regulatory sequence now controls also the 
production of GFP. Therefore only those cells in which the tagged gene is expressed, 
or the target proteins are produced, will reveal fluorescence. This process made it 
possible to understand many biologically important processes like protein folding, 
protein transport, etc.[47] 
 
Figure 2.17: Mice expressing GFP under UV light (left & right), compared to normal mouse (center).
[2]
 
GFP has been used as well in cancer research to label and detect cancer cells. 
GFP-labelled cancer cells have been used to model metastasis.[48] 
2.5 Nanoparticles as fluorescent labels 
In spite of the large amount of known fluorophores, there are still some 
limitations of fluorescent detection in bioanalytics. Besides the labelling reaction 
difficulties, the fluorescent dyes themselves have photobleaching problems, pH 
sensitivity, low quantum yields and short lifetimes; they very often exhibit narrow 
excitation bands, broad emission spectra, small Stokes shift, etc. The recent 
developments in nanosized luminescent agents may be the solution of these 
problems. Nanoparticles (like quantum dots and gold nanoparticles) may change 
drastically bioanalytical fluorescence measurements.[49,12] 
Unlike classical dye, nanoparticals could overcome much chemical and spectral 
limitation, and they are becoming commercially available. The newly developed 
nanoparticles can be applied as well for absorbance and emission in the near-
infrared region.[49]  
An advantage of nanoparticles is that they can access even hidden target 
molecules (e.g proteins), through conjugation of specific targeting groups on their 
surface. Furthermore, due to their optoelectronic properties they could be detected 
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with high sensitivities.[49] Inorganic nanoparticles based on noble metals and 
semiconductor quantum dots seem to be mostly interesting in bioanalytical 
measurements. Gold nanoparticles are widely used in Life Sciences.  
Quantum dots 
Quantum dot is a nanocrystal made of semiconductor materials. Its size is small 
enough (2- to 10-nm) to possess quantum mechanical properties. It is similar to the 
size of proteins and DNA (Figure 2.18).[12] Its excitions are confined in all three spatial 
dimensions.[50] The properties of quantum dots are inbetween bulky semiconductors 
and discrete molecules.[51,52] quantum dots were discovered by Alexey Ekimov in 
1981 [53] and later by Louis E. Brus in 1985.[54] They can be applied in transistors, solar 
cells, LEDs, diode lasers, as well as agents for bioanalytical and medical imaging.  
 
Figure 2.18: Relative size of nanoparticles.
[2] 
The properties of quantum dots depend on many factors. One of them is the 
material they are made of (for example, CdSe, CdS, CdTe), which influence the 
wavelength of emitted light.  Another factor is the size, namely decreasing size 
results in increasing of the frequency of emitted light. This means that the colour 
changes from red to blue. Since the size of quantum dots is tunable it allows using 
them as highly multiplexed markers to label different parts of the target molecule 
with different nanoparticles.[12] 
Furthermore, these photostable semiconductor crystals have sharp and 
symmetrical emission peak, which allows the simultaneous excitation of different 
quantum dots with one excitation source.  
 
Figure 2.19: Structure of quantum dot.
[2] 
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Nevertheless quantum dots have one major drawback: their lack of 
biocompatibility. The heavy metal-containing crystals are toxic and may interfere in 
biological processes.[19] 
2.6 Fluorescent labeling techniques of biomolecules 
Nowadays the number of known fluorophore dyes is vast; it is possible to choose 
a specific dye with optimal characteristics for the given experiment. However a lot of 
work is still needed in the development of new dyes and improvement of the 
existing ones (e.g. relaxing of limitations). In design and synthesis of fluorophores as 
well it is important to include a functional group which is capable to bond selectively 
to a specific functional group of a biomolecule.[8] In the last decades many protein-
labelling methods have been developed.[19] Inspite of the fact that a lot of 
modification methods of biomolecules are known, scientist are still developing 
methods which are more specific and can be applied for a particular residue of the 
protein.[55] 
The fluorophore can be attached to the target molecule chemically (covalently or 
non-covanlently) or biologically (genetic combination of unnatural amino acids, 
fusion of biomolecules with a fluorescent peptide, or enzyme catalysis). Classical 
protein labeling methods which allow the coupling of small organic fluorophores 
substantially comprise simple reactions, which act selectively on the functionality in 
the side chains of the canonical, proteinogenic amino acids.[56] Cysteine and lysine 
are the most commonly modified residues. Labelling of amines proceedes usually 
very fast and furnishes amide or secondary amine bond in high yield.[55]  
2.6.1. Chemical labelling  
Amine labelling 
It is essential that a fluorescent dye reacts selectively with the target molecule, 
and at the same time does not influence its biological activity, i.e. maintaining both 
protein integrity and function. The “ideal” reactions are those which require the 
same conditions as proteins, like functional group tolerance compatibility, selectivity, 
water as a solvent (or pH  7), room temperature, high reaction rates, low reactant 
concentration, nontoxic reagents. Methods that meet these requirements can be 
perfect for in vivo analysis.[56] 
The lysine residue of the protein is one of the most important targets due to high 
nucleophilic properties of the amino group [55] and its natural abundance. NHS-esters 
(N-hydroxysuccinimide ester) are most widely used reagents for labelling lysine 
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residue (Scheme 2.5c).[57] Among the other classical reagents are isocyanates (which 
are available from acyl azides using the Curtius rearangement), isothiocyanates 
(Scheme 2.5a and d), as well as sulfonyl chlorides (Scheme 2.5e). 
Another possible labelling method is reductive alkylation (Scheme 2.5b), which 
can be carried out by interaction of the protein and aldehydes and consequent 
reduction with NaB(CN)H3 or NaB(OAc)3H. Francis and McFarland developed the 
reductive alkylation of proteins using a water stable Iridium complex ([Cp*Ir- 
(bipy)(H2O)]SO4 for transfer hydrogenation.
[58] In comparison with the alkylation 
using sodium boronhydride, which proceeds at low pH, this method gives the desired 
product in high yield also at pH > 7.4.[19] 
 
Scheme 2.5: Labelling of Lysine-residue. 
The kinetically controlled labelling approach is a new attractive labelling method 
reported.[59] A single lysine moiety of a biomolecule reacts with an activated 
biotinylation reagent, which requires mild conditions, physiological pH and 
temperature, giving the desired product in high yield. Amino group of lysine residues 
serves as good nucleophiles for the aza-Michael addition reaction.[60] Cyclohexene 
sulphonamide derivatives have been used for selective labelling of Lys in human 
serum albumin (HSA).[63] 
Thiol labelling 
Cysteine is in comparison with lysine a rare amino acid. Introduction of a uniquely 
reactive cysteine is possible by means of genetic methods. As a relatively rare amino 
acid cysteine is often used for single-site modification.[56] Reagents used in 
modification of cysteine are usually commercially available. By deprotonation of the 
thiol group of cysteine (pKa  8) a thiolate nucleophile is generated which reacts with 
“soft” electrophiles, like iodoacetamides (Scheme 2.6a), maleimides (Scheme 2.6b), 
acrylamides, and vinyl sulfones (Scheme 2.6d). As a result a new carbon-sulfur bond 
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is generated. Many of these reagents can modify lysine residue as well. The 
concurrent reaction can be avoided at relatively low pH, which causes the 
protonation of amino group. Furthermore the thiol group of cysteine by exchange of 
disulfide group with exogenous disulfides forming disulfides on the protein surface 
(Scheme 2.6e). The efficiency of the reaction can be improved in case of application 
of asymmetric disulfides. By coupling cysteine-alkylating groups to small molecules 
that bind to specific sites on a protein an additional level of labeling selectivity can 
be achieved.[56]  
Among the modern modification methods of cysteine the one developed by Davis 
et al should be mentioned.[61] It is a two-step process where cysteine is converted 
first to dehydroalanine by reaction with O-mesitylenesulfonylhydroxyl-amine under 
basic conditions. Afterwards the dehydroalanine reacts with thiol reagent forming 
thiol ether (Scheme 2.6c). The Michael addition is not stereospecific resulting in 
formation of mixture of diastereomers. 
Another modern technique for labelling of cysteine is based on Thiol-En-Click-
Chemistry (Scheme 2.6f).[56] The reaction proceeds by a radical chain (UV- or 
initiator-induces) giving usually quantitative yields. Thiol-En-Click reactions are wide 
in scope, stereospecific and usually require mild conditions.[62,63] 
Reactions with thiols are usually fast and produce compounds bearing stable 
thiother or disulphide bonds in high yields. 
 
Scheme 2.6: Labelling of Cysteine-residue. 
Chemical reactions of tyrosine residues 
Reagents used for modification of lysine residues can also be coupled to hydroxyl 
(-OH) groups of the amino acid. The reaction is basically carried out in organic 
solvent like DMSO which absorbs the formed water molecule and thus hydrolysis can 
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be avoided. For labelling reactions hydroxyl groups are not very specific because of 
the existence of multiply hydroxyl groups in biomolecule (serine, threonine, and 
tyrosine).[55] 
In Scheme 2.7 are shown the most important modification reactions of tyrosine 
residue. One of the well-known labelling methods is the reaction with diazonium 
salts (Scheme 2.7a) resulting in the formation of azo compounds.[64] The pH range 
should be 8-10 for the formation of a phenolate anion. Another method is the three-
component Mannich-type reaction (Scheme 2.7b), which involves the condensation 
of an aniline derivative with aldehydes followed by the nucleophilic addition of 
tyrosine with formation of a new carbon-carbon bond. Aliphatic amines do not 
participate in this reaction; therefore side reaction with proteins can be avoided.[65] 
Scheme 2.7: Labelling of Tyrosine-residue. 
 
Examples of metall-catalyzed modification reactions are the oxidative coupling of 
two phenol groups and the palladium-catalyzed alkylation of the phenol. In the first 
method (Scheme 2.7c) a persulfate ion oxidizes the Ni(II) ion bind to (His)6tags to 
Ni(III). The metal ion takes an electron from a tyrosine and creates a radical 
intermediate, which couples with another tyrosine thus forming a dityrosine link. 
During the second approach (Scheme 2.7d) Palladium(0) complexes activate allylic 
substrates to form electrophilic -allyl-complexes. At pH 8-10 these complexes react 
with the phenolate anions of tyrosine residues under formation of an aryl ether and 
the Pd(0) catalyst is regenerated.[57] 
Chemical labelling of other amino acids 
Besides the residues described above, the surface of various proteins has many 
aspartic and glutamic residues. The carboxylate groups can be activated with as N -
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ethyl-3-N’,N’-dimethylaminopropyl carbodiimide (EDC), (Scheme 2.8). EDC forms an 
O-acylisourea intermediate which reacts with amine forming amides.[57] 
 Scheme 2.8: Labelling of aspartic/glutamic acid. 
Several strategies have been developed for tryptophan chemical labelling. 
Tryptophan is the most fluorescent of the native amino acids. The chemical 
modification of this residue allows the control of the features, like emission 
wavelength and fluorescent intensity.[57] A recent method reported is the 
modification of a nitrogen atom of the indole ring with malonyl dialdehyde 
derivatives (Scheme 2.9a).[66] The aldehyde can further react to hydrozone 
formation. The transition metal catalysed modification of tryptophan residues 
proceed with high chemoselectivity.[57] By degradation of vinyldiazo compounds by 
rhodium-salts metallcarbenoid intermediates are formed, which react with indole 
residue forming a mixture of N- and 2-substituted products (Scheme 2.9b).   
 
 
 
Scheme 2.9: Chemical labelling of tryptophan. 
Modification of the N- and C-Termini 
Often in the protein chain several rare amino acids are present the labelling of 
which is not possible using the above described methods. To overcome this problem 
several methods have been developed that are applicable to the unique chemical 
reactivities of the polypeptide termini. These methods have been used to form 
native-like peptide links.[57]  
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The N-terminal amino group of the peptide chain is less basic [pKa = 6–8] than 
lysine amino groups, which makes single-site modification possible.[67] Due to its 
relative lower pKa value in comparison with the amino group of the lysine side 
chains, it can be selectively acylated or alkylated in the presence of many lysine 
residues.  
One of the most known methodologies to modify the N-terminus is the Edman 
degradation (Scheme 2.8a). In this protocol the N-terminal amino group reacts with 
phenylisothiocyanate to furnish a thiourea. The following acidification results in the 
removal of the first amino acid from the polypeptide chain. The thiazolidinone 
rearranges forming a stable thiohydantoin. 
 
Scheme 2.10: Modification of N-terminus. 
Among the more selective methods is the oxidation of β-amino alcohols of N-
terminal serine and threonine residues, which results in the formation of the 
aldehyde group, which can be further, modified (Scheme 2.10b). The condensation 
of N-terminal serine and cysteine residues with aldehydes gives oxazolines and 
thiazolidines, respectively (Scheme 2.10c). N-terminal tryptophan reacts with 
aldehydes giving Pictet-Spengler products in a high yield (Scheme 2.10d). 
2 Introduction  
29 
 
Transamination is the most important method for the selective modification of N-
terminus. The first significant transamination that proceeds under physiological 
conditions without the addition of metals or bases was described by Francis et al.[68] 
Through the condensation of the N-terminal amine with pyridoxal-5-phosphate and 
subsequent hydrolysis the pyruvamide is formed. The resulting pyruvamide-keto 
group can react with hydrazine- or aminooxyreagents allowing further modifications 
of the protein. The best results with this method produce amino acids such as 
alanine, glycine, aspartic acid, glutamic acid and asparagine in N-terminal position. 
N-terminal residues can also participate in native chemical ligations with thioesters. 
Native chemical ligation or NCL is an important extenstion of the chemical ligation 
to construct large polypeptide chains by reaction of two or more unprotected 
peptides.[69] NCL is an important and widely used method for extension of the 
peptide backbone or modification. In general it is a ligation between two peptides 
having a C-terminal thioester and N-terminal cysteine, respectively, which forms a 
“native” amide bond (Scheme 2.11).  
 
Scheme 2.11: Modification of the C-terminus through native chemical ligation (NCL).
[57] 
The N-terminal portion of the target peptide is connected directly to the intein 
domain. The intein catalysed an N-to-S acyl shift forming a thioester between the 
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peptide target and a cysteine thiol at the end of the intein sequence. During this 
process a transthioesterification takes place joining two coupling parts of the protein 
and releasing the intein. A final S-to-N acyl shift forms the native peptide bond to 
yield the desired product.[57] 
The NCL method has been widely used to link biologically interesting molecules to 
the C-terminus of proteins, like lipids and polysaccharides, as well as to attach 
fluorophores, affinity tags, and metal chelating agents.[70] 
Bioorthogonal labelling of protein 
Naturally occurring proteins usually contain a wide range of different functional 
groups and it is important to target a unique functional group to label only a goal 
biomolecule. The “bioorthogonal” labelling reactions made it possible to insert    
functional groups into biomolecules, which afterwards react selectively with a 
fluorophore or biomolecular label. 
Aldehydes and ketones functionalities are attractive functional groups in 
bioorthogonal labelling due to their small size. These groups can be introduced into a 
biomolecule through the periodate oxidation of N-terminal serine residues,[71] 
transamination,[72] or carbohydrate oxidation with periodate.[73] Under the mild 
acidic conditions (pH = 5 ∼ 6), carbonyl group reacts with a primary amine to form a 
reversible Schiff base where equilibrium typically favors the free carbonyl form. 
Aldehydes and ketones are virtually inert towards other endogenous groups at 
neutral pH; by condensation with hydrazine and alkoxyamine derivatives they form 
hydrazine- and oxime-type compounds, respectively (Scheme 2.12). 
 
 
Scheme 2.12: Modification of ketones and aldehydes. 
These reactions proceed in mildly acidic condition (pH 6.5) in order to accelerate 
the dehydration step without full protonation of nucleophilic agents. This method is 
chemoselective, though the presence of competing ketone and aldehyde 
metabolites does not allow protein labelling in crude cell lysates.[57] 
The azide group does not occur naturally in amino acids and therefore cannot be 
found in proteins. On the other hand, this group can be incorporated into 
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biomolecules using different synthetic methods. The azide group is small and 
therefore has minimal impact on the substrate. Recently azide groups became very 
popular targets for chemoselective labelling of proteins. Among the bioorthogonal 
reactions with azides the most widely used are the Staudinger ligation with 
phosphines, copper(I)-catalyzed cycloadditon with terminal alkynes and strain-
promoted cycloaddtion with cyclooctynes.[74] One of the classical applications of 
azides in bioorthogonal labelling is the Staudinger ligation with triphenylphosphines 
(Scheme 2.13).[75] 
 
Scheme 2.13: Chemoselective modification strategies targeting non-native functional groups. 
The Staudinger-Ligation is a variation of the classical Staudinger-reduction. As 
shown in Scheme 2.14, the substitution of aryl substituents of the phosphine (1) with 
ester functionality results in the formation of aza-ylide intermediate (2), which 
undergoes the intramolecular amineformation (3) releasing the methanol molecule. 
The subsequent hydrolysis results in formation of the ligation product 4, which 
contains phosphanoxid unit. 
This method found its application in many biological systems. Bertozzi et al. 
engineered the surface of Jurkat cells with azide functional group, and subsequently 
rendered the cell surfaces with biotin using Staudinger ligation method.[75] 
Furthermore, Staudinger ligation has been used for enrichment of glycoprotein in 
the cell lysates,[76] addition of new functionalities to proteins and biological 
systems,[77] for attachment of fluorescent marker[78] and detection of active 
proteasome in living cells.[79] Staudinger ligation is a very good method to modify 
biomolecules under mild conditions; the reaction proceeds with high chemo-
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selectivity. Naturally, it has some disadvantages, like oxidation of phosphine in air or 
by metaboilic enzymes, which can be avoided by using an excess of phosphine 
reagent. Another disadvantage is a slow reaction rate. [80]  
 
Scheme 2.14: The Staudinger-Ligation. 
Another application of azide groups is a [3+2] cyclization reaction with acetylenes 
to yield triazoles, which was described by Huisgen more than four decades ago.[81] 
Usually the classical reaction proceeds termally, but the reaction with the terminal 
alkynes can be accelerated using copper salts (Cu-catalyzed azide-alkyne 
cycloaddition CuAAC). This CuI-catalyzed azide-alkyne 1,3-dipolar cycloaddition 
reaction, now known as “click chemistry”, proceeds extremely efficiently under 
physiological conditions at neutral pH.  
Click chemistry found ample application on fast reaction kinetics and tolerance of 
other functional groups. It has been used in virus surface remodelling,[82] 
immobilization of nucleic acid and selective protein modification.[83] The main 
advantage of click chemistry is its fast rate, though application of this method is 
limited due to cytotoxicity of copper.[56] For this reason several metal-free 
azidealkyne cycloaddition methods have been developed.[84] Bertozzi et al. used the 
ring strain present in cyclooctyne to accelerate the reaction with azide at room 
temperature (Scheme 2.14).[56] 
About four decades ago, Huisgen and co-workers reported a photoactivated 1,3-
dipolar cycloaddition reaction between 2,5-diphenyltetrazole and methyl crotonate. 
[85] According to the proposed reaction mechanism the diaryltetrazole undergoes a 
facile cycloreversion reaction upon photoirradiation to release a nitrogen molecule 
and generate in situ a nitrileimine dipole which then cyclizes spontaneously with an 
alkene dipolarophile to afford a pyrazoline cycloadduct (Scheme 2.15). 
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Scheme 2.15: Photoinduced cycloaddition reaction. 
Further studies showed that this photoinduced cycloaddtion can be applied as 
well to modify the tetrazole-containg proteins. Because the terminal alkenes do not 
exist in live systems, this photoclick chemistry has a high degree of bioorthogonality. 
The main advantage of this method is that it is light induced (allows the control over 
the reaction initiation) and mild conditions.  
2.6.2 Enzymatic labelling 
In comparison with chemical labelling methods, enzymatic labelling has several 
advantages. They are usually fast, efficient and more selective, rendering them good 
candidates for application in vivo and in vitro. Among the disadvantages is their 
bulkiness or application of a large polypeptide tag, which can result in changing of 
biological properties of the target molecule. Enzymatic labelling also proceeds with 
lower yields in comparison to chemical labelling.[74] 
In general there are two basic types of enzymatic labelling. In first case, the 
enzyme acts as a catalyst (for example, Transglutaminase), and in the second case, 
the enzyme undergoes self-modification before labelling the target protein. 
Labelling catalysed by post-translational enzyme modification 
Transglutaminases also known as TGases are widely used as catalyst for the 
fluorescent labelling of cells by forming an isopeptidebond between Gln and Lys 
residues.[86] During the reaction an acyl group is transferred from -carboxamide 
group of a glutamine residue of a biomolecule to the -amino group of a lysine 
residue, which is connected to the fluorophore. A new -(-glutamyl)lysine 
isopeptide connection between the protein and a fluorescent marker is formed 
(Scheme 2.16).[74] 
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Scheme 2.16: 1 Enzymatic labelling of protein catalysed by transglutaminase.
[87]
 
Sortase Enzyme with transpeptidase activity is used to label proteins with 
fluorescent marker connected to an amine group. The main task of sortase is to 
anchor important cell surface proteins to peptidoglycans as a part of the cell wall of 
gram-positive bacteria. The enzyme catalyzes hydrolysis of the peptide bond 
between Thr and Gly and formes consequently a new peptide bond between the 
carboxyl group of the Thr and amine residue of penta- or tri-glycine (Scheme 2.17). 
Enzymatic fluorescent labelling using sortase as a catalyst allows site-specific 
labelling of the biomolecule, though only at the C-terminus of the target molecule. 
 
Scheme 2.17: Enzymatic labelling of protein catalysed by sortase.
[87]
 
Labelling with self-modified enzymes. 
Cutinase is a serine esterase with the native activity of cutin. During the 
fluorescent labeling, an alkyl phosphonate, which is connected to a fluorescent 
marker, forms a covalent adduct with cutinase on conjugation with the Ser residue in 
the enzyme active site. The mechanism of this process is the following: at the 
beginning the target molecule is fused to cutinase and afterwards the fused 
molecule couples with p-nitrophenyl phosphonate, which is connected to a 
fluorophore (Scheme. 2.18). Enzymatic labelling using cutinase is widely applied for 
targeting proteins, which are immobilized on a self-assembled monolayer.[88] This 
method also has some drawbacks, the first of which is the large size of cutinase 
itself, which limits the labelling of small proteins. Also there is a possibility that after 
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cutinase is fused with the biomolecule it may change the biological activity of the 
target protein.[74] 
 
 
 
Scheme 2.18: Labelling with self-modified enzymes. 
Inteins are segment of a protein that are expressed in frame with flanking N- and 
C-terminal polypeptides (exteins) and are engineered to carry out selective labeling 
in the protein segments (Scheme 2.11). Intein is able to join the remaining portions 
(the exteins) with a peptide bond during the process known as protein splicing.[89] 
The mechanism of this native chemical ligation was described before (See Chap. 
2.6.1). The main advantage of this process is the site specificity and the lack of non-
specific labelling, though it cannot be used to label the loops inside the protein.[74] 
2.7 Pd-catalyzed cross-coupling reactions 
The 2010 Nobel Prize in Chemistry to Richard Heck, Ei-ichi Negishi[90] and Akira 
Suzuki[91] was a significant event in the world of chemistry. Their discoveries started 
a new chaper in the field of palladium-catalyzed cross-coupling reactions. Nowadays 
palladium-catalyzed cross-coupling reactions are still attractive in different fields of 
research both in academic research and in industry. 
The general mechanism is shown in Figure 2.20.[92] The first step – oxidative 
addition of the aryl halide (or pseudohalide) to the catalytically active LnPd
0 species – 
is the same in case of both coupling reactions. In case of Mizoroki-Heck coupling, the 
reaction proceeds by coordination of an alkene to the PdII and consequent syn 
migratory insertion. The regioselectivity depends usually on the nature of the alkene, 
the catalyst, and the reaction conditions. The formation of the alkene product occurs 
through syn-β-hydride elimination; LnPd
0 catalyst is regenerated by subsequent base-
assisted elimination. In the Negishi and Suzuki-Miyaura reactions (as well as related 
Corriu-Kumada, Stille, and Hiyama couplings) after oxidative addition occurs, 
transmetalation of an organometallic species and PdII intermediate with two organic 
coupling partner fragments is generated. During the following reductive elimination 
a new C-C bond is formed and Pd-catalyst is regenerated.[93] 
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Figure 2.20: General mechanism for Palladium-catalyzed cross-coupling reactions. 
The interest towards these reactions is incredible. As a result many Pd-catalyzed 
reactions have been developed which require milder conditions and lower amount 
of calatyst, using more efficient catalytic systems, as well as different ligands. Today 
palladium-catalyzed reactions play a major role in modern organic synthesis. The 
idea of applying this type of reactions on the living systems as well is very 
fascinating, though Pd-catalyzed modifications on proteins were not widely spread. 
The success of CuAAC reactions on protein stimulated the use of the Pd-chemistry, 
as well. [94]  
Pd-catalyzed protein biorthogonal labelling 
The application of palladium-catalysts in investigations of biological processes has 
seen fast growth in the past few years. The first reactions suffered from harsch 
conditions, low yields, and lack of bioorthogonality. In recent years great progress 
has been made in this field. In 2007, Yokoyama et al. used for the first time 
Pd(OAc)2-triphenylphosphine-3,3’,3’’-trisulfonate complex for Sonogashira coupling 
reaction between the iodophenylalanine-encoded Ras protein and propargylic biotin 
to yield the desired product with 25% yield.[95] Francis and co-workers managed to 
label a tyrosine residue using the -allyl palladium complex, though with only 30% 
yield. [96] Schultz et al. were the first to perform the Suzuki cross-coupling on 
biosynthetic proteins.[97] The biggest disadvantage of this reaction were high 
temperature (70 °C) and low yield (around 30%), limitating its wide application. 
With the discovery of an effective ADHP (2-amino-4,6-dihydroxypyrimidine, L2)-
based catalyst system [Pd(OAc)2(L2)2] full conversion has been achieved between an 
aryl iodide group incorporated into the protein with different aryl-/vinyl-boronic 
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acids.[98] Chen et al. reported a ligand free Sonogashira-coupling reaction for 
fluorescent labelling of protein. They used Pd(NO3)2 which was able to catalyse the 
cross-coupling between alkyne-encoded GFP and rhodamine-conjugated phenyl 
iodide.[94] Due to high efficiency, chemoselectivity and biocompatibility, the cross-
couplings found broad application in protein modifications and labelling. Though 
only few of them have so far proved to work under living conditions. 
Davis et al. used Pd-cross coupling reactions in conjugation with “tag and modify” 
stragedy to label an outer membrane of protein. By metabolic and genetic 
incorporation they obtain bacterial strain with four “tags” with good accessibility. 
They managed to label the bacteria with boronic acid-functionalized fluorescein 
(BAF) via Suzuki-Miyaura cross-coupling reaction (Figure 2.21).[99] 
 
Figure 2.21: Palladium-catalyzed cross-coupling labelling of living Gram-negative bacterial cells.
[81]
 
Good results promoted further investigations and optimizations of these 
reactions. Lin et al. developed water-soluble [Pd(OAc)2(L3)2] complex to catalyse the 
copper-free Sonogashira coupling reactions on the living cell (Figure 2.21). All these 
results clearly show that cross-coupling reactions can be readily used on the living 
cells, since they require mild conditions, are biorthogonal and give the desired 
transformations in high yields. The main advantages of these methods are (a) high 
tolerance of the functional groups, (b) less toxicity, (c) chemical bioorthogonality, (d) 
air- and moisture-stable ligands allow to conduct reactions without inert atmosphere 
and water-free solvents, (e) irreversibility of the reactions. 
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2.8 Pd-catalyzed allylic alkylation reactions 
Besides the known labelling methods of N- and C-termini which were discussed 
above, in the group of Prof. Kazmaier[19] a labelling method of the peptide backbone 
through Palladium-catalyzed allylic alkylation reaction was developed. 
For many years the group of Prof. Kazmaier has been concentrated on the 
stereoselective synthesis of amino acids. The main target are chelated ester enolates 
of amino acids that can be used as highly reactive nucleophiles in C-C-bond 
formation reactions like esterenolate Claisen-Rearrangement, Aldol reaction or 
Michael addition, as well as Palladium-catalyzed allylic alkylation reaction, which 
gives the ,-unsaturated amino acids with high regio- and stereoselectivity. 
The biggest advantage of these reactions is the formation of C-C, C-O, C-N and C-
S-bonds, as well as mild conditions and tolerance of many functional groups. Among 
them is the Palladium-catalyzed allylic alkylation reaction or the Tsuji-Trost 
reaction.[100,101] The Tsuji-Trost reaction involves an allylic substrate with a leaving 
group. The mechanism of the reaction is as follows[102]: in the first step the double 
bond of the allylic substrate coordinates on Pd(0)-complex forming a 2-Olefin-
Palladium complex A. The further oxidadive addition of Palladium to the allylic C-X 
bond (X = carboxylate, carbonate, halogenid, phosphate, etc.) results in formation of 
3-Allyl-Palladium(II)-complex B, which is usually neutral. In the next step through 
the exchange of anionic ligands X with the neutral ligands L (for instance, 
phosphine), the positively charged complex C (3- complex) is formed, which due to 
its electrophilic nature can react with different nucleophiles. As a result of reductive 
elimination 2-Olefin-Palladium complex D is built again. After its dissociation 
Palladium-catalyst is regenerated. 
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Figure 2.22: Mechanism of Palladium-catalyzed allylic substitution.  
Regioselectivity in allylic substitution 
Monosubstituted allyl substrates A, B and C are the most interesting substrates 
for allylic substitution (Scheme 2.19). In the course of the substitution they give rise 
to following regioisomers D, E and F. The control of the regioselectivity in these 
types of reactions is very important. In the formation of the regioisomer E as well as 
enantioselectivity should be considered. 
 
Scheme 2.19: Transition metal-catalyzed allylation with monosubstituted substrates. 
There are different ways of controlling the regioselectivity of allylic substitution. 
The most important is the choice of transition metal catalyst. Furthermore, 
electronic and/or steric properties of the transition metal can be controlled by 
application of certain ligands or additives. 
Generally three different possibilities can be observed in regioselectivity: 
1. Formation of linear products is favoured: Pd,[103] (Ru,[104] Fe).[105] 
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Linear and branched allyl substrates, A and B, give rise to a linear product D 
(Scheme 2.20); 
2. Formation of branched products is favoured: Ir,[106] Rh,[107] Ru,[108] Mo,[109] W,[110] 
(Pd).[111] 
In course of a reaction with linear and branched allyl substrates, A and B, the 
branched product E is formed preferably (Scheme 2.20); 
3. Regioretention (regiochemical Memory-Effect): Rh,[112] Ru,[113] Fe,[114] (Pd,[115] Ir). 
[116] 
The nucleophile attacks from the side of the leaving group. Linear substrate A 
gives the linear product D and branched substrate B results in formation of the 
branched product E (Scheme 2.21).[117] 
 
Scheme 2.20: Regioselectivity in transition metal-catalyzed allylic substitutions.
[117] 
 
Scheme 2.21: Regioretention in transition metal-catalyzed allylic substitutions.
[117]
 
The backbone labelling via palladium-catalyzed allylic alkylation. 
In the work of L. Wirtz[19] a new method for fluorescence labeling of amino acids 
and peptides was developed. This labeling technique of the peptide backbone is 
based on the palladium-catalyzed allylic substitution reaction. Different fluorescent 
labels with allylcarbonate side chain based on 7- aminocoumarin (Figure 2.23) were 
synthesized using Titan-catalyzed Pechmann condensation reaction.  
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Figure 2.23: Coumarin-based fluorescent labels for allylic alkylation reactions. 
The synthesized allyl carbonate labels were applied for fluorescence labeling of 
TFA-glycine-tert-butyl ester. The palladium-catalyzed allylic alkylation proceeded in 
moderate to good yields. The allylation with 7-aminocoumarin labels 1 and 2 
resulted in the formation of two regioisomers 5, 6, 7 and 8 (Scheme 2.22), while 
while 7-methoxycoumarin labels 3 and 4 gave rise to only one regiosomer 9 and 10, 
respectively (Scheme 2.23). 
 
Scheme 2.22: Backbone labelling through palladium-catalyzed allylic alkylation with fluorescent dyes 
1 and 2. 
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Scheme 2.23: Backbone labelling through palladium-catalyzed allylic alkylation with fluorescent dyes 
3 and 4. 
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3 
 
Results and 
Discussion 
 
3.1 The aims of the thesis 
In recent years labelling reagents (dyes and fluorophores) became an essential 
component for the detection of biomolecules. With the development of fluorescent 
spectroscopy, fluorescent labelling has been employed in a variety of areas like 
environmental analysis, disease diagnostics, pharmaceutical screening, proteomic 
and genomic studies.[49] 
Green fluorescent protein (GFP) was the first fluorescent dye which was 
genetically introduced into the target protein. The main disadvantages of GFP like its 
size and limited windows of fluorescent spectra do not allow its wide application in 
fluorescent labelling techniques. Contrariwise, synthetical dyes are smaller in size, do 
not usually have any effect on the target compound, often possess improved 
photochemical properties, as well as offer a wide range of colours. For this reason a 
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lot of investigations have been done for the development of new fluorescent dyes 
(Chap. 2.3) and the synthetic work is still ongoing. Coumarins with an electron-
donating subtituent at 7-position are characterized by strong fluorescence. For 
instance, 7-aminocoumarins reveal strong fluorescence, low pH-dependence, they 
are active at a wide pH range, as well as exhibit high fluorescence intensity and 
excellent fluorescent quantum yield.[118] 7-dialkylaminocoumarins and derivatives 
were synthesized in the group of Prof. Kazmaier with good yield and were further 
used for bioorthogonal labelling of amino acids and peptides (Chap. 2.8).[19] 
Encouraged by previous results, we decided to continue investigations in this 
area. Therefore the aims of the presented thesis were: 
1. Synthesis of further 7-dialkylaminocoumarin and its derivatives; 
2. Study their application in bioorthogonal labelling of biomolecules. 
 
The possible sites for the bioorthogonal labelling are N-/C-termini, as well as the 
backbone of the peptide (Figure 3.1). The methods chosen for the studies were: 
1. C-C cross-coupling reactions, for instance Sonogashira, Suzuki-Miyaura, Stille 
couplings.[152]  
2. Buchwald-Hartwig C-N coupling under CO-insertion 
3. Michael addition with different nucleophiles, amines and thiols, as well as C-
nucleophiles. 
4. Pd-catalyzed allylic alkylation.[19] 
 
Figure 3.1: Possible sites of the protein for fluorescent labelling. 
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3.2 Synthesis of 7-dialkylaminocoumarin 
Among the different methodologies developed for the synthesis of coumarins 
(Chap. 2.3), the most important and popular is the Pechmann reaction,[119] which is 
based on condensation of phenols with malonates or β-oxo esters in the presence of 
strong acids, such as H2SO4. Though application of strong acids in the synthesis of 
aminocoumarins is limited because of protonation of the amino group and therefore 
deactivation of the aromatic system.[33] 
For the development of new aminocoumarins the work started with the synthesis 
of β-ketoester, which was performed according to the method developed by 
Hashiguchi (Scheme 3.1).120 4-pentenoic acid was activated with cabonyldiimidazole 
(CDI) to form a mixed anhydride. The attack of the released imidazole on the mixed 
anhydride results in the formation of an imidazolide, which was converted by action 
of a magnesium chelated monomethylmalonate and subsequent elimination of CO2 
to the β-keto ester 1. 
 
Scheme 3.1: Syntheis of β-keto ester from 4-pentenoic acid according to Hashiguchi.
[120]
 
For the synthesis of the aminocoumarin scaffold the Pechmann-condensation was 
applied and different reaction conditions were screened.  S. Frère et al reported that 
the synthesis of aminocoumarin using concentrated sulfuric acid as a catalyst does 
not proceed smoothly.[121] As it was expected no product could be isolated in the 
first experiment (table 1, entry 1). Therefore, milder conditions were chosen and 
instead of strong Broensted acids, Lewis acids were employed as catalyst. The 
reaction was allowed to reflux in toluene overnight in the presence of 5 mol% 
Bismuthchloride[122] (Entry 2), though only traces of the fluorescent product could be 
observed. Kazmaier et al.[33] could isolate 7-dialkylaminocoumarins in almost 80% 
yield with 2 eq. of Ti(OiPr)3Cl. Under these conditions the target product was isolated 
only in 25% yield and a significant side reaction was observed – the 
transesterification of the keto-ester. Titanalkoxides are widely known as good 
catalyst for transesterification reactions.[123] In synthesis of 7-diethylaminocoumarin 
derivative  J. Burkhart[157] observed as well the formation of the side product. 
Furthermore the condensation was performed at room temperature and at 60 °C 
(entries 4 and 5) but in none of the cases the formation of the target compound was 
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observed. The ammonium metavanadate[124] catalysed reaction yielded only traces 
of the desired product (entry 6 and 7). Also Ti(OiPr)4 as catalyst did not give any 
satisfying results (entry 8). 
Microwave accelarated condensations (30 min, 90 W, 130 °C) with 75 wt.-% 
montmorillonite and 4-5 drop conc. H2SO4, respectively (entries 9 and 10) did not 
afford the target coumarin 2. Ti(OiPr)3Cl (entry 11) yielded 2a as a main product 
(65% yield) and only 15% of 2 could be isolated. Bismuth chloride afforded only 
traces of the desired compound. 
Table 3.1 Synthesis of 7-diethylaminocoumarin via Pechmann-condenstion reaction: 
 
 Catalyst Conditions Yield [%] 
1 1.0 eq. conc. H2SO4 1 h, 75 °C --- 
2 5 mol-%. BiCl3 on, 130 °C, toluene traces 
3 2.0 eq. Ti(OiPr)3 Cl on, reflux, toluene 25 (2)/ 65 (2a)  
4 2.0 eq. Ti(OiPr)3 Cl on, rt, toluene --- 
5 2.0 eq. Ti(OiPr)3 Cl on, 60 °C, toluene --- 
6 10mol% NH4VO3 on, 60 °C, toluene traces 
7 10mol% NH4VO3 on, reflux, toluene traces 
8 1.0 eq. Ti(OiPr)4 on, reflux, toluene --- 
9 75 wt.-% Montmorillonite 30 min, 90 W, 130 °C --- 
10 4-5 drop conc. H2SO4 30 min, 90 W, 130 °C --- 
11 2.0 eq. Ti(OiPr)3Cl 30 min, 90 W, 130 °C 25 (2)/ 65 (2a)  
12 10 mol-%. BiCl3 30 min, 90 W, 110 °C traces 
 
Since all the methods applied could not provide a preparative ammount of the 
coumarin 2 for further modifications, 4-hydroxy-7-diethylaminocoumarin 4 was 
prepared according to a reported procedure.[125] As shown in scheme 3.2 malonic 
acid was converted to the activated bisphenylester 3, which was subsequently 
condensed with commercially available 3-diethylaminophenol. Unfortunaly only 30% 
of the target molecule could be isolated probably due to an intramolecular 
condensation as a side reaction.  
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Scheme 3.2: Synthsis of 4-hydroxycoumarin 4. 
In order to avoid the formation of this side product trisubstituted phenol 5 was 
used to form activated bis(2,4,6-trichlorophenyl) ester 5, which after condensation 
and purification furnished the target compound 4 in 70% yield. Analytically pure 
compound was applied directly for further modifications. 
 
Scheme 3.3: Syntheis of 4-hydroxycoumarin 4. 
3.3  Modifications of 4-hydroxy-7-diethylaminocoumarin 
As it was discussed in the introduction (Chap. 2.6.1) for the design and synthesis 
of fluorophores it is important to include a functional group which is capable of 
creating selectively a covalent bond with a target molecule. For further modifications 
of 4-hydroxy-7-diethylaminocoumarin 4, it was subjected to allylation reactions and 
to studies towards the development of a methodology for selective O-allylation, as 
well as C-allylation in 3-position. 
In the first test reaction a protocol described for 4-hydroxycoumarin[126] (Table 
3.2, entry 1) was applied. Due to high C-H acidity of position 3 only 34% of the O-
allylated compound were obtained and traces of the mono C-allylated product. As a 
main product C-diallylated coumarin was isolated. In THF as solvent the formation of 
the same compounds (entry 2) was observed. NaH as a base provided a mixture of all 
three products (entry 3). 
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Table 3.2 Allylation of aminocoumarin 4: 
 
 Base Solvent Yield Product 
A [%] 
Yield Product 
B [%] 
Yield  Product 
C [%] 
1 K2CO3 Acetone 34 traces 56 
2 K2CO3 THF 15 traces 70 
3 NaH DMF Mixture of all three products (TLC control) 
Since the conditions employed above could not provide selective allylation, 
palladium-catalalyzed alkylations were applied, using allylpalladium chloride dimer in 
combination with triphenyphosphine as a ligand (Table 3.3). The test experiments 
were performed under microwave irradiation. Reactions carried out in THF as a 
solvent, at room temperature and 60 °C, respectively, yielded only traces of C-
monoallylated product (entries 1 and 2). Dimethylformamide at 80 °C gave similar 
results (entry 3). The addition of K2CO3 as a base for deprotonation changed the 
reaction course drastically, yielding 84% of the target molecule 7. The same reaction 
was upscaled and performed overnight at 90 °C furnishing the C-monoallylated 
product in 87% yield. 
Table 3.3 Palladium-catalalyzed alkylation of 4: 
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 Base Solvent Conditions Product Yield 
1 ----- THF 
25 °C, 90W, 15 
min 
C-monoallylated product + 
Starting material 
Traces 
2 ----- THF 
60 °C, 90W, 30 
min 
C-monoallylated product + 
Starting material 
Traces 
3 ----- DMF 
80 °C, 90W, 30 
min 
C-monoallylated product + 
Starting material 
Traces 
4 K2CO3 DMF 
90 °C, 90W, 30 
min 
C-monoallylated product 84% 
5 K2CO3 DMF 90 °C, overnight C-monoallylated product 87% 
 
O-allylations with high selectivity under Mitsunobu conditions using PPh3 in 
combination with either diethyl azodicarboxylate (DEAD) or 1,1’-
(azodicarbonyl)dipiperidine (ADDP) were reported by Jacobsen et al. [127] Following 
this methodology, it was possible to isolate the target O-allylated molecule 8 in 89% 
yield (Scheme 3.4). 
 
 
Scheme 3.4: O-allylation under Mitsunobu conditions. 
Unfortunately, further attempts of oxidative cleavage of the allylic double bond to 
yield the corresponding aldehydes did not afford the desired compounds (Scheme 
3.5). No formation of product 9 was observed, and compound 10 decomposed the 
following day.  
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Scheme 3.5: Studies towards the oxidative cleavage of the allylic double bonds of compounds 7 and 8. 
3.4 Pd-catalyzed cross-coupling reactions 
In modern synthetic chemistry the application of transition metall-catalyzed-
coupling reactions has grown incredibly in the past few years.[90,91,128] During the last 
two decades they have been also widely used for bioorthogonal labelling of 
biomolecules.[99] These reactions usually proceed under mild conditions and tolerate 
many functional groups (Chap. 2.7). 
In order to incorporate such a functional group which would be appropriate for 
different types of cross-coupling reactions, 4-hydroxycoumarin 4  was transferred 
into a triflat according to a reported methodology[129] using trifluoromethane-
sulfonic anhydride (Scheme 3.6), which gave the functionalyzed coumarin 12 in 90% 
yield. It should be mentioned, that the yield depends highly on the quality of 
anhydride. Only newly purchased reagent provided high yields.  
 
Scheme 3.6: Synthesis of 7-diethylamino-4- trifluoromethylsulfonyloxy-coumarin 12. 
Vinyl triflate 12 was employed in different cross-couplings as possible labelling 
methods of amino acids and peptides. In Figure 3.2 possible residues for cross-
coupling reactions are depicted. 
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Figure 3.2: Possible sites for Pd-catalyzed cross-coupling labellings. 
3.4.1 Suzuki-Miyaura coupling 
Among naturally occurring coumarins, 4-arylcoumarins (neoflavones) are an 
important class of flavonoids, which possess a wide range of pharmacological 
activities[130], like anticancer,[131] antimalarial,[132] antibacterial[133] and cytotoxic 
activities.[134] Classically, these compounds are synthesized by condensation of 
phenols with carbonyl compounds. Arylations of coumarin using Suzuki-Miyaura 
coupling have been recently reported.[135] In a one-pot reaction of 4-trifluoromethyl-
sulfonyloxy-6-bromocoumarin with various arylboronic acids 4-arylcoumarins could 
be isolated in high yields.[129] Davis et al. reported about the labelling of bacteria 
with boronic acid-functionalized fluorescein (BAF) via a Suzuki-Miyaura cross-
coupling reaction (Figure 2.21).[99] Since boronic acid residue can also be 
incorporated into biomolecule,[136] the Suzuki-Miyaura coupling was applied as one 
of the labelling methods. 
The reactions were performed in toluene at reflux overnight using K2CO3 as a base 
and tetrakis(triphenylphosphine)palladium(0) catalyst. Different boronic acids were 
screened. The results are summarized in the table 3.4. The yields in all cases were 
close to quantitative. The low yield in case of (2,4,6-trimethylpyridin-3-yl)boronic 
acid can be explained by its bulkiness. 
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Table 3.4 Suzuki-Miyaura reactions with fluorescent marker 12: 
 
 
 Boronic acid Product Yield [%]  
1 3-nitrophenylboronic acid 13 89% 
2 p-tolylboronic acid 14 93% 
3 (2,4,6-trimethylpyridin-3-
yl)boronic acid 
15 40% 
4 (4-chlorophenyl)boronic acid 16 94% 
5 (4-fluorophenyl)boronic acid 17 89% 
6 4-methoxyphenylboronic acid 18 95% 
7 phenylboronic acid 19 quant. 
 
The Suzuki-Miyaura coupling was performed as well under CO atmosphere (15 
bar), what afforded only 26% of the target molecule 20. As a main product was 
isolated the direct coupling compound 19. 
 
Scheme 3.7: Suzuki-Miyaura coupling with CO-insertion. 
3.4.2 Sonogashira coupling 
Another transition metal-catalyzed cross-coupling, which became a powerful tool 
in organic synthesis and has been used as a new labelling method of biomolecules, is 
the Sonogashira coupling reaction (Chap. 2.7). A test reaction was performed with 
propargylic alcohol under standard conditions reported.[137] The coupling proceeded 
smoothly affording strong fluorescenting alcohol 21 in almost quantitative yield 
(Scheme 3.8). 
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Scheme 3.8: Sonogashira coupling reaction with propargylic alcohol. 
 
Encouraged by this result it was decided to apply this methodology for further 
direct labelling of several amino acids, as well as peptides. For this reason it was 
necessary to modify the side chain of amino acids by incorporation of a propargylic 
residue. 
Synthesis and fluorescent labelling of amino acids and peptides with 
propargylic residue 
Serine and tyrosine amino acids that are famous targets for bioorthogonal 
labelling (Chap. 2.6.1) were chosen for further modifications, which were performed 
according to the scheme 3.9. The desired propargylic ether of serine 23 could be 
isolated in 70% yield. 
 
 
Scheme 3.9: Propargylation of Boc-serine. 
 
The propargylation of Boc-protected tyrosineester 24 furnished the desired ether 
25 in 98% yield (Scheme 3.10): 
 
 
Scheme 3.10: Propargylation of Boc-tyrosine. 
After these modifications the amino acid ethers 23 and 25 were subjected to 
Sonogashira coupling with the target fluorescent marker 12. In both cases the 
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couplings proceeded smoothly furnishing the desired labelled compounds 26 and 27 
in excellent yields (Scheme 3.11). 
 
 
Scheme 3.11: Fluorescent labelling of Boc-Tyr 25 and Boc-Ser 23 via Sonogashira coupling. 
Since the labelling of amino acids gave very good results, this methodology was 
applied furthermore for labelling dipeptide 28 and tripeptide 30, which were 
previously synthesized and successfully used in cupfer-catalyzed click reactions by L. 
Wirtz[19]. The desired labelling was achieved after 1 hour under standard conditions 
yielding 29 and 30 in very good yields (Scheme 3.12). 
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Scheme 3.12: Fluorescent labelling of dipeptide and tripeptide via Sonogashira coupling reaction. 
Synthesis of peptides via Ugi-reaction using 4-(propargyloxy)-
benzaldehyde 
The Ugi reaction is a multi-component reaction (MCR) involving an aldehyde, an 
amine, an isocyanide and a carboxylic acid to form a dipeptide. It is named after Ivar 
Karl Ugi, who first published this reaction in 1959.[138] MCRs are one-pot reactions 
which the allow synthesis of complex molecules from relatively simple precursors. A 
proposed mechanism of this process is shown in Scheme 3.13. In the first step 
aldehyde b condenses with amine a forming imine c, a Schiff base. Afterwards the 
acid component d protonates the nitrogen atom of imine c, therefore increasing the 
electrophilicity of the C=N bond. The electrophilic iminium ion and the nucleophilic 
acid anion add to the carbon atom of isocyanide forming adduct h, which after the 
Mumm rearrangement forms a stable Ugi product i. 
 
Scheme 3.13: Mechanism of the Ugi-MCR.  
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The synthesis of peptides under Ugi conditions was performed using an aldehyde 
with a propargylic residue. Benzaldehyde was modified according to the literature 
procedure in 95% yield (Scheme 3.14).[139] 
 
 
 
Scheme 3.14: Propargylation of benzaldehyde. 
The Ugi multi-component reaction was performed in DCM at 0 °C using benzyl 
amine, ethyl isocyanoacetate and several Boc-protected amino acids.[140] The target 
peptides 33-35 were isolated in 58-75% yield, respectively.  After chromatographical 
purification they were directly subjected to coupling with 4-trifluoromethyl-
sulfonyloxy-7-diethylamino-coumarin 12. The labelled compounds 36-38 were 
formed in excellent yields. The results are summarized in Table 3.5. 
Table 3.5 Ugi reaction with subsequent coupling: 
 
 
R Product 
Yield [%], Ugi 
reaction Product 
Yield [%], 
Sonogashira 
reaction 
1 H 33 65 36 92 
2 Me 34 60 37 90 
3 Bn 35 58 38 91 
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3.4.3 Studies towards the biolabeling with coumarine derivatives through 
cross-coupling with CO-Insertion 
Besides the above described direct C-C-couplings it should be possible as well to 
perform the coupling of diethylaminocoumarin 12 with different nucleophiles 
through Buchwald-Hartwig C-N cross-coupling with CO-Insertion (Figure 3.3). 
 
 
Figure 3.3: Labelling amino functionality through Buchwald-Hartwig C-N cross-coupling. 
Initally MeOH was selected as simplified nucleophilic cross-coupling partner for 
triflate 12. Treatment of coumarine derivative 12 with catalytic amounts of Pd(PPh3)4 
in methanol under 1 atm of CO provided the desired methylester 39 in only 13% 
yield (table 3.6, entry 1). In DMF as solvent with stoichiometric amounts of MeOH 
only small traces of the cross coupling product 39 were observed (entry 2). With 
Pd(OAc)2 and PPh3 as precursor for the catalytically active species in MeOH/DMF 1:1 
no conversion of the starting triflate occurred (entry 3). In entry 1-3 mostly 
unreacted starting material 39 was reisolated. However, increasing the CO-pressure 
to 15 bar afforded the ester 39 in 70% isolated yield (entry 4). 
Table 3.6 Buchwald-Hartwig cross-coupling with MeOH under CO-atmosphere: 
 
 
 Solvent Conditions  Catalyst  Yield 
1 abs. methanol 
room 
temperature 
2h, CO (1 bar) 
6 mol% 
Pd(PPh3)4 
13% product + 
starting material 
2 
abs. DMF 
2 eq. methanol 
room 
temperature 
CO (1 bar) 
6 mol% 
Pd(PPh3)4 
traces of the product, 
starting material 
3 
abs. methanol 
abs. DMF 
40 °C, 12h 
CO (1 bar) 
0.1eq Pd(OAc)2 
0.2eq PPh3 
no product formation 
starting material 
reisolated 
4 abs. methanol reflux 10 mol% 70% 
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abs. toluene (1:6) CO (15 bar) Pd(PPh3)2Cl2 
Fortunately, under the optimized conditions of the cross-coupling with MeOH 
(table 3.6, entry 4, in toluene as a solvent) various amines could be utilized as 
nucleophiles to give the aspired amides 40-48 in good to excellent yields (table 3.7). 
Several hydrochloride salts of amino acid and dipeptide esters delivered the 
coumarine labeled derivatives 40-44 (entry 1-5). Moreover different amines and 
anilines served as excellent coupling partners for triflate 12 (entries 6-9). 
Table 3.7 Cross-coupling reactions with different nucleophiles under CO-atmosphere: 
 
 
 Nucleophile Product Yield [%] 
1 GlyOMe . HCl 40 86% 
2 AlaOMe . HCl 41 71% 
3 PheOMe . HCl 42 75% 
4 LeuOMe . HCl 43 62% 
5 PheGlyOMe . HCl 44 70% 
6 Benzylamine 45 83% 
7 Aniline 46 78% 
8 Cyclohexylamine 47 92% 
9 Anisidine 48 quant 
Surprisingly, more nucleophilic amines (e.g. morpholine) provided enamines of 
type 49 without CO-insertion. Indeed even in the absence of a Pd-catalyst the 
enamine 49 was formed in an excellent yield. Therefore, the (transition metal-free) 
conjugate substitution (Michael addition + elimination of TfOH) leading to 49 must 
be significantly faster than the Buchwald-Hartwig amination including CO-Insertion 
giving 49 in 95% yield (Scheme 3.15). 
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Scheme 3.15: Buchwald-Hartwig amination. 
One of the amino acids, namely LeuOMe hydrochloride, was subjected to direct 
substitution in absence of palladium species. Firstly THF was used as a solvent and 
unfortunately after stirring overnight at room temperature no conversion was 
observed (table 3.8, entry 2). Under microwave accelerated conditions at 60 °C 
starting material was reisolated (entry 3), whereas in 10 minutes traces of purple 
fluorescent compound were formed. Furthermore the solvent was exchanged for 
toluene and amino acid refluxed with 12 overnight, what resulted in substitution 
product 50 in 62% yield. 
Table 3.8 Substitution reaction with amino acid: 
 
 
 Solvent Conditions  Catalyst  Yield 
1 abs. toluene 
80 °C 
on, CO (15 bar) 
10 mol% 
Pd(PPh3)2Cl2 
65% 
2 abs. THF 
room 
temperature 
on 
-------------- 
 
starting material 
(TLC monitoring) 
3 abs. THF 
60 °C, 90 W 
1 min 
-------------- 
 
starting material 
(TLC monitoring) 
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4 abs. THF 
60 °C, 90 W 
10 min 
-------------- 
 
starting material + 
traces of purple fluor. 
comp (TLC monitor.) 
5 abs. toluene reflux, overnight -------------- 62% 
Coupling under CO-atmosphere resulted in amide formation and no substitution 
occured (entry 1). It could be visually determined under UV-light whether 
substitution with or without CO-insertion took place. The direct substitution product 
is fluorescing purple, whereas the CO-insertion compound (expansion of the π-
system and shifting towards longer wave), showed yellow fluorescence. 
Various secondary amines were screened under substitution conditions. 
Pyrrolidine and piperidine (table 3.9, entry 1 and 2) yielded the substitution 
compounds in almost quantitative yield, whereas diethylamine, dibenzylamine and 
ephedrine in 68%, 60% and 56%, respectively. The better yields in the case of 
pyrrolidine, piperidine and morpholine can be explained by their stronger 
nucleophilic properties, principally because the lone pair is less hindered due to the 
fixed geometry of the two alkyl “substituents” making the approach to electrophile 
much easier.[141] 
 
Table 3.9 Substitution reaction with different secondary amines: 
 
 
 Nucleophile Product Yield [%] 
1 Pyrrolidine 51 97 
2 Piperidine 52 98 
3 Diethylamine 53 68 
4 Dibenzylamine 54 60 
5 Ephedrine 55 56 
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3.5 Synthesis of fluorescenting  aldehyde 
For the synthesis of fluorescenting aldehyde the Pd-catalyzed coupling with CO-
insertion was applied (Scheme 3.16). Unfortunately aldehyde 56 was not formed 
under these conditions. Apparently compound 12 is not stable in presence of formic 
acid.  
 
Scheme 3.16: Attempt to synthesis of aldehyde 56 via Pd-catalyzed reaction with CO-insertion. 
In the literature it was reported that the palladium-catalyzed formylation of a 
wide variety of organic substrates including vinyl triflates with tin hydride and 
carbon monoxide gave good yields of aldehydes.[142] The authors observed formation 
of a side product as well, which can be explained by two overlapping catalytic cycles 
(Scheme 3.17). In each catalytic cycle first the oxidative addition of a to the 
palladium (0) catalyst occurs to form the alkylpalladium(II) complex b, which under 
CO atmosphere undergoes the carbon monoxide insertion to form the 
acylpalladium(II) complex c. Further transmetallation with tributyltinhydride d gives 
rise to an acylhydridopalladium (II) complex e, which by subsequent reductive 
elimination furnishes the aldehyde and regenerates the palladium(0) catalyst 
(catalytic cycle A). The undesired side product is formed according to the cycle B. In 
competition with the carbon monoxide insertion the palladim(II) complex b 
undergoes transmetalation with tributyltin hydride forming an alkylhydrido-
palladium(II) complex g, which after further reductive elimination forms the reduced 
product and regenerated palladium(0) catalyst. 
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Scheme 3.17: The proposed catalytic cycle. 
 Unfortunately also under these conditions only reduction of the vinyl triflate 
occured (the B catalytic cycle) because the Bu3SnH had to be added slowly in the 
portion. It was impossible to keep the reaction mixture under the CO-atmosphere 
and slowly add tributyltin hydride via syringe (Scheme 3.18). 
 
 
Scheme 3.18: Attempted synthesis of aldehyde 56 via Pd-catalyzed reaction with CO-insertion. 
 In the previous chapter 3.4 was shown that 4-trifluoromethylsulfonyloxy-7-
diethylamino-coumarin 12 is a good candidate for different metal-catalyzed cross-
couplings. Therefore, the vinyl triflate 12 was subjected to Stille coupling with 
vinylstannene using allylpalladium(II) chloride dimer with PPh3 as a ligand,
[143] what 
furnished the desired molecule 58 in 95% yield. It should be mentioned that 58 is 
unstable and undergoes probably photoinduced 1,2-addition reactions. For this 
reason it should be kept under a nitrogen atmosphere and protected from light. The 
subsequent oxidation of the double bond with OsO4 (Lemieux-Johnson oxidation) 
resulted in formation of aldehyde 56 in 60% yield (Scheme 3.19). 
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Scheme 3.19: Synthesis of the aldehyde 56 through Stille-coupling reaction and subsequent oxidation. 
The obtained aldehyde 56 was successfully used in fluorescence labelling of 
Miuraenamide via aldol addition. [144] 
3.6 Labelling backbone of the protein 
Most of the methods known for fluorescent labeling of proteins are based on the 
modification of various side chains and the N- or C- termini (Chap. 2.6.1). In the 
group of Prof. Kazmaier also C-C bond forming reactions (namely Pd-catalyzed allylic 
alkylation and Claisen rearrangement) were successfully applied as possible labeling 
methods of the backbone of a peptide (Chap. 2.8). Based on the previous results, 
further allylic fluorescent dyes were developed and studied their application in Pd-
catalyzed allylic alkylations.  
 
 
Figure 3.4: Labelling backbone of the peptide using Palladium-catalyzed allylic alkylation reaction. 
3.6.1 Fluorescent labelling via palladium-catalyzed allylic alkylation 
For the labelling amino acids or peptides via palladium catalyzed allylic alkylation 
7-aminocoumarins with a terminal allylic side chain were developed. Since the 
methodology developed by L. Wirtz[19] could not be further applied due to the low 
yield of Pechmann condensation (Table 3.1), a different protocol was developed for 
the synthesis of allylic dyes. 
 
Previously synthesized fluorescent alcohol 21 was subjected to hydrogenation in 
the presence of palladium on charcoal delivering the desired product 59 in 
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quantitative yield (Scheme 3.20). Further oxidation of the alcohol 59 to the aldehyde 
60 with Dess-Martin periodinane afforded the fluorescenting compound 60 in good 
yield too. Further Grignard reaction with vinylmagnesium bromide followed by 
esterification furnished the desired allylcarbonate 62. 
 
Scheme 3.20: Synthesis of 7-aminocoumarin 62 with allylcarbonate side chain. 
The aldehyde 60 was furthermore transformed to the trans-α,β-unsaturated 
ketone 63 in 95% yield through Wittig reaction. The ketone 63 was subsequently 
reduced to the racemic alcohol 64 via Luche reduction followed by esterification to 
afford allylic dye 65 (Scheme 3.21). 
  
 
 
Scheme 3.21: Synthesis of 7-aminocoumarin 65 with allylcarbonate side chain. 
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The synthesized allylcarbonate-labels 62 and 65 were subjected consequently to 
palladium-catalyzed allylic alkylation of TFA-glycine-tert-butyl ester as a nucleophile, 
under conditions described by L. Wirtz (Scheme 3.22). Here, the allylic substitution 
reaction again proved to be an excellent method for fluorescent labeling of amino 
acid esters. Both allylic alkylations provided the fluorescently labeled amino acid 
esters 66, 67, 68 and 69 in good yields (around 80%). In reaction with the carbonate 
62 the formation of both - linear and branched products 66 and 67 was observed 
(ratio 60:40), (Scheme 3.22, A). Unfortunately chromatographic separation of the 
two esters 66 and 67 was not possible. The selectivity could only be estimated from 
the 1H-NMR spectra. The reaction of the carbonate 65 (Scheme 3.22, B) also 
provided two regioisomers 68 and 69 with the ratio of 75:25 and again it was not 
possible to separate both isomers during purification. 
Similar observations were made by L. Wirtz in the allylic substitution of TFA-
glycine-tert-butyl ester with allylic fluorescent dyes.[19] In studies of monoalkylated, 
terminal allyl carbonates, such as carbonate 62, and asymmetrically substituted allyl 
carbonates (analog carbonate 65) mixtures of two regiosomers were also obtained. 
[145] In addition, it was shown in studies of F. L. Zumpe that in allylic alkylation the 
anti-diastereomer is formed preferably.[146]  
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Scheme 3.22: Allylic alkylations of TFA-glycine-tert-butylester with 7-diethyl-aminocoumarin-labels 
   62 and 65.  
In order to improve the regioselectivity a fluorescent dye with a shorter allylic 
residue was developed. For the synthesis the previously synthesized aldehyde 56 
(Scheme 3.19) was used, which was subjected to Grignard reaction and subsequently 
converted to allylcarbonate 71 in 60% yield over two steps (Scheme 3.23). 
 
 
Scheme 3.23: Synthesis of 7-aminocoumarin 71 with shorter allylcarbonate side chain. 
The obtained allylcarbonate 71 was subjected to Pd-catalyzed allylic alkylation 
and afforded E-configurated fluorescenting ester 72 in 72% yield (Scheme 3.24). 
Unlike 7-aminocoumarins 62 and 65, allylic alkylation proceeded with the formation 
of only one regioisomer. Compound 71 has two CH2 groups less, what results in 
formation of only one regioisomer, since the branched position of monosubstituted 
π-allyl complex is prevented by the coumarin ring for an attack of the nucleophile.  
 
Scheme 3.24: Allylic alkylation with 7-aminocoumarin label 71. 
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In the work of L. Wirtz shortened 7-methoxycoumarins were subjected to allylic 
alkylation[19]. However, the labeling with 7-diethylaminocoumarin has more 
advantages because aminocoumarins unlike methoxycoumarins exhibit fluorescence 
and excellent quantum yields at physiological pH.[147] In order to detect a 
biomolecule marked with a methoxycoumarin, the methyl group should be first 
cleaved and the resulting alcohol deprotonated at pH > 10. Optimized labelling 
technique can be further applied for di- and tri-peptides. 
3.6.2 Fluorescent allylic label with an expanded -system 
Since 7-diethylaminocoumarins with an allylic carbonate residue gave good 
results in Pd-catalyzed allylic alkylations of the amino acid, further allylic substrates 
with an expanded -system were developed. For the synthesis of allylic dyes 
Sonogarshira coupling with propargylated diol was applied. 
Propargylation of the diol proceeded selectively furnishing the mono-
propargylated compound 73 as the main product in 78% yield. The formation of the 
di-propargylated compound was observed as well (Scheme 3.25). 
 
 
Scheme 3.25: Mono-propargylation of diol. 
The following Sonogashira coupling with vinyl triflate 12 and esterification of the 
formed alcohol provided the new Z-configurated fluorescent label in 87% yield over 
2 steps (Scheme 3.26). 
 
 
 
Scheme 3.26: Synthesis of allylic carbonate label 75 with an expanded -system. 
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The fluorescent dye 75 was screened in allylic alkylation reactions with various 
nucleophiles. Pd-catalyzed allylic alkylation of TFA-glycine-tert-butyl ester under 
standard conditions proceeded successfully, forming the mixture of E/Z-configurated 
isomers 76a and 76b with a ration 72:28 (NMR) in 69% yield (Scheme 3.27). The 
problem we faced here was the separation of the starting material from product, 
since the conversion was not complete and the Rf values of both compounds were 
identical. The chromatographic separation of the product was only possible after 
quenching with morpholine, converting the remaining starting material to the 
corresponding morpholino allylamide, which is more polar. 
 
 
Scheme 3.27: Allylic alkylation of TFA-glycine-tert-butyl ester with 7-aminocoumarin label 75. 
Since the synthesis of allylic substrate with an expanded -system 75 proceeded 
smoothly, in only two steps and gave the desired fluorescent dye 75 in excellent 
yield, it was further screened in labelling of various N- and O-nucleophiles. 
As O-nucleophiles Boc-protected serine and phenol were chosen. The allylation of 
Boc-serine proceeded in 63% yield (Scheme 3.28). The modification of phenol 
provided two regioisomers, linear 78 (E/Z 85:15) and branched 79 in a ratio of 83:17 
and in an overall yield of 70% (Scheme 3.29). The chromatographic separation of 
both regioisomers was not possible. 
 
Scheme 3.28: O-allylation of Boc-serine with 75. 
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 Scheme 3.29: O-allylation of phenol with 75 
For N-alkylation piperidene was chosen as a first candidate. Under the conditions 
described by Kazmaier et al,[148] [AllylPdCl]2/PPh3 as a catalyst and THF as a solvent, 
the desired allylated compound 80 (E/Z 89:11) was isolated in 73% yield  (Table 3.10, 
entry 1). 
Table 3.10 N-alkylation reactions with 75: 
 
 
 Nucleophile Conditions Product Yield E/Z ratio 
1 Piperidine 
5 mol% [AllylPdCl]2/ 
20 mol% PPh3, THF 
–78 °C -> rt 
80 73% 89:11 
2 Piperidine 
5 mol% Pd(PPh3)4, DMF 
–20 °C -> rt 
80 88% 86:14 
3 Morpholine 
5 mol% [AllylPdCl]2/ 
20 mol% PPh3, DMF 
–20 °C -> rt 
81 84% 93:7 
4 Aniline 
5 mol% Pd(PPh3)4, THF 
rt 
82-83 71% 82:18 
5 N-methylanilin 
5 mol% Pd(PPh3)4, THF 
rt 
84 75% 90:10 
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The yield was significantly increased using Pd(PPh3)4 and dimethylformamide as a 
solvent (entry 2), what gave rise to the N-alkylated product in 88% yield. The 
allylation of morpholine proceeded in 84% yield (E/Z 93:7) (entry 3). In case of 
aniline the overall yield was 71% at room temperature (entry 4, Scheme 3.30) and 
gave rise to regioisomers linear 82 (E/Z 82:18) and branched 83 with a ratio 83:17, 
(Scheme 3.30), which were separated through chromatography. N-methylanilin 
yielded 84 (E/Z 90:10) in 75% yield (entry 5). 
Scheme 3.30: N-alkylation of aniline with 75. 
Pd-catalyzed allylic alkylations with Z-configurated carbonat 72 proceeded in good 
yields with formation of E-configurated compounds preferably. Aniline and phenol 
gave rise to formation of linear and brached regioisomers, as well. 
3.7 Labelling of molecules based on Michael addition 
reactions 
Coumarin derivatives are reported to be good Michael acceptors for ratiometric 
detection of in vivo biothiols.[149] Since Michael additions have been studied for years 
in the group of Prof. Kazmaier, the development of Michael acceptors based on the 
coumarin moiety and their subsequent application in fluorescent labelling was an 
attractive aim of this thesis. The possible sites for fluorescent labelling through 
Michael addition are shown in Figure 3.5. 
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Figure 3.5: Possible sites for fluorescent labelling through Michael addition. 
In the course of the development of a new possible allylic fluorescent label and its 
subsequent application in Pd-catalyzed allylic alkylation, no allylation took place. The 
allylic carbonate was synthesized under Sonogashira coupling conditions with 
propargylic ester and subsequent hydrogenation of the triple bond using Lindlar 
catalyst, what furnished the desired Z-product 86 in almost quantitative yield 
(Scheme 3.31). 
  
Scheme 3.31: Synthesis of fluorescent allylic substrate 86. 
The new substate 86 was screened in allylic alkylation of the TFA-glycine-tert-
butyl ester under standard conditions. The reaction proceeded with the formation of 
a new product the 1H NMR-spectra and LC-MS analysis (Figure 3.6) of which did not 
correspond the allylation product’s structure (Scheme 3.32)  
 
Scheme 3.32: Attempts in allylic alkylation with fluorescent dye 86. 
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It turned out that fluorescenting dye 86 represents a good Michael system. The 
same phenomenon was observed as well by Kazmaier et al with other substrates,[150] 
when instead of palladium-catalyzed allylation a Michael addition took place, since 
the addition reaction proceeds much faster then the allylation. The Michael addition 
product 88 is only an intermediate and could be isolated only if the reaction mixture 
was quenched at –50 °C. If the reaction was allowed to warm up to room 
temperature the lactone 89 was isolated (Scheme 3.33).  
 
Scheme 3.33: Michael addition with fluorescent dye 86. 
 
Figure 3.6: LC-MS chromatogram of Michael addition reaction with fluorescent dye 86. 
If the reaction mixture was allowed to warm overnight to ambient temperature 
without the isolation of the intermediate, only lactone 89 was isolated in 65% yield. 
The proposed mechanism of this reaction is depicted in scheme 3.34.  
 
345 
Coum 86 
573 
Michael prod. 88  
527 
Lactone 89 
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Scheme 3.34: Proposed mechanism of Michael-addition/Lactonisation 
The Michael acceptor 86 was subjected to standard Michael addition conditions, 
[19] i.e. without Pd-catalyst. In this case only cleavage of carbonate group was 
observed and alcohol 90 was isolated in 60% yield (Scheme 3.35). 
 
Scheme 3.35: Michael-addition without Palladium-catalyst 
Since the Michael-acceptor 86 with a carbonat leaving group was giving two 
different products 88 and 89 further Michael acceptors were developed in order to 
avoid the formation of a lactone. 
The synthesis of the propargylic ether 91 with a tetrahydropyranyl ether 
protecting group proceeded in almost quantative yield. Following Pd-catalyzed 
Sonogashira coupling reaction resulted in the formation of alkine 92 in 98% yield, 
which was subsequently subjected to Lindlar-hydrogenation (Scheme 3.36). 
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 Scheme 3.36: Synthesis of the Michael-acceptor 93. 
The Michael addition with fluorescent dye 93 provided the addition compound 94 
(TLC and LC-MS control, the change of fluorescence colour from yellow to purple, 
Figure 3.7), though the stereo center in a tetrahydropyranyl group resulted in the 
formation of a mixture of diastereomeres (yield 60%), the separation of which was 
not possible through chromatography. 
 
Scheme 3.37: Michael-addition with fluorescent label 93. 
 
Figure 3.7: LC-MS chromatogram of Michael addition reaction with fluorescent dye 94. 
 
 
584 
Michael prod. 94  
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Synthesis of a Michael-acceptor through Stille coupling reaction  
In chapter 3.5 the synthesis of vinyl coumarin 58 via Stille-coupling was described. 
Compound 58 was also screened as a potential Michael-acceptor. The Michael-
addition proceeded in 60% yield (Scheme 3.38). 
 
Scheme 3.38: Michael-addition with vinyl coumarin fluorescent label. 
The Michael acceptor 58 was used for labelling of further nucleophiles. It was 
shown in chapter 2.6.1 that biomolecules with an N-terminus, as well as thiols, are 
good nucleophiles for Michael addition reaction. The fluorescent labelling of several 
amines was performed. The reaction with benzylamine at room temperature did not 
give any changes (table 3.11, entry 1), even after refluxing the reaction mixture for 
2h (entry 2). After addition of LiCl traces of a purple fluorescenting product were 
observed already after 2 h of refluxing (entry 3). Refluxing of the reaction mixture 
overnight in presence of LiCl furnished the desired product 93 in 83% yield (entry 4). 
The Li-salt as a Lewis acid propably increased the electrophility of the coumarin 
through coordination to the carbonyl group. 
Table 3.11 Michael-addition reaction with benzylamine: 
 
 
 Conditons Yield 
1 Room temperature, 2h No reaction 
2 2h, reflux No reaction 
3 +LiCl, 2h, reflux Traces of the product 
4 +LiCl, reflux, overnight 83% 
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The further N-nucleophile Leucine methylester.HCl furnished the addition 
compound 97 in 60% yield. 
 
Scheme 3.39: Michael-addition reaction with BocLeucine methylester. 
The thiol nucleophiles which were successfully used in En-Click-Chemistry[165] 
were employed as possible nucleophiles in Michael-addition with fluorescent dye 58. 
1-hexanthiol and benzylmercaptan furnished the addition compounds 98 and 99 in 
88% and 85% yield, correspondingly (Scheme 3.40). 
 
Scheme 3.40: Michael-addition reaction with 1-hexanthiol and benzylmercaptan. 
Cystein is one of the most known targets for fluorescent labelling (Chap.2.6.1). 
Therefore, BocCysOMe[165] was chosen as a target nucleophile for Michael-addition, 
which proceeded in a very good yield (Scheme 3.41). 
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Scheme 3.41: Fluorescent labelling of Boc-Cystein methylester. 
 
3.8 Spectral characteristics of aminocoumarins 
Absorption, excitation, emission spectra and life times of all synthesized 7-
aminocoumarin derivatives were measured at Saarland University in the group of 
Prof. G. Jung by Andreas Grüter. The measurements were done in quartz cuvettes 
with 1 cm diameter in spectroscopically pure DMSO. The absorption spectra were 
measured with V-650 spectrometer of Jasco Company, while excitation and emission 
spectra were done using FP-6500 spectrometer of Jasco Company. The obtained 
data were processed with the Software Origin 6.1. Absorption, excitation and 
emmistion maxima are given in table 3.12. 
Table 3.12 Absorption, excitation and emmision maxima of all the coumarins: 
 
 
Compound 
max,abs 
[nm] 
max,ex 
[nm] 
max, em [nm] 
1 85 405 410 502 
2 92 397 404 481 
3 21 399 404 479 
4 71 393  484 
5 75 396  478 
6 26 401 409 498 
7 29 400 407 483 
8 31 398 407 485 
9 27 400 409 488 
10 36 398 411 490 
11 37 400 411 489 
12 38 404 411 486 
13 39 396 410 536 
14 44 386 388 520 
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15 40 386 387 522 
16 41 386 388 520 
17 42 384 389 524 
18 45 384 388 517 
19 46 381 390 528 
20 47 383 385 513 
21 48 388 391 531 
22 20 388 389 500 
23 49 356 358 412 
24 50 345 345 390 
25 51 346 350 405 
26 53 352 416 417 
27 54 356 359 418 
28 52 355 356 409 
29 55 351 361 410 
30 96 364 370 420 
31 97 363 368 421 
32 56 441 369 432 
 
Absorption maxima for all the coumarin lay in the range between 345-414 nm, 
while emission maxima are in the range between 384-528 nm (in the range between 
violet and yellow). Coumarins synthesized through Sonogashira coupling reactions 
(Chap. 3.4.2, Table 3.12, entries 1-12) exhibit (due to -system expansion) 
absorption maxima at the range around 400 nm, emission occurs in the range 
between 479-502 nm (Figure 3.8 and 3.9). 
 
Figure 3.8: Absorption spectra of coumarins obtained through Sonogashira coupling. 
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Figure 3.9: Emmision spectra of coumarins obtained through Sonogashira coupling. 
An interesting observation was made for the coumarins obtained through Pd-
catalyzed cross-coupling with CO-insertion (Chap. 3.4.3, entries 13-22). For these 
amides absorption occurs at the range between 381-388 nm, while the emission 
occurs at over 500 nm (Table 3.12, Figure 3.10-3.11). 
 
 
Figure 3.10: Absorption spectra of coumarins obtained through cross-coupling with CO-insertion and 
through direct substitution. 
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Figure 3.11: Emission spectra of coumarins obtained through cross-coupling with CO-insertion and 
through direct substitution. 
Coumarins obtained through direct substitutions (Chap. 3.4.3, table 3.12, entries 
23-32) do not emit at longer wavelength, in this case absorption was observed in the 
range 345-366 nm, and emission at 396-423 nm. Fluorescenting aldehyde (Chap. 3.5, 
table 3.12, entry 42) reveals anti-Stokes shift, while absorption occurs at 441 nm and 
emmisiton maxima is at 432 nm (Figure 3.10 and 3.11). 
The fluorescent data of all other coumarins are given in the experimental section. 
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4  
 
Experimental 
Section 
 
 
4.1 General information 
 
All reactions were carried out in oven-dried glassware (100 °C) under nitrogen 
atmosphere unless otherwise stated. For drying of organic phases water-free sodium 
sulphate was used. 
1H-NMR spectra were recorded on a 400 MHz nuclear magnetic resonance 
spectrometer (model Bruker AVII-400). CDCl3 was used as solvent. The solvent peak 
was calibrated according the used solvent (CDCl3:  δ=7.26 ppm). The analysis of 
spectra was done with PC-software MestRe-C. Multiplicities are reported as (br) 
broad, (s) singlet, (d) doublet, (dd) doublet of doublets, (t) triplet, (q) quartet and (m) 
multiplet. Chemical shifts are δ-values and reported in ppm. 
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 13C-NMR-spectra were recorded on a frequency of 100 MHz on a nuclear 
magnetic resonance spectrometer (Bruker AV-400). CDCl3 was used as solvent. The 
solvent peak was calibrated at 77.0 ppm. The analysis of spectra was done with PC-
software MestRe-C. Multiplicities are reported as: (s) singlet (quarterly C- atom), (d) 
doublet (CH-group), (t) triplet (CH2-group), (q) quartet (CH3-group). Chemical shifts 
are δ-values and reported in ppm. Two-dimensional measuring methods as H,H-
COSY and HSQC were used for the correlation of 1H- and 13C-signals. 
 The products were purified by flash chromatography on silica gel columns 
(Macherey-Nagel 60, 0.063-0.2 mm). 
Melting points were measured in open glass capillaries on apparatus MEL-TEMP II 
purchased from Laboratory Devices and are uncorrected. 
Thin-layer chromatography was done by using commercially available precoated 
Polygram® SIL-G/UV 254 plates purchased from Fluka. The detection of spots was 
done under UV-light, Ninhydrin or KMnO4 solution. 
Elemental analysis was performed at the Institute for Organic Chemistry, 
University of Saarland by Ms Susanne Harling on the instrument Leco (model 
CHN900). 
High resolution mass spectrometry (HRMS) was performed at the Institute for 
Organic Chemistry, University of Saarland by Mr. Rudi Thomas on the instrument 
MAT 95Q purchased from the company Finnigan. The fragmentation was carried out 
through chemical ionization (CI) or electron ionization (EI). 
Dried solvents were distilled before use: THF was dried over sodium with 
benzophenone as an indicator, dichloromethane (DCM) was dried over powdered 
CaH2. Commercial grade solvents like ethyl acetate, hexane, diethylether were 
distilled prior to use. 
Absorption, excitation, emission spectra and life times were measured at 
Saarland University in the group of Prof. G. Jung by Andreas Grüter. The 
measurements were done in quartz cuvettes with 1 cm diameter in spectroscopically 
pure DMSO. The absorption spectra were measured with V-650 spectrometer of 
Jasco Company, while excitation and emission spectra were done using FP-6500 
spectrometer of Jasco Company. 
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4.2 General Experimental Procedures (GPs) 
GP 1: Suzuki-Miyaura coupling [93] 
To the solution of Pd(PPh3)4 (2 mol%), K2CO3 (2 eq.) and enol triflate 12 (1eq.) in 
toluene (5 mL/mmol) under nitrogen atmosphere arylboronic acid (1.2 eq.) was 
added at rt and the reaction mixture was refluxed until complete conversion of the 
coumarin was observed. Afterwards the reaction was quenched with 1M NH4Cl and 
extracted with EA. The combined organic phase was dried over anhydrous Na2SO4, 
concentrated and chromatographed on silica gel column to afford the desired 
product. 
GP 2: Sonogashira coupling reaction [137] 
To the solution of Pd(PPh3)4 (2 mol%), CuI (4 mol%) and enol triflate 12 (1eq.) in 
abs. THF (5 mL/mmol) under nitrogen atmosphere Et3N (1 eq.) and propargylic 
substrate (2 eq.) were added at rt; the reaction mixture was stirred at rt until 
complete conversion of coumarin was observed. Afterwards the reaction was 
quenched with 1M NH4Cl, extracted with DCM. The combined organic phase was 
dried over anhydrous Na2SO4, concentrated, and chromatographed on silica gel 
column to afford the desired product. 
GP 3: Ugi reaction 
To the solution of benzyl amine (1 eq.) in dry DCM (2 ml/mmol) aldehyde 32 (1 
eq.) in 0.5 ml dry DCM was added at 0 °C. The mixture was stirred for 30 min at this 
temperature before amino acid (1 eq.) in 0.5 ml dry DCM was added. The mixture 
was stirred for another 30 minutes. Solution of isocyanide (1 eq. 1 mmol) in 0.5 ml 
dry DCM was added slowly and the reaction mixture was warmed up to rt overnight. 
The reaction mixture was dissolved with DCM, washed 2x with conc. NaHCO3 and 1M 
KHSO4 solutions. The combined organic phase was dried over anhydrous Na2SO4, 
concentrated, and chromatographed on silica gel column to afford the desired 
product.   
GP 4: Palladium-catalyzed carbonylation of enol triflates [151] 
To the solution of enol triflate 12 (1 eq.) and amine (1.2 eq.)  in dry toluene (10 ml 
/mmol) Pd(PPh3)2Cl2 (10 mol%) and Et3N (2 eq.) were added. The reaction mixture 
was stirred under CO atmosphere (15 bar) overnight before it was diluted with DCM 
and quenched with 1M NH4Cl-solution. The aqueous layer was extracted three times 
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with DCM and combined organic layers were dried over Na2SO4. The solvent was 
evaporated in vacuo and the crude product purified by column chromatography. 
GP 5: Nucleophilic substitution 
To the solution of enol triflate 12 (1 eq.) and amine (1.2 eq.) in dry toluene (10 ml 
/mmol) Et3N (2 eq.) was added. The reaction mixture was refluxed overnight. 
Afterwards it was diluted with DCM and quenched with 1M NH4Cl-solution. The 
aqueous layer was extracted three times with DCM and combined organic layers 
were dried over Na2SO4. The solvent was evaporated in vacuo and the crude product 
purified by column chromatography. 
GP 6: Dess-Martin oxidation   
To the solution of the corresponding alcohol (1 eq) in DCM (20 mL/mmol) Dess-
Martin periodinane (1.2 eq.) was added at rt and the resulting solution was stirred 
until the complete conversion of alcohol at rt. Afterwards the reaction mixture was 
washed with sat. solution of Na2S2O3 and NaOH. The aqueous layer was extracted 
three times with DCM and combined organic layers were dried over Na2SO4. The 
solvent was evaporated in vacuo and the crude product purified by column 
chromatography. 
GP 7:  Grignard Reaction 
To the solution of the corresponding aldehyde (1 eq) in abs. THF (1.2 ml/mmol) 
1M Vinylmagnesiumbromide-solution in THF (1.3 eq) was added slowly at –20 °C. 
The cooling bath was removed and the mixture was stirred until complete 
conversion was observed. Afterwards the reaction mixture was diluted with DCM 
and hydrolyzed at 0 °C with 1M NH4Cl-solution. The aqueous layer was extracted 
three times with DCM and the combined organic layers were dried over Na2SO4. The 
solvent was evaporated in vacuo and the crude product purified by column 
chromatography. 
GP 8: Synthesis of carbonates [152] 
To the solution of an allylalcohol (1 eq.) in dry pyridine (1ml/mmol) ethyl 
chloroformate (2 eq.) was added dropwise at 0 °C. The reaction mixture was allowed 
to warm to rt overnight before it was diluted with DCM and the organic layer was 
washed with 1M copper(II)solution until complete removal of the pyridine. The 
combined organic layers were dried over Na2SO4, the solvent evaporated in vacuo 
and the crude product purified by column chromatography. 
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GP 9: Pd-catalyzed allylic alkylation of amino acids [152,117] 
In a Schlenk flask HMDS (2.8 eq) was dissolved in abs. THF (2 ml), n-Buli (1.6M in 
hexane, 2.5 eq.) was added dropwise at –78 °C. The cooling bath was removed and 
the colourless mixture was stirred for 10 min at room temperature. After cooling 
again to –78 °C, TFA-glycin-tert-butylester (1 eq.), dissolved in abs. THF (5 ml/mmol) 
was added slowly. The mixture was stirred for another 15 minutes. In the second 
Schlenk flask ZnCl2 (1.1 eq) was heated carefully in vacuo, and after cooling down to 
room temperature it was dissolved in 1 ml abs. THF. The ZnCl2-solution was added 
dropwise at –78 °C to the Li-enolate and the resulting mixture was stirred for 
additional 45 minutes to complete transmetallation. 
Meanwhile, allylpalldium(II) chloride dimer (1 mol%) and triphenylphosphine (4.5 
mol%) were dissolved in THF (2 ml) and stirred for 10 minutes at rt before the 
allylcarbonate (0.7 eq.) was added. 
The catalyst-substrate solution was added dropwise to the Zink-enolate solution 
at –78 °C. The reaction mixture was warmed up overnight to rt, after monitoring by 
TLC, the reaction mixture was diluted with EA and quenched with 1N KHSO4-solution. 
The aqueous layer was extracted three times with EA and combined organic layers 
were dried over Na2SO4. The solvent was removed in vacuo and the crude product 
purified by column chromatography. 
GP 10: Michael addition of Thiols/amines [153] 
To the solution of the corresponding thiol/amine (1.2 eq) in 1.4-dioxane (5 
mL/mmol) Et3N (1.0 eq.) and vinyl coumarin (1 eq.) solution in 1.4-Dioxane were 
added at rt. The resulting solution was stirred until complete conversion of the 
coumarin at rt. Afterwards the reaction mixture was diluted with DCM and quenched 
with 1M NH4Cl-solution. The aqueous layer was extracted three times with DCM and 
combined organic layers were dried over Na2SO4. The solvent was removed in vacuo 
and the crude product was purified by column chromatography. 
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4.3 Synthesis of compounds 
Methyl 3-oxohept-6-enoate (1)[120] 
A suspension of 2.40 g (25.3 mmol, 1.04 eq.) magnesiumchloride and 5.70 g 
(36.5 mmol, 1.50 eq.) methyl-potassiummalonate in 35 ml abs. THF was mixed under 
nitrogen atmosphere at 50 °C for 4 h. Meanwhile in another Schlenk flask 4.73 g 
(29.2 mmol, 1.20 eq.) 1,1’-carbonyldiimidazole was added in portions to the solution 
of 2.43 g (24.3 mmol, 1.00 eq.) 4-Pentenoic acid in 50 ml abs. THF at 5 °C and the 
mixture was stirred for one h at rt. The imidazolid solution of the second flask was 
added to methylmagnesiummalonatsolution at rt and was stirred overnight at rt. The 
solvent was removed in vacuo and the crude product was suspended in ethylacetate. 
The suspension was washed with 1 M KHSO4-solution, sat. NaHCO3-solution and sat. 
NaCl-solution. The organic layer was dried (Na2SO4) and the solvent was evaporated 
in vacuo. The crude product was purified by column chromatography (silica gel, 
Hex:EA 8:2) to furnish 2.93 g (18.7 mmol, 87%) of 1 a slightly yellow oil. 
Rf(1) = 0.32 (Hex:EA 8:2) 
 
1 
1H-NMR (400 MHz, CDCl3):  
 = 2.34 (m, 2 H, 3-H), 2.64 (t, 3J4,3 = 7.3 Hz, 2 H, 4-H), 3.45 (s, 2 H, 6-H), 
3.73 (s, 3 H, 8-H), 5.04 (m, 2 H, 1-H), 5.79 (ddt, 3J2,1cis  = 16.8 Hz, 
3J2,1trans =  
10.2 Hz, 3J2,3 = 6.5 Hz,  1 H, 2-H).   
13C-NMR (100 MHz, CDCl3):  
 = 27.4 (t, C-3), 42.0 (t, C-4), 49.0 (t, C-6), 52.3 (q, C-8), 115.6 (t, C-1), 
136.5 (d, C-2), 167.5 (s, C-7), 201.8 (s, C-5). 
4-(But-3-enyl)-7-(diethylamino)-2H-chromen-2-one (2) [19] 
1.65 g (10.0 mmol, 1.00 eq.) 3-diethylaminophenol and 1.5 g (10.0 mmol, 1.00 
eq.) β-Ketoester 1 were suspended in 30 ml abs. toluene. Afterwards 20 ml 
(20.0 mmol, 2.00 eq.) 1 M chlorotri-iso-propoxytitan solution in hexane was added. 
The reaction mixture was refluxed overnight. After cooling down to room 
temperature the mixture was diluted with dichlomethane, poured into the sat. 
Na-/K-Tatrat-solution and stirred until phases separation. The phases were 
separated in the separation funnel and the water phase was extracted three times 
with DCM. The combined organic layers were dried over Na2SO4 and the solvent was 
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evaporated in vacuo. The crude product was purified by column chromatography 
(silica gel, PE:EA 7:3) to furnish 810 mg (3 mmol, 30%) of 2 as a yellow oil. 
Rf(2) = 0.11 (DCM:EA 95:5) 
 
2 
1H-NMR (400 MHz, CDCl3):  
 = 1.21 (t, 3J13,12 = 
3J11,10 = 7.1 Hz, 6 H, 13-H, 11-H), 2.42 (td, 
3J15,14 = 7.7 
Hz, 3J15,16 = 6.5 Hz,   2 H, 15-H), 2.74–2.78 (sh, 2 H, 17-H), 3.41 (q, 
3J12,13 = 
3J10,11 = 7.1 Hz, 4 H, 12-H, 10-H), 5.07 (m, 2 H, 14-H), 5.87 (ddt, 
3J16,17cis  = 
16.8 Hz, 3J16,17trans = 10.2 Hz, 
3J16,15 = 6.5 Hz, 1 H, 16-H), 5.94 (s, 1 H, 8-H), 
6.50 (d, 4J3,1  = 2.6, 1 H, 3-H), 6.58 (dd,
 3J1,6  =  9.0 Hz, 
4J1,3 = 2.6 Hz, 1 H, 1-
H), 7.40 (d, 3J6,1 =  9.0 Hz, 1 H, 6-H) 
13C-NMR (100 MHz, CDCl3):  
 = 12.5 (q, C-11/C-13), 31.0 (t, C-15), 32.4 (t, C-14), 44.7 (t, C-10/C-12), 
97.9 (d, C-3), 107.8 (d, C-1), 108.2 (s, C-5), 108.4 (d, C-8), 115.9 (t, C-17), 
125.2 (d, C-6), 136.8 (d, C-16),  150.4 (s, C-2), 155.9 (s, C-4), 156.3 (s, C-
9), 162.4 (s, C-7). 
Elemental Analysis:  
C17H21NO2  Calculated C 74.68 H 7.44 N 5.44 
271.3600  Found  C 74.94 H 7.44 N 5.73 
HRMS (CI):   Calculated   Found 
C17H21NO2[M+H]
+: 272.1645  272.1649    
Absorption max.:  369 nm 
Exitation max.: 368 nm 
Emission max.: 423 nm 
Lifetime:  3.11 ns 
7-(Diethylamino)-4-hydroxy-2H-chromen-2-one (4) [154] 
10.7 g (65.0 mmol, 1 eq) 3-diethylaminophenol and 30 g (65.0 mmol, 1 eq.) 
bis(2,4,6-trichlorphenyl)malonate 6 were dissolved in anhydrous toluene (195 ml) 
and heated to reflux overnight. Cooling to room temperature afforded a precipitate 
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that was filtered off. The crude product was washed with toluene to furnish 11 g (47 
mmol, 72%) of 4 as a light-green solid compound. 
Rf(4) = 0.14 (DCM:MeOH 95:5) 
 
4 
1H-NMR (400 MHz, CDCl3):  
 = 1.25 (t, 3J11.10 =  
3J13.12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.48 (q, 
3J10,11 =  
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 5.51 (s, 1 H, 8-H), 6.52 (d, 
4J3,1 = 2.5 Hz, 
1 H, 3-H), 6.72 (dd, 3J1,6 = 9.2 Hz, 
4J1,3 = 2.5 Hz, 1 H, 1-H), 7.87 (d, 
3J6,1 = 
9.2 Hz, 1 H, 6-H), 10.99 (s, 1 H, OH) 
13C-NMR (100 MHz, CDCl3): 
 = 12.3 (q, C-11/C13), 44.0 (t, C-12/C-10), 86.1 (d, C-8), 96.4 (d, C-3), 
103.5 (s, C-5), 108.2 (d, C-1), 124.2 (d, C-6), 150.9 (s, C-2), 156.1 (s, C-4), 
163.0 (s, C-7), 166.6 (s, C-9). 
Elemental Analysis:  
C13H15NO3 Calculated C 66.94 H 6.48 N 6.00 
(233.2665) Found  C 66.67 H 6.52 N 5.97 
HRMS (CI):   Calculated   Found 
C13H15NO3[M]
+: 233.1046 233.1047  
Absorption max.:   350 nm 
Exitation max.:  349 nm 
Emission max.:  387 nm 
Lifetime:   2.61/1.31 ns  
Melting point:  234-236 °C (lit 238 °C) 
Bis(2,4,6-trichlorphenyl)malonate (6) [154]  
15.8 g (80.0 mmol, 1 eq) 2,4,6-trichlorphenol and 4.16 g (40.0  mmol, 0.5 eq.) 
malonic acid were refluxed in 10 ml (107 mmol, 1.2 eq) phosphorus (V) oxychloride 
for 3 h. After cooling to rt, the reaction mixture was quenched with ice water (50 
ml), and the resulting precipitate was collected by filtration. The crude product was 
suspended in water (20 ml), saturated sodium hydrogen carbonate solution (5 ml) 
was added, and the suspension was stirred for 15 min. The undissolved material was 
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filtered off and recrystallized from ethyl acetate to furnish 6 15.2 g (33 mmol, 83%) 
as colorless cubes. 
Rf(6) = 0.44 (PE:EA 7:3) 
 
6 
1H-NMR (400 MHz, CDCl3):  
 = 4.04 (s, 2 H, 8-H), 7.38 (s, 4 H, 2-H, 6-H, 12-H, 14-H). 
13C-NMR (100 MHz, CDCl3):  
 = 39.7 (t, C-8), 128.7 (d, C-12/C-14/C-2/C-6), 129.5 (d, C-12/C-14/C-2/C-
6), 132.7 (s, C-3/C5/C-11/C-15/C-13/C-1), 142.4 (s, C-10/C4), 161.4 (s, C-
7/C-9). 
3-Allyl-7-(diethylamino)-4-hydroxy-2H-chromen-2-one (7) 
58 mg (0.25 mmol, 1 eq.) 4-hydroxycoumarin 4,  36 mg (0.28 mmol, 1.1 eq.) allyl 
ethyl carbonate, 1 mg (2.5 µmol, 2 mol%) allylpalladium(II) chloride dimer, 3 mg 
(11 µmol, 4.5 mol%) PPh3  and 45 mg (0.33 mmol, 1.3 eq.) K2CO3 were dissolved in 1 
ml DMF. The mixture was refluxed overnight. After cooling down to room 
temperature the mixture was filtered through celite, the filtrate was concentrated in 
vacuo and the crude product purified by column chromatography (silica gel, 
DCM:MeOH 98:2) to furnish 57.6 mg (0.21 mmol, 84%) of 7 as a yellow oil. 
Rf(7) = 0.21 (DCM:MeOH 98:2) 
 
7 
1H-NMR (400 MHz, CDCl3):  
 = 1.19 (t, 3J11.10 =  
3J13.12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.39 (q, 
3J10,11 =  
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 3.44 (td, 
3J14,15 = 6.4 Hz, 
4J14,16cis = 
4J14,16trans = 1.6 Hz, 2 H, 14 H), 5.21 (ddd, 
3J16trans,15 = 10.0 Hz, 
2J16trans,16cis  
= 4J16trans14 = 1.4 Hz, 1 H, 16 trans-H), 5.33 (ddd, 
3J16cis,15 =  17.2 Hz, 
2J16cis,16trans = 
4J16cis14 = 1.6 Hz, 1 H, 16c is-H), 6.02 (ddd, 
3J15,16cis = 16.4 Hz, 
3J15,16trans = 10.0 Hz, 
3J15,14 = 6.4 Hz, 1 H, 15-H), 6.46 (d, 
4J3,1 = 2.3 Hz, 1 H, 
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3-H), 6.58 (dd, 3J1,6 = 9.0 Hz, 
4J1,3 = 2.5 Hz, 1 H, 1-H), 7.60 (d, 
3J6,1 = 9.0 Hz, 
1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 28.4 (t, C-14) 44.7 (t, C-12/C-10), 96.6 (d, C-3), 
97.0 (s, C-8) 103.4 (s, C-5), 108.4 (d, C-1), 117.0 (t, C-16) 123.7 (d, C-6), 
135.8 (d, C-15), 150.7 (s, C-2), 155.0 (s, C-4), 162.4 (s, C-9), 164.7 (s, C-7). 
Elemental Analysis:  
C16H19NO3 Calculated C 70.31 H 7.01 N 5.12 
(273.3270) Found  C 70.24 H 7.06 N 5.15 
HRMS (CI):   Calculated Found 
C16H20NO3 [M+H]
+: 274.1438 274.1438  
Absorption max.:   348 nm 
Exitation max.:  352 nm 
Emission max.:  396 nm 
Lifetime:   2.44/0.87 ns  
4-(Allyloxy)-7-(diethylamino)-2H-chromen-2-one (8) [155] 
Method A 
233 mg (1 mmol, 1 eq.) 4-hydroxycoumarin 4, 0.09 ml (1 mmol, 1 eq.) 
allylbromide and 180 mg (1.3 mmol, 1.3 eq.) K2CO3 were dissolved in 1.3 ml acetone. 
The mixture was refluxed overnight. After cooling down to room temperature the 
mixture was filtered through a celite plug, the filtrate was concentrated in vacuo and 
the crude product was purified by column chromatography (silica gel, DCM:MeOH 
98:2) to furnish 93 mg (0.34 mmol, 34%) of 8 as a yellow oil. 
Method B (Mitsunobu reaction) [156] 
1.57 g (6 mmol, 1.5 eq) PPh3 was dissolved in 8 ml abs. THF, and the solution was 
cooled to –20 °C. 1.2 g (1.17 ml, 40 wt% solution in toluene, 6 mmol, 1.5 eq.) DIAD, 
0.3 ml (4.8 mmol, 1.2 eq) allyl alcohol and 933 mg (4 mmol, 1.0 eq.) 4-
hydroxycoumarin 4 were added successively. The reaction was allowed to warm to 
room temperature over 2 h and stirred at room temperature until complete 
converstion of 4-hydroxycoumarin 4. 80 ml hexane was added to the reaction 
mixture to precipitate the triphenylphosphine oxide by-product. After filtration 
through celite, the filtrate was concentrated under reduced pressure. The crude 
product was purified by column chromatography (silica gel, DCM:MeOH 98:2) to 
furnish 967 mg (3.54 mmol, 89%) of 8 as a yellow oil. 
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Rf(8) = 0.33 (DCM:MeOH 98:2) 
 
8 
1H-NMR (400 MHz, CDCl3):  
 = 1.19 (t, 3J11.10 =  
3J13.12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.40 (q, 
3J10,11 =  
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 4.63 (dt, 
3J14,15 = 5.3 Hz, 
4J14,16cis = 
4J14,16trans = 1.4 Hz, 2 H, 14-H), 5.37 (ddd, 
3J16trans15 = 10.6 Hz, 
2J16trans,16cis  =   
2.4 Hz, 4J16trans14 = 1.2 Hz, 2 H, 16 trans-H), 5.41 (s, 1 H, 8-H), 5.47 (ddd, 
3J16cis,15 = 17.3 Hz, 
2J16cis,16trans  = 2.8 Hz, 
4J16cis,14 = 1.5 Hz, 1 H, 16cis-H), 
6.06 (ddt, 3J15,16cis = 17.2 Hz, 
3J15,16trans = 10.6 Hz,  
3J15,14 = 5.4 Hz, 1 H, 15-
H), 6.46 (d, 4J3,1 = 2.5 Hz, 1 H, 3-H), 6.55 (dd, 
3J1,6 = 9.0 Hz, 
4J1,3 =  2.5 Hz, 1 
H, 1-H), 7.59 (d, 3J6,1  = 9.0 Hz, 1 H, 6-H) 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 44.7 (t, C-12/C-10), 69.4 (t, C-14), 86.0 (d, C-8), 
97.1 (d, C-3), 103.8 (s, C-5), 108.2 (d, C-1), 118.9 (t, C-16) 123.9 (d, C-6), 
131.2 (d, C-15), 151.0 (s, C-2), 155.8 (s, C-4), 164.2 (s, C-7), 166.2 (s, C-9). 
Elemental Analysis:  
C16H19NO3 Calculated C 70.31 H 7.01 N 5.12 
(273.3270) Found  C 70.25 H 7.12 N 5.09 
HRMS (CI):   Calculated Found 
C16H20NO3 [M+H]
+: 274.1438 274.1444  
Absorption max.:   350 nm 
Exitation max.:  350 nm 
Emission max.:  398 nm 
Lifetime:   2.44/0.87 ns    
7-(Diethylamino)-2-oxo-2H-chromen-4-yl trifluoromethanesulfonate (12) [129] 
Under nitrogen atmosphere 3.2 g (13.8 mmol, 1 eq.) 4-hydroxycoumarin 4 was 
dissolved in dry DCM (69 mL) and 3.8 ml (27.6 mmol, 2 eq.) Et3N was added. The 
solution was cooled to –20 °C, and treated with dropwise addition of 5 ml (5 g, 18 
mmol, 1.3 eq.) fresh triflic anhydride. The resulting mixture was stirred for additional 
2 h. After complete conversion of 4, the mixture was passed through a pad of silica 
gel with 1:30 EA/hexane washings, until no more aryl triflate was eluted out. The 
filtrate was concentrated under reduced pressure. The crude product was purified by 
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column chromatography (silica gel, DCM) to furnish 4.8 g (13.2 mmol, 96%) of 12 as a 
yellow solid compound. 
Rf(12) = 0.15 (DCM:EA, 98:2) 
 
12 
1H-NMR (400 MHz, CDCl3):  
 = 1.22 (t, 3J11.10 =  
3J13.12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.43 (q, 
3J10,11 =  
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 6.05 (s, 1 H, 8-H), 6.51 (d, 
4J3,1 = 2.4 Hz, 
1 H, 3-H), 6.64 (dd, 3J1,6 = 9.1 Hz, 
4J1,3 = 2.5 Hz, 1 H, 1-H), 7.42 (d, 
3J6,1 = 
9.1 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.3 (q, C-11/C13), 45.0 (t, C-12/C-10), 97.4 (d, C-3), 98.5 (s, C-8) 
102.0 (s, C-5), 109.4 (d, C-1), 116.9 (s, C-14) 123.5 (d, C-6), 152.1 (s, C-2), 
156.3 (s, C-4), 158.1 (s, C-7), 161.3 (s, C-9). 
Elemental Analysis:  
C14H14F3NO5S  Calculated C 46.03 H 3.86 N 3.83 
(365.3249) Found  C 46.30 H 3.69 N 3.88 
HRMS (CI):   Calculated Found 
C14H15F3NO5S  [M]
+:  365.0539 365.0531  
Absorption max.:   351 nm 
Exitation max.:  383 nm 
Emission max.:  384 nm 
Lifetime:   2.93/0.22 ns  
Melting point:   77-79 °C 
7-(Diethylamino)-4-(3-nitrophenyl)-2H-chromen-2-one (13) 
According to the GP-1 to the solution of 73 mg (0.2 mmol, 1 eq.) enol triflate 12, 
4.6 mg (4 µmol, 2 mol%.) Pd(PPh3)4 and 33 mg (0.24 mmol, 2 eq.) K2CO3 in 1 ml dry 
toluone 40 mg (0.24 mmol, 1.2 eq.) 3-nitrophenylboronic acid was added. The 
reaction mixture was refluxed for 1 h. After work-up and column chromatography 
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(silica gel, DCM:EA 95:5) 60 mg (0.18 mmol, 89%) of 13 was isolated as an orange 
solid compound. 
Rf(13) = 0.38 (DCM:EA 9:1) 
 
13 
1H-NMR (400 MHz, CDCl3):  
 = 1.22 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.43 (q, 
3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 6.02 (s, 1 H, 8-H), 6.53 (dd, 
3J1,6  = 9.1 Hz, 
4J1,3 = 2.5 Hz, 1 H, 1-H), 6.58 (d, 
4J3,1 = 2.5 Hz, 1 H, 3-H), 7.10 (d, 
3J6,1 = 9.0 
Hz, 1 H, 6-H), 7.68-7.78, 8.32-8.36 (2m, 4 H, Phe). 
13C-NMR (100 MHz, CDCl3): 
 = 12.5 (q, C-11/C13), 44.9 (t, C-12/C-10), 98.0 (d, C-3), 107.1 (d, C-1/C-
8), 108.9 (s, C-5), 123.4 (d, C-15/C-17), 124.1 (d, C-15/C-17), 127.1 (d, C-
6), 130.0 (s, C-14), 134.3 (d, C-19), 137.9 (s, C-9), 148.4 (s, C-16), 151.0 (s, 
C-2), 156.9 (s, C-4), 161.5 (s, C-7). 
Elemental Analysis:  
C19H18N2O4  Calculated C 67.45 H 5.36 N 8.28 
(338.3630) Found  C 67.30 H 5.61 N 8.12 
HRMS (CI):   Calculated   Found 
C19H18N2O4 [M]
+: 338.1261 338.1263 
Absorption max.:   382 nm 
Exitation max.:  367 nm 
Emission max.:  420 nm 
Melting point:   69-75 °C 
7-(Diethylamino)-4-(p-tolyl)-2H-chromen-2-one (14) 
According to the GP-1 to the solution of 73 mg (0.2 mmol, 1 eq.) enol triflate 12, 
4.6 mg (4 µmol, 2 mol%.) Pd(PPh3)4 and 33 mg (0.24 mmol, 2 eq.) K2CO3 in 1 ml dry 
toluone 33 mg (0.24 mmol, 1.2 eq.) p-tolylboronic acid was added. The reaction 
mixture was refluxed for 1 h. After work-up and column chromatography (silica gel, 
PE:EA 7:3) 60.1 mg (0.19 mmol, 95%) of 14 was isolated as a yellow solid compound. 
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Rf(14) = 0.22 (DCM:EA 98:2) 
 
14 
1H-NMR (400 MHz, CDCl3):  
 = 1.23 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 2.46 (s, 3 H, 20-H), 
3.43 (q, 3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 6.02 (s, 1 H, 8-H), 6.53 
(dd, 3J1,6 = 9.0 Hz, 
4J1,3 = 2.5 Hz, 1 H, 1-H), 6.59 (d, 
4J3,1  = 2.4 Hz, 1 H, 3-H), 
7.32 (m, 5 H, 6-H, Phe). 
13C-NMR (100 MHz, CDCl3): 
 = 12.5 (q, C-11/C13), 21.3 (q, C-20), 44.8 (t, C-12/C-10), 97.9 (d, C-3), 
108.0 (d, C-1/C-8), 108.4 (s, C-5), 126.9 (d, C-6), 128.4-129.2 (4d, C-Phe), 
133.4 (s, C-14), 139.3 (s, C-17), 150.6 (s, C-2), 156.2 (s, C-4), 156.8 (s, C-
9), 162.2 (s, C-7). 
Elemental Analysis:  
C20H21NO2  Calculated C 78.15 H 6.89 N 4.56 
(307.3920) Found  C 77.82 H 6.94 N 4.50 
HRMS (CI):   Calculated   Found 
C20H21NO2 [M]
+: 307.1567 307.1578 
Absorption max.:   373 nm 
Exitation max.:  375 nm 
Emission max.:  454 nm 
Melting point:   121-123 °C 
7-(Diethylamino)-4-(2,4,6-trimethylpyridin-3-yl)-2H-chromen-2-one (15) 
According to the GP-1 to the solution of 73 mg (0.2 mmol, 1 eq.) enol triflate 12, 
4.6 mg (4 µmol, 2 mol%.) Pd(PPh3)4 and 33 mg (0.24 mmol, 2 eq.) K2CO3 in 1 ml dry 
toluone 40 mg (0.24 mmol, 1.2 eq (2,4,6-trimethylpyridin-3-yl)boronic acid was 
added. The reaction mixture was refluxed for 1 h. After work-up and column 
chromatography (silica gel, DCM:EA 95:5) 26.7 mg (0.079 mmol, 40%) of 15 was 
isolated as a yellow solid compound. 
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Rf(15) = 0.17 (DCM:EA 9:1) 
 
15 
1H-NMR (400 MHz, CDCl3):  
 = 1.50 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 2.37 (s, 3 H, 20-H), 
2.61 (s, 3 H, 19-H), 2.85 (s, 3 H, 21-H), 3.70 (q3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 
12-H, 10-H), 6.19 (s, 1 H, 8-H), 6.73 (dd, 3J1,6 = 9.0 Hz, 
4J1,3 = 2.5 Hz, 1 H, 
1-H), 6.86 (d, 4J3,1 = 2.5 Hz, 1 H, 3-H), 7.00 (d, 
3J6,1 = 9.0 Hz, 1 H, 6-H), 7.26 
(s, 1 H, 17-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 19.4 (q, C-21), 22.8 (q, C-19), 24.2 (q, C-20), 44.8 
(t, C-12/C-10), 97.7 (d, C-3), 107.8 (d, C-1/C-8), 108.8 (d, C-1/C-8), 109.1 
(s, C-5), 122.2 (d, C-17), 126.8 (s, C-14), 127.1 (d, C-6), 145.3 (s, C-2/C-
18), 151.0 (s, C-4), 154.1 (s, C-9), 156.7 (s, C15/C-16), 157.6 (s, C-15/C-
16), 162.1 (s, C-7). 
Elemental Analysis:  
C21H24N2O2  Calculated C 74.97 H 7.19 N 8.33 
(336.4350) Found  C 74.07 H 7.21 N 7.76 
HRMS (CI):   Calculated   Found 
C21H24N2O2 [M]
+: 336.1838 336.1852 
Absorption max.:  376 nm 
Exitation max.: 378 nm 
Emission max.:  434 nm 
Melting point:  126-130 °C 
4-(4-Chlorophenyl)-7-(diethylamino)-2H-chromen-2-one (16) 
According to the GP-1 to the solution of 73 mg (0.2 mmol, 1 eq.) enol triflate 12, 
4.6 mg (4 µmol, 2 mol%.) Pd(PPh3)4 and 33 mg (0.24 mmol, 2 eq.) K2CO3 in 1 ml dry 
toluone 38 mg (0.24 mmol, 1.2 eq) 4-chlorophenylboronic acid was added. The 
reaction mixture was refluxed for 2 h. After work-up and column chromatography 
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(silica gel, DCM:EA 95:5) 61.8 mg (0.19 mmol, 94%) of 16 was isolated as a yellow 
solid compound. 
Rf(16) = 0.37 (DCM:EA 9:1) 
 
16 
1H-NMR (400 MHz, CDCl3):  
 = 1.21 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.41 (q, 
3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 5.98 (s, 1 H, 8-H), 6.51 (dd, 
3J1,6  = 9.0 Hz, 
4J1,3 = 2.6 Hz, 1 H, 1-H), 6.56 (d, 
4J3,1 = 2.6 Hz, 1 H, 3-H), 7.19 (d, 
3J6,1 = 9.0 
Hz, 1 H, 6-H), 7.39 (dt, 3J19,18 = 
3J15,16 = 8.5 Hz, 
4J19,15 = 
4J15,19 = 2.2 Hz, 2 H, 
19-H, 15-H), 7.48 (d, 3J16,15 = 
3J18,19 = 8.5 Hz, 
4J16,18 = 
4J18,16 = 2.2 Hz, 2 H, 
16-H, 18-H).
13C-NMR (100 MHz, CDCl3): 
 = 12.5 (q, C-11/C13), 44.8 (t, C-12/C-10), 97.9 (d, C-3), 107.6 (d, C-1/C-
8), 108.4 (d, C-1/C-8), 108.6 (s, C-5), 127.6 (d, C-6), 129.0 (d, C-19/C-15), 
129.7 (d, C-16/C-18), 134.7 (s, C-17), 135.4 (s, C-14), 150.8 (s, C-2), 154.8 
(s, C-4), 156.8 (s, C-9), 161.9 (s, C-7). 
Elemental Analysis:  
C19H18ClNO2  Calculated C 69.62 H 5.53 N 4.27 
(327.8080) Found  C 69.50 H 5.75 N 4.39 
HRMS (CI):   Calculated   Found 
C19H18ClNO2 [M]
+: 327.1021 327.1021 
Absorption max.:  380 nm 
Exitation max.: 383 nm 
Emission max.:  477 nm 
Lifetime: 4.11 ns 
Melting point:  126-130 °C 
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7-(Diethylamino)-4-(4-fluorophenyl)-2H-chromen-2-one (17) 
According to the GP-1 to the solution of 73 mg (0.2 mmol, 1 eq.) enol triflate 12, 
4.6 mg (4 µmol, 2 mol%.) Pd(PPh3)4 and 33 mg (0.24 mmol, 2 eq.) K2CO3 in 1 ml dry 
toluone 33.6 mg (0.24 mmol, 1.2 eq) 4-fluorophenylboronic acid was added. The 
reaction mixture was refluxed for 2 h. After work-up and column chromatography 
(silica gel, DCM:EA 95:5) 46.3 mg (0.15 mmol, 85%) of 17 was isolated as a yellow 
solid compound. 
Rf(17) = 0.18 (DCM:EA 9:1) 
 
17 
1H-NMR (400 MHz, CDCl3):  
 = 1.21 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.42 (q, 
3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 5.98 (s, 1 H, 8-H), 6.52 (dd, 
3J1,6  = 9.0 Hz, 
4J1,3 = 2.6 Hz, 1 H, 1-H), 6.57 (d, 
4J3,1 = 2.6 Hz, 1 H, 3-H), 7.19 (m, 3 H, 6-H, 
19-H, 15-H), 7.42 (m, 2 H, 16-H, 18-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.5 (q, C-11/C13), 44.8 (t, C-12/C-10), 97.9 (d, C-3), 106.7 (d, C-1/C-
8), 107.8 (d, C-1/C-8), 108.56 (s, C-5), 115.9 (d, C-18/C-16), 127.7 (d, C-6), 
130.3 (d, C-15/C-19), 132.3 (s, C-14), 150.7 (s, C-2/C-4), 155.0 (s, C-9), 
162.0 (s, C-7), 164.5 (s, C-17). 
Elemental Analysis:  
C19H18FNO2  Calculated C 73.30 H 5.83 N 4.50 
(311.3564) Found  C 72.12 H 4.84 N 4.36 
HRMS (CI):   Calculated   Found 
C19H18FNO2 [M]
+: 311.1316 311.1319 
Absorption max.:  375 nm 
Exitation max.: 381 nm 
Emission max.:  460 nm 
Lifetime: 3.62 ns 
Melting point:  125-128 °C  
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7-(Diethylamino)-4-(4-methoxyphenyl)-2H-chromen-2-one (18) 
According to the GP-1 to the solution of 73 mg (0.2 mmol, 1 eq.) enol triflate 12, 
4.6 mg (4 µmol, 2 mol%.) Pd(PPh3)4 and 33 mg (0.24 mmol, 2 eq.) K2CO3 in 1 ml dry 
toluone 36.4 mg (0.24 mmol, 1.2 eq.) 4-methoxyphenylboronic acid was added. The 
reaction mixture was refluxed for 1 h. After work-up and column chromatography 
(silica gel, PE:EA 7:3) 60.7 mg (0.19 mmol, 95%) of 18 was isolated as a yellow solid 
compound. 
Rf(18) = 0.59 (DCM:EA 95:5) 
 
18 
1H-NMR (400 MHz, CDCl3):  
 = 1.21 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.41 (q, 
3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 3.88 (s, 3 H, 21-H), 5.99 (s, 1 H, 8-H), 
6.52 (dd, 3J1,6 = 9.0 Hz, 
4J1,3 = 2.6 Hz, 1 H, 1-H), 6.56 (d, 
4J3,1 = 2.6 Hz, 1 H, 
3-H), 7.01 (dt, 3J18,16 = 
3J17,15 = 8.8 Hz, 
4J18,17 = 
4J17,18 = 2.8 Hz, 2 H, 18-H, 
17-H), 7.31 (d, 3J6,1 =  9.1 Hz, 1 H, 6-H), 7.39 (dt, 
3J16,18 = 
3J15,17 = 8.8 Hz, 
4J16,15 = 
4J15,16 = 2.8 Hz, 2 H, 15-H, 16-H) 
13C-NMR (100 MHz, CDCl3): 
 = 12.5 (q, C-11/C13), 44.8 (t, C-12/C-10), 55.4 (q, C-20), 97.9 (d, C-3), 
108.0 (d, C-1/C-8), 108.4 (s, C-5), 114.1 (d, C-18/C-17), 127.9 (s, C-14), 
128.6 (d, C-6), 129.8 (d, C-16/C-15), 150.5 (s, C-2), 155.8 (s, C-4), 156.8 (s, 
C-9), 160.5 (s, C-19), 162.3 (s, C-7). 
Elemental Analysis:  
C20H21NO3  Calculated C 74.28 H 6.55 N 4.33 
(323.3920) Found  C 73.80 H 6.91 N 4.00 
HRMS (CI):   Calculated   Found 
C20H21NO3 [M]
+: 323.1516 323.1488 
Absorption max.:  376 nm 
Exitation max.: 379 nm 
Emission max.:  456 nm 
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Melting point:   121-123 °C 
7-(Diethylamino)-4-phenyl-2H-chromen-2-one (19) 
According to the GP-1 to the solution of 73 mg (0.2 mmol, 1 eq.) enol triflate 12, 
4.6 mg (4 µmol, 2 mol%.) Pd(PPh3)4 and 33 mg (0.24 mmol, 2 eq.) K2CO3 in 1 ml dry 
toluone 29 mg (0.24 mmol, 1.2 eq.) phenylboronic acid was added. The reaction 
mixture was refluxed for 1 h. After work-up and column chromatography (silica gel, 
PE:EA 7:3) 61.6 mg (0.2 mmol, quant) of 19 was isolated as a yellow solid compound. 
Rf(19) = 0.25 (PE:EA 7:3) 
 
19 
1H-NMR (400 MHz, CDCl3):  
 = 1.20 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.41 (q, 
3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 6.01 (s, 1 H, 8-H), 6.51 (dd, 
3J1,6  = 9.0 Hz, 
4J1,3 = 2.4 Hz, 1 H, 1-H), 6.57 (d, 
4J3,1 = 2.4 Hz, 1 H, 3-H), 7.25 (d, 
3J6,1 = 9.1 
Hz, 1 H, 6-H), 7.45 (m, 5 H, Phe).
13C-NMR (100 MHz, CDCl3): 
 = 12.5 (q, C-11/C13), 44.8 (t, C-12/C-10), 97.8 (d, C-3), 108.0 (d, C-1/C-
8), 108.5 (s, C-5), 127.9 (s, C-14), 128.4-129.2 (5d, C-Phe), 136.8 (s, C-14), 
150.6 (s, C-2), 156.1 (s, C-4), 156.8 (s, C-9), 162.2 (s, C-7). 
Elemental Analysis:  
C19H19NO2  Calculated C 77.79 H 6.53 N 4.77 
(293.3660) Found  C 77.76 H 6.71 N 4.62 
HRMS (CI):   Calculated   Found 
C19H19NO2 [M]
+: 293.1410 293.1410 
Absorption max.:  376 nm 
Exitation max.: 379 nm 
Emission max.:  464 nm 
Melting point:  119-120 °C 
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4-Benzoyl-7-(diethylamino)-2H-chromen-2-one (20) [157] 
To the solution of 73 mg (0.2 mmol, 1 eq.) enol triflate 12, 14 mg (20 µmol, 10 
mol%.) Pd(PPh3)2Cl2 and 33 mg (0.24 mmol, 2 eq.) K2CO3 in 2 ml anisole 29 mg (0.24 
mmol, 1.2 eq) phenylboronic acid was added. The reaction mixture was refluxed 
under CO atmosphere (15 bar) overnight Afterwards the reaction was quenched with 
1M NH4Cl, extracted with EA. The combined organic phase was dried over anhydrous 
Na2SO4, concentrated, and purified by column chromatography (silica gel, DCM, 
DCM:EA 95:5) to furnish 10.2 mg (0.032 mmol, 16%) of 20 as a yellow oil. 
Rf(20) = 0.35 (DCM:EA 9:1) 
 
20 
1H-NMR (400 MHz, CDCl3):  
 = 1.20 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.41 (q, 
3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 6.03 (s, 1 H, 8-H), 6.50 (dd, 
3J1,6  = 9.0 Hz, 
4J1,3 = 2.6 Hz, 1 H, 1-H), 6.55 (d, 
4J3,1 = 2.5 Hz, 1 H, 3-H), 7.17 (d, 
3J6,1 = 9.0 
Hz, 1 H, 6-H), 7.50 (m, 2 H, 17-H, 18-H ), 7.66 (m, 1 H, 19 H), 7.96 (m, 2 H, 
20-H, 16-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.5 (q, C-11/C13), 44.8 (t, C-12/C-10), 97.3 (d, C-3), 107.9 (d, C-1/C-
8), 108.4 (d, C-1/C-8), 108.5 (s, C-5), 127.7 (d, C-6), 128.4 (d, C-16/C-20), 
128.6 (d, C-19/C-17), 134.5 (d, C-18), 137.9 (s, C-15), 150.6 (s, C-2/C-4), 
156.1 (s, C-9), 159.3 (s, C-7), 197.5 (s, C-14) 
Elemental Analysis:  
C20H19NO3  Calculated C 74.75 H 5.96 N 4.36 
(321.3760) Found  C 74.50 H 6.24 N 4.16 
HRMS (CI):   Calculated   Found 
C20H19NO3 [M]
+: 321.1365 321.1362 
Absorption max.:  388 nm 
Exitation max.: 389 nm 
Emission max.:  500 nm 
Lifetime: 2.99 ns 
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7-(Diethylamino)-4-(3-hydroxyprop-1-yn-1-yl)-2H-chromen-2-one (21) 
According to the GP-2 to the solution of 23 mg (20 µmol, 2 mol%) Pd(PPh3)4, 4.5 
mg (23 µmol, 4 mol%) CuI and 365 mg (1 mmol, 1 eq.) enol triflate 12 in 5 ml abs. 
THF under nitrogen atmosphere 0.15 ml (1 mmol, 1 eq) Et3N and 0.1 ml (2 mmol, 2 
eq.) propargylic alcohol were added at rt. The reaction mixture was stirred for 2 h. 
After work-up and column chromatography (silica gel, DCM:EA 95:5) 218 mg (0.8 
mmol, 80%) of 21 was isolated as a yellow solid compound.  
Rf(21) = 0.24 (DCM:EA 9:1) 
 
21 
1H-NMR (400 MHz, CDCl3):  
 =  1.20 (t, 3J11.10 = 
3J13.12 = 7.1 Hz, 6 H, 13-H, 11-H), 2.15 (sh, 1 H, OH), 
3.41 (q, 3J10,11 =  
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 4.60 (s, 2 H, 16-H), 6.17 
(s, 1 H, 8-H), 6.45 (d, 4J3,1 = 2.5 Hz, 1 H, 3-H), 6.57 (dd, 
3J1,6 = 9.0 Hz, 
4J1,3 =  
2.5 Hz, 1 H, 1-H), 7.57 (d, 3J6,1 = 9.0 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3):  
 = 12.4 (q, C-11/C13), 44.8 (t, C-12/C-10), 51.5 (t, C-16), 80.0 (s, C-14), 
97.4 (s, C-15), 98.6 (d, C-3), 107.8 (d, C-1), 108.8 (s, C-5), 111.7 (d, C-8) 
127.5 (d, C-6), 136.8 (s, C-9), 151.1 (s, C-2), 156.1 (s, C-4), 161.7 (s, C-7). 
Elemental Analysis:  
C16H17NO3 Calculated C 70.83 H 6.32 N 5.16 
(271.32) Found  C 70.95 H 6.41 N 4.87 
HRMS (CI):   Calculated Found 
C16H18NO3 [M]
+: 271.1203 271.1209   
Absorption max.:  399 nm 
Exitation max.: 404 nm 
Emission max.:  479 nm 
Lifetime: 5.417 ns 
Melting point:  144-145 °C 
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N-(tert-butoxycarbonyl)-O-(prop-2-yn-1-yl)-L-serine (23) [158] 
To 25 mg (1.03 mmol, 1.03 eq.) NaH suspension in 1 ml abs. DMF the solution of 
219 mg (1 mmol, 1 eq.) N-Boc-L-serine in 1 ml abs. DMF was added at 0 °C. The 
reaction mixture was stirred for 1 h at 0 °C before 91 µl (121.73 mg, 1.03 mmol, 1.03 
eq.) propargylic bromide was added. The reaction mixture was stirred overnight. The 
solvent was evaporated in vacuo and the crude product was dissolved in dest. H2O 
and extracted 3x with diethylether; the water phase acidified with conc. HCl-solution 
to pH 2 and extracted again with EA. The combined organic layers were dried over 
Na2SO4 and the solvent was evaporated in vacuo. The crude product was purified by 
column chromatography (silica gel, PE:EA:HOAc 1:1:0.01) to furnish 170 mg (0.7 
mmol, 70%) of the desired product 23 as a light yellow oil. 
Rf(23) = 0.54 (PE:EA 1:1) 
 
23 
1H-NMR (400 MHz, CDCl3):  
 = 1.46 (s, 9 H, 1-H), 2.50 (t, 3J8,6 =  2.5 Hz, 1 H, 8-H), 3.90-4.02 (m, 2 H, 
5-H), 4.43 (s, 1 H), 4.42 (sh, 1 H, 4-H), 4.78 (d, 3J6,8 = 2.5 Hz, 1 H, 6-H), 
5.42 (sh, 1 H, NH).  
13C-NMR (100 MHz, CDCl3): 
 = 28.3 (q, C-1), 53.7 (d, C-4), 58.7 (t, C-6), 69.5 (t, C-5), 75.3 (d, C-8), 
78.7 (s, C-2), 80.4 (s, C-7), 155.7 (s, C-3), 175.1 (s, C-9). 
L-tert-Butyloxycarbonyl-O-propargyl-L-tyrosine methyl ester (25)  
563 mg (2 mmol, 1 eq.) Boc-tyrosine was dissolved in 4 ml abs. DMF, 331.7 mg 
(2.4 mmol, 1.2 eq.) K2CO3 and 0.18 ml (243 mg, 2.06 mmol, 1.03 eq.) propargylic 
bromide were added at 0 °C.  The reaction mixture was stirred overnight at rt before 
it was washed with sat. NaCl-solution. The aqueous layer was extracted 3x with EA 
and combined organic layers were dried over Na2SO4. The solvent was removed in 
vacuo and the crude product purified by column chromatography (silica gel, PE:EA 
7:3) to furnish 628 mg (1.97 mmol, 98.5 %) of 25 as a colourless oil. 
Rf(25) = 0.32 (PE:EA 7:3)
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25 
1H-NMR (400 MHz, CDCl3):  
 =  1.41 (s, 9 H, 13-H), 2.51 (t, 4J16,14 = 2.4 Hz, 1 H, 16-H), 3.02 (dq, 
3J7,8 = 
5.9 Hz, 2J7,7’  = 
2J7’ ,7 = 14.0 Hz, 2 H, 7-H, 7’-H), 3.70 (s, 3 H, 10-H), 4.54 (m, 
1 H, 8-H), 4.7 (d, 4J14,16 = 2.4 Hz, 2 H, 14-H), 4.96 (d, 
3JNH,8 = 7.9 Hz, 1H, 
NH), 6.90 (d, 3J3,4 = 
3J1,6 = 8.7 Hz, 2 H, 1-H, 3-H), 7.05 (d, 
3J4,3  = 
3J6,1 = 8.5 
Hz, 2 H, 6-H, 4-H). 
13C-NMR (100 MHz, CDCl3): 
 = 28.3 (q, C-13), 37.5 (t, C-7), 52.2 (q, C-10), 54.5 (t, C-14), 55.8 (d, C-8), 
75.2 (d, C-16), 78.6 (s, C-15/C-12), 79.9 (s, C-15/C-12), 115.0 (d, C-1/C-3) 
129.0 (s, C-5), 130.3 (d, C-4/C-6), 155.1 (s, C-2/C-11), 156.7 (s, C-2/C-11),  
172.4 (s, C-9). 
Elemental Analysis:  
C18H23NO5 Calculated C 64.85 H 6.95 N 4.20 
(333.3840) Found  C 64.57 H 6.84 N 4.71 
HRMS (CI):   Calculated Found 
C18H24NO5 [M+H]
+: 334.1649 334.1636  
N-(tert-Butoxycarbonyl)-O-(3-(7-(diethylamino)-2-oxo-2H-chromen-4-
yl)prop-argyl-L-serine (26) 
According to the GP-2 to the solution of 4.6 mg (4 µmol, 2 mol%) Pd(PPh3)4, 1.5 
mg (8 µmol, 4 mol%) CuI and 72 mg (0.2 mmol, 1 eq.) enol triflate 12 in 1 ml abs. THF 
under nitrogen atmosphere 27 µl (20 mg, 0.2 mmol, 1 eq) Et3N and 48 mg (0.2 mmol, 
1 eq.) N-(tert-butoxycarbonyl)-O-(prop-2-yn-1-yl)-L-serine 23 were added at rt. The 
reaction mixture was stirred for 1 h. After work-up and column chromatography 
(silica gel, DCM:MeOH 98:2) 81.5 mg (0.178 mmol, 90%) of 26 was isolated as a 
yellow solid compound. 
Rf(26) = 0.15 (DCM:MeOH 95:5)
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26 
1H-NMR (400 MHz, CDCl3):  
 = 1.18 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 1.43 (s, 9 H, 22-H), 
3.09 (sh, 1 H, OH), 3.38 (q, 3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 3.93 
(d, 2J17,17’  = 11.0 Hz, 1 H, 17-H), 4.07-4.12 (sh, 1 H, 17’-H), 4.44 (sh, 1 H, 
18-H), 5.05 (s, 2 H, 16-H), 5.62 (d, 3JNH,18 = 7.4 Hz, 1 H, NH), 6.08 (s, 1 H, 
8-H), 6.40 (d, 4J3,1  = 2.5 Hz, 1 H, 3-H), 6.56 (dd, 
3J1,6 = 9.0 Hz, 
4J1,3 = 2.5 Hz, 
1 H, 1-H), 7.49 (d, 3J6,1 = 9.0 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 14.1 (q, C-11/C13), 28.3 (q, C-22), 44.8 (t, C-12/C-10), 53.2 (d, C-18), 
55.8 (t, C-16), 63.2 (t, C-17), 80.3 (s, C-14/C-21), 81.1 (s, C-14/C-21), 93.5 
(s, C-15), 97.3 (d, C-3), 107.6 (d, C-1), 109.0 (s, C-5), 111.6 (d, C-8) 127.5 
(d, C-6), 136.3 (s, C-9), 151.1 (s, C-2), 151.1 (s, C-4), 156.1 (s, C-20), 161.6 
(s, C-7), 170 (s, C-19). 
Elemental Analysis:  
C24H30N2O7 Calculated C 62.87 H 6.59 N 6.11 
(458.5110) Found  C 63.13 H 6.13 N 5.85 
HRMS (CI):   Calculated Found 
C24H30N2O7 [M]
+: 458.2048 458.2033  
Absorption max.:  401 nm 
Exitation max.: 409 nm 
Emission max.:  498 nm 
Lifetime: 5.90 ns 
Melting point:  88-90 °C 
L-tert-Butyloxycarbonyl-(3-(7-(diethylamino)-2-oxo-2H-chromen-4-yl)-O-pro-
pargyl-L-tyrosine methyl ester (27) 
According to the GP-2 to the solution of 6 mg (5 µmol, 2 mol%) Pd(PPh3)4, 1.9 mg 
(10 µmol, 4 mol%) CuI and 91 mg (0.25 mmol, 1.3 eq.) enol triflate 12 in 1.25 ml abs. 
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THF under nitrogen atmosphere 40 µl (25 mg, 0.25 mmol, 1.3 eq) Et3N and 61 mg 
(0.19 mmol, 1 eq.) L-tert-butyloxycarbonyl-O-propargyl-L-tyrosine methyl ester 25 
were added at rt. The reaction mixture was stirred for 2 h. After work-up and column 
chromatography (silica gel, PE:EA 7:3) 97.5 mg (0.178 mmol, 94%) of 27 was isolated 
as a yellow solid compound. 
Rf(27) = 0.30 (DCM:EA 95:5) 
 
27 
1H-NMR (400 MHz, CDCl3):  
 = 1.20 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 1.41 (s, 9 H, 29-H), 
3.05 (sh, 2 H, 23-H), 3.41 (q, 3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 3.70 
(s, 3 H, 26-H), 4.56 (m, 1 H, 24-H), 4.98 (s, 2 H, 16-H), 6.15 (s, 1 H, 8-H), 
6.45 (d, 4J3,1 = 2.5 Hz, 1 H, 3-H), 6.55 (dd, 
3J1,6 = 9.0 Hz, 
4J1,3 = 2.5 Hz, 1 H, 
1-H), 6.97 (d, 3J22,21 = 
3J18,19 = 8.6 Hz, 2 H, 22-H, 18-H), 7.09 (d, 
3J21,22 = 
3J19,18 = 8.6 Hz, 2 H, 21-H, 19-H), 7.43 (d, 
3J6,1 = 8.9 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 28.3 (q, C-29), 37.6 (t, C-23), 44.8 (t, C-12/C-10), 
52.2 (q, C-26), 54.5 (t, C-16), 56.5 (d, C-24), 80.1 (s, C-28), 81.6 (s, C-14), 
94.0 (s, C-15), 97.4 (d, C-3), 107.7 (d, C-1), 108.9 (s, C-5), 115.4 (d, C-
18/C-22) 127.6 (d, C-6), 129.3 (d, C-20), 130.5 (d, C-19/C-21), 146.5 (s, C-
2/C-9), 151.1 (s, C-4), 155.1 (s, C-17), 161.4 (s, C-7), 172.3 (s, C-25). 
Elemental Analysis:  
C31H36N2O7 Calculated C 67.87 H 6.61 N 5.11 
(548.6360) Found  C 66.46 H 6.67 N 4.85 
HRMS (CI):   Calculated Found 
C31H36N2O7 [M]
+: 548.2523 548.2523  
Absorption max.:  400 nm 
Exitation max.: 409 nm 
Emission max.:  488 nm 
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Lifetime: 5.81 ns 
Melting point:  89-91 °C 
N-(tert-Butoxycarbonyl)-O-(3-(7-(diethylamino)-2-oxo-2H-chromen-4-
yl)prop-2-yn-1-yl)-L-seryl-L-leucine methyl ester (29) 
According to the GP-2 to the solution of 6 mg (5 µmol, 2 mol%) Pd(PPh3)4, 1.9 mg 
(10 µmol, 4 mol%) CuI and 91 mg (0.25 mmol, 1.3 eq.) enol triflate 12 in 1.25 ml abs. 
THF under nitrogen atmosphere 40 µl (25 mg, 0.25 mmol, 1.3 eq) Et3N  and 70 mg 
(0.19 mmol, 1 eq.) dipeptide 28 were added at rt. The reaction mixture was stirred 
for 2 h. After work-up and column chromatography (silica gel, DCM:EA 95:5) 105.4 
mg (0.18 mmol, 95%) of 29 was isolated as a yellow solid compound. 
Rf(29) = 0.22 (DCM:EA 95:5) 
 
29 
1H-NMR (400 MHz, CDCl3):  
 = 0.91 (dd, 3J26,25 = 5.9 Hz, 6 H, 26-H), 1.20 (t, 
3J11.10 =  
3J13.12  =  7.1 Hz, 6 
H, 13-H, 11-H), 1.46 (s, 9 H, 21-H), 1.60-1.69 (sh, 3 H, 25-H, 24-H), 3.41 
(q, 3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 3.69-3.71 (m, 4 H, 17’-H, 28-
H), 4.06 (dd, 3J17,17’ = 9.05 Hz, 
3J17,18 = 3.8 Hz, 1 H, 17-H), 4.35 (bs, 1 H, 18-
H), 4.52 (s, 2 H, 16-H), 4.64 (m, 1 H, 23-H), 5.42 (bs, 1 H, NH-Ser), 6.17 (s, 
1 H, 8-H), 6.45 (d, 4J3,1 = 2.5 Hz, 1 H, 3-H), 6.61 (dd, 
3J1,6 =  9.0 Hz, 
4J1,3 = 
2.5 Hz, 1 H, 1-H), 6.87 (d, 3JNH-I le,23 = 6.2 Hz, 1 H, NH-Ile), 7.56 (d, 
3J6,1 =  
8.9 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 22.9 (q, C-26), 24.8 (d, C-25), 28.3 (q, C-21), 41.6 
(t, C-24), 44.8 (t, C-12/C-10), 50.9 (q, C-28), 51.6 (d, C-23/C-18), 52.3 (d, 
C-23/C-18), 59.3 (t, C-16), 69.8 (t, C-17), C-20 under CDCl3, 81.3 (s, C-14), 
97.4 (d, C-3), 107.7 (d, C-1), 108.9 (s, C-5), 111.9 (d, C-8) 127.6 (d, C-6), 
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136.5 (s, C-9), 151.1 (s, C-2), 156.4 (s, C-4), 161.4 (s, C-19), 169.8 (s, C-7), 
173.0 (s, C-22/C-27), 173.4 (s, C-22/C-27). 
Elemental Analysis:  
C31H43N3O8 Calculated C 63.57 H 7.40 N 7.17 
(585.6980) Found  C 62.69 H 7.59 N 6.41 
HRMS (CI):   Calculated Found 
C31H43N3O8 [M]
+: 585.3045 585.3055  
Absorption max.:  400 nm 
Exitation max.: 407 nm 
Emission max.:  483 nm 
Lifetime: 5.69 ns 
Melting point:  98-100 °C 
N-(tert-Butoxycarbonyl)-O-(3-(7-(diethylamino)-2-oxo-2H-chromen-4-
yl)prop-2-yn-1-yl)-L-seryl-L-valyl-L-phenylalanine methyl ester (31) 
According to the GP-2 to the solution of 6 mg (5 µmol, 2 mol%) Pd(PPh3)4, 1.9 mg 
(10 µmol, 4 mol%) CuI and 91 mg (0.25 mmol, 1.3 eq.) enol triflate 12 in 1.25 ml abs. 
THF under nitrogen atmosphere 40 µl (25 mg, 0.25 mmol, 1.3 eq) Et3N and 96 mg 
(0.19 mmol, 1 eq.) tripeptide 30 were added at rt. The reaction mixture was stirred 
for 2 h. After work-up and column chromatography (silica gel, DCM:EA 95:5) 105.4 
mg (0.18 mmol, 95%) of 31 was isolated as a yellow solid compound. 
Rf(31) = 0.13 (DCM:EA 9:1) 
 
31 
 
1H-NMR (400 MHz, CDCl3):  
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 = 0.86 and 0.92 (2d, 3J26/25,24 = 6.8 Hz, 6 H, 26-H, 25-H), 1.20 (
3J11.10 = 
3J13.12 = 7.1 Hz, 6 H, 13-H, 11-H), 1.46 (s, 9 H, 21-H), 2.17 (dt, 
3J24,26/25 = 
6.7 Hz, 3J24,23 = 13.1 Hz, 1 H, 24-H), 3.09 (m, 2H, 29-H, 29’-H), 3.41 (q, 
3J10,11 = 
3J12,13 =  7.1 Hz, 4 H, 12-H, 10-H), 3.67-3.72 (sh, 4 H, 17’-H, 35-H), 
4.05 (dd, 3J17,17’ = 9.0 Hz,  
3J17,18 = 4.0 Hz, 1 H, 17-H), 4.27 (dd, 
3J23,24 = 8.7 
Hz,  
3J23,NH = 5.9 Hz, 1 H, 23-H), 4.35 (bs, 1 H, 18-H), 4.52 (s, 2 H, 16-H), 
4.64  (m, 1 H, 23-H), 5.42 (bs, 1 H, NH-Ser), 6.17 (s, 1 H, 8-H), 6.45 (d, 4J3,1 
= 2.5 Hz, 1 H, 3-H), 6.61 (dd, 3J1,6 = 9.0 Hz, 
4J1,3 = 2.5 Hz, 1 H, 1-H), 6.87 (d, 
3JNH-I le,23 = 6.2 Hz, 1 H, NH-Ile), 7.56 (d, 
3J6,1  = 8.9 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 22.9 (q, C-26), 24.8 (d, C-25), 28.3 (q, C-21), 41.6 
(t, C-24), 44.8 (t, C-12/C-10), 50.9 (q, C-28), 51.6 (d, C-23/C-18), 52.3 (d, 
C-23/C-18), 59.3 (t, C-16), 69.8 (t, C-17), C-20 under CDCl3, 81.3 (s, C-14), 
97.4 (d, C-3), 107.7 (d, C-1), 108.9 (s, C-5), 111.9 (d, C-8) 127.6 (d, C-6), 
136.5 (s, C-9), 151.1 (s, C-2), 156.4 (s, C-4), 161.4 (s, C-19), 169.8 (s, C-7), 
173.0 (s, C-22/C-27), 173.4 (s, C-22/C-27). 
Elemental Analysis:  
C39H50N4O9 Calculated C 65.16 H 7.01 N 7.79 
(718.8480) Found  C 64.40 H 7.10 N 7.55 
HRMS (CI):   Calculated Found 
C39H50N4O9 [M]
+: 718.3572 718.3586  
Absorption max.:  398 nm 
Exitation max.: 407 nm 
Emission max.:  485 nm 
Lifetime: 5.72 ns 
Melting point:  101-104 °C 
4-O-proparg-benzaldehyde (32) [139] 
To the solution of 1.22 g (10 mmol, 1 eq.) 4-hydroxybenzaldehyde in 50 ml 
acetone 1.94 g (14 mmol, 1.4 eq) K2CO3 was added and the mixture was refluxed for 
30 minute. 2.22 ml (20 mmol, 2 eq.) propargylbromide was added and the mixture 
was refluxed for another 2 h before the solvent was evaporated in vacuo. The crude 
product was dissolved in water and extracted 3x with EA. The combined organic 
layers were washed with water and brine, dried over Na2SO4. The solvent was 
removed in vacuo. The crude product was purified by column chromatography (silica 
gel, PE:EA 7:3) to furnish 1.5 g (9.5 mmol, 95%) of the desired product 32 as a white 
solid compound. 
Rf(32) = 0.29 (PE:EA 7:3) 
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32 
1H-NMR (400 MHz, CDCl3):  
 = 2.57 (t, 2J10,8 = 2.4 Hz, 1 H, 10-H), 4.78 (d, 
2J8,10 = 2.4 Hz, 2 H, 8-H), 
7.09 (dt, 3J2,1 = 
3J4,5 =  8.8 Hz, 
4J2,4 = 
4J4,2 =  2.6 Hz, 2 H, 2-H, 4-H), 7.86 (dt, 
3J1,2 = 
3J5,4 =  8.8 Hz, 
4J1,5 = 
4J5,1 =  2.6 Hz, 2 H, 1-H, 5-H), 9.90 (s, 1 H, 7-H). 
13C-NMR (100 MHz, CDCl3): 
 = 56.0 (t, C-8), 76.4 (d, C-10), 77.5 (s, C-9), 115.2 (d, C-2/C-4), 130.6 (s, 
C-6), 131.9 (d, C1/C-5), 162.4 (s, C-3), 190.8 (s, C-7). 
2-(N-Benzyl-2-((tert-butoxycarbonyl)amino)acetamido)-2-(4-(prop-2-yn-1-yl-
oxy)phenyl)acetyl)glycine ester (33) 
According to the GP 3 0.1 ml (107 mg, 1 mmol, 1 eq.) benzylamine, 160 mg (1 
mmol, 1 eq.) aldehyde 32, and 175 mg (1 mmol, 1 eq.) Boc-glycine reacted with 113 
mg (1 mmol, 1 eq.) isocyanide. The reaction mixture was stirred for 24 h. Work-up 
and column purification (silica gel, DCM:EA 98:2, 9:1) furnished 323 mg (0.6 mmol, 
60%) of the product 33 as a white solid compound. 
Rf(33) = 0.32 (DCM:EA 8:2) 
 
33 
1H-NMR (400 MHz, CDCl3):  
 = 1.26 (t, 3J1,2 = 7.1 Hz, 3 H, 1-H), 1.41 (s, 9 H, 16-H), 2.50 (t, 
4J23,21 = 2.4 
Hz, 1 H, 23-H), 3.78 (dd, 3J13,NHa = 17.3 Hz, 
2J13,13’  = 3.9 Hz, 1 H, 13-H), 4.04 
(m, 3 H, 13’-H, 4-H), 4.18 (q, 3J2,1 = 7.1 Hz, 2 H, 2-H), 4.48 (d, 
2J17,17’  = 17.5 
Hz, 17-H), 4.63 (d, 4J21,23 = 2.4 Hz, 2 H, 21-H), 4.63-4,65 (sh, 1 H, 17’-H), 
5.44 (bs, 1 H, NHa), 5.81 (bs, 1 H, 6-H), 6.28 (bs, 1 H, NHb), 6.85-7.32 (m, 9 
H, HAr). 
13C-NMR (100 MHz, CDCl3): 
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 = 14.1 (q, C-1), 28.3 (q, C-16), 41.5 (t, C-13), 43.0 (t, C-4), 55.8 (t, C-7), 
61.5 (t, C-2), 63.1 (t, C-21), 75.8 (d, C-23), 78.1 (s, C-22/C-15), 115.2 (d, C-
19), 126.2-128.6 (d, C-9/C-10/C-11/C-17/C-18), 131.4 (s, C-8), 157.9 (s, C-
20/C-14), 169.5 (s, C-5/C-3). 
Elemental Analysis:  
C29H35N3O7 Calculated C 64.79 H 6.56 N 7.82  
(537.6130) Found  C 63.93 H 6.53 N 7.78 
HRMS (CI):   Calculated   Found 
C29H36N3O7 [M+H]
+: 538.2548 538.2552  
Melting point:   97-99 °C 
2-((S)-N-Benzyl-2-((tert-butoxycarbonyl)amino)propanamido)-2-(4-(prop-2-
yn-1-yloxy)phenyl)acetyl)glycine ester (34) 
According to the GP 3 0.1 ml (107 mg, 1 mmol, 1 eq.) benzylamine, 160 mg (1 
mmol, 1 eq.) aldehyde 32, and 189 mg (1 mmol, 1 eq.) Boc-alanine reacted with 113 
mg (1 mmol, 1 eq.) isocyanide. The reaction mixture was stirred for 24 h. Work-up 
and column chromatography (silica gel, DCM:EA 98:2, 9:1) furnished 331 mg (0.6 
mmol, 60%) of the product 34 as a white solid compound (dr = 58:42). 
Rf(34) = 0.13 (DCM:EA 9:1) 
 
34 
Mixture of diastereomers 
1H-NMR (400 MHz, CDCl3):  
 ppm 1.23-1.29 (t, 3J1,2 = 7.1 Hz, 3 H, 1-H), 1.49-1.45 (s, 9 H, 17-H), 2.50 
(t, 4J24,22 = 2.4 Hz, 1 H, 24-H), 3.78-4.27 (m, 4 H, 2-H, 4-H), 4.33 (m, 1 H, 
13-H), 4.50-4.74 (m, 4 H, 22-H, 7-H),  5.77 (bs, 1 H, NHa), 6.03 (bs, 1 H, 6-
H), 6.30 (bs, 1 H, NHb), 6.79-7.37 (m, 9 H, HAr). 
13C-NMR (100 MHz, CDCl3): 
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 = 14.1 (q, C-1), 17.3 (q, C-14), 28.3 (q, C-17), 41.6 (t, C-4), 47.1 (t, C-7), 
50.1 (d, C-13), 55.8 (t, C-22), 61.5 (t, C-2), 63.2 (t, C-6), 75.7 (d, C-24), 
78.3 (s, C-23), 80.2 (s, C-16), 115.2 (d, C-19), 126.6-128.6 (d, C-9/C-10/C-
11/C-18/C-20), 131.6 (s, C-8), 156.1 (s, C-21), 157.7 (s, C-15), 169.5 (s, C-
5/C-3/C-15). 
Elemental Analysis:  
C30H37N3O7 Calculated C 65.32 H 6.76 N 7.62  
(551.6307) Found  C 64.87 H 6.74N 7.50 
HRMS (CI):   Calculated   Found 
C30H38N3O7 [M+H]
+: 552.2704 552.2723  
Melting point:   60-64 °C 
2-((S)-N-Benzyl-2-((tert-butoxycarbonyl)amino)-3-phenylpropanamido)-2-(4-
(prop-2-yn-1-yloxy)phenyl)acetyl)glycine ester (35) 
According to the GP 3 0.1 ml (107 mg, 1 mmol, 1 eq.) benzylamine, 160 mg (1 
mmol, 1 eq.) aldehyde 32, and 265 mg (1 mmol, 1 eq.) Boc-phenylalanine reacted 
with 113 mg (1 mmol, 1 eq.) isocyanide. The reaction mixture was stirred for 24 h. 
Work-up and column purification (silica gel, PE:EA 7:3, 6:4) furnished 365 mg (0.63 
mmol, 63%) of the product 35 as a white solid compound. 
Rf(35) = 0.13 (PE:EA 7:3) 
 
35 
Mixture of diastereomers (dr = 53:47)  
1H-NMR (400 MHz, CDCl3):  
 = 1.25-1.31 (m, 3 H, 1-H), 1.35-1.37 (s, 9 H, 21-H), 2.49 (t, 4J24,22 = 2.2 
Hz, 1 H, 24-H), 2.57-2.69 (m, 2 H, 14-H), 3.80-4.29 (m, 4 H, 2-H, 4-H), 
4.37-4.43 (m, 1 H, 13-H), 4.48-4.74 (m, 4 H, 22-H, 7-H),  5.57 (bs, 1 H, 
NHa), 6.18 (s, 1 H, 6-H), 6.65-7.37 (m, 15 H, HAr,  NHb). 
13C-NMR (100 MHz, CDCl3): 
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 = 14.1 (q, C-1), 28.3 (q, C-21), 38.0 (t, C-14), 41.6 (t, C-4), 50.1 (t, C-7),  
55.8 (t, C-22/d, C-13), 61.4 (t, C-2), 63.02 (t, C-6), 75.7 (d, C-24), 78.3 (s, 
C-23), 79.6 (s, C-20), 115.2 (d, C-20), 126.5-129.6 (d, C-9/C-10/C-11/C-
13/C-17/C-18/C-19), 136.3 (s, C-8/C-15), 137.4 (s, C-8/C-15), 156.1 (s, C-
21/C-19), 157.7 (s, C-21/C-19), 169.5 (s, C-5/C-3/C-12). 
Elemental Analysis:  
C36H41N3O7 Calculated C 68.88 H 6.58  N 6.69  
(627.7266) Found  C 68.52 H 6.52  N 6.65 
HRMS (CI):   Calculated   Found 
C36H42N3O7 [M+H]
+: 628.3017 628.3029  
Melting point:   60-64 °C 
2-(N-Benzyl-2-((tert-butoxycarbonyl)amino)acetamido)-2-(4-((3-(7-(diethyl-
amino)-2-oxo-2H-chromen-4-yl)prop-2-yn-1-yl)oxy)phenyl)acetyl)glycine 
ester (36) 
According to the GP 2 to the solution of 6 mg (5 µmol, 2 mol%) Pd(PPh3)4, 1.9 mg 
(10 µmol, 4 mol%) CuI and 91 mg (0.25 mmol, 1.3 eq.) enol triflate 12 in 1.25 ml abs. 
THF 45 µl (32.9 mg, 0.325 mmol, 1.3 eq.) Et3N and 102 mg (0.19 mmol, 1 eq.) 
tripeptide 33 were added at rt and the reaction mixture was stirred at rt for 2 h. 
Work-up and column chromatography (silica gel, DCM:MeOH 98:2) furnished 140.78 
mg (0.187 mmol, 98%) of the product 36 as a yellow solid compound. 
Rf(36) = 0.34 (DCM:MeOH 95:5)
  
 
36 
1H-NMR (400 MHz, CDCl3):  
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 = 1.16 (t, 3J11,10  = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 1.21 (t, 
3J17,18 = 7.1 
Hz, 3 H, 17-H), 1.37 (s, 9 H, 32-H), 3.37 (q, 3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-
H, 10-H), 3.72 (dd, 3J29,NHa = 2.8 Hz, 1 H, 29-H), 3.99 (m, 3 H, 29’-H, 20-H), 
4.18 (q, 3J18,17 = 7.1 Hz, 2 H, 18-H), 4.47 (d, 
2J23,23’  = 17.7 Hz, 1 H, 23-H), 
4.65 (d, 2J23’,23 = 17.5 Hz, 1 H, 23’-H), 4.90 (s, 2 H, 16-H), 5.47 (bs, 1 H, 
NHa), 5.93 (bs, 1 H, 22-H), 6.05 (s, 1 H, 8-H), 6.40 (d, 
4J3,1 = 2.3 Hz, 1 H, 3-
H), 6.53 (dd, 3J1,6 = 9.0 Hz, 
4J1,3 = 2.2 Hz, 1 H, 1-H), 6.63 (bs, 1 H, NHb), 
6.87-7.33 (m, 9 H, HAr), 7.42 (d, 
3J6,1  = 8.9 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 14.2 (q, C-17), 28.3 (q, C-32), 41.5 (t, C-20), 43.0 
(t, C-29), 44.8 (t, C-12/C-10), 49.5 (t, C-23), 56.4 (t, C-16), 61.5 (t, C-18), 
C-22 not seen, 79.6 (s, C-31), 81.7 (s, C-14), 94.4 (s, C-15), 97.4 (d, C-3), 
107.6 (d, C-1), 108.8 (s, C-5), 112.0 (d, C-8), 115.3 (d, C-35), 126.2-128.9 
(d, C-6/C-25/C-26/C-27/C-33/C-34), 136.2 (s, C-24/C-9), 151.1 (s, C-2), 
156.2 (s, C-4/C-36), 157.8 (s, C-30), 161.3 (s, C-28/C-7), 169.5 (s, C-21/C-
19), 170.7 (s, C-21/C-19). 
Elemental Analysis:  
C42H48N4O9 Calculated C 67.01 H 6.43 N 7.44 
(752.8650) Found  C 66.76 H 6.66 N 7.31 
HRMS (CI):   Calculated Found 
C42H49N4O9 [M+H]
+: 753.3494 753.3475  
Absorption max.:  398 nm 
Exitation max.: 411 nm 
Emission max.:  490 nm 
Lifetime: 5.85 ns 
Melting point:  99-101 °C 
2-((S)-N-Benzyl-2-((tert-butoxycarbonyl)amino)propanamido)-2-(4-((3-(7-(di-
ethylamino)-2-oxo-2H-chromen-4-yl)prop-2-yn-1-yl)oxy)phenyl)acetyl)glyci-
ne ester (37) 
According to the GP 2 to the solution of 6 mg (5 µmol, 2 mol%) Pd(PPh3)4, 1.9 mg 
(10 µmol, 4 mol%) CuI and 91 mg (0.25 mmol, 1.3 eq.) enol triflate 12 in 1.25 ml abs. 
THF 45 µl (32.9 mg, 0.325 mmol, 1.3 eq.) Et3N and 105 mg (0.19 mmol, 1 eq.) 
tripeptide 34 were added at rt and the reaction mixture was stirred at rt for 2 h. 
Work-up and column chromatography (silica gel, DCM:MeOH 98:2) furnished 136.9 
mg (0.179 mmol, 94%) of the product 37 as a yellow solid compound. 
Rf(37) = 0.11 (DCM:EA 95:5) 
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37 
1H-NMR (400 MHz, CDCl3):  
 = 0.89 (d, 3J30,29 = 6.6 Hz, 3 H, 30-H), 1.19 (t, 
3J11,10 =  
3J13,12 = 7.1 Hz, 6 H, 
11-H, 13-H), 1.23-1.29 (t, 3J1,2 = 7.1 Hz, 3 H, 17-H), 1.39-1.46 (s, 9 H, 33-
H), 3.40 (q, 3J10,11 = 
3J12,13 = 7.0 Hz, 4 H, 10-H, 12-H), 3.92-4.24 (m, 4 H, 
20-H, 18-H), 4.33 (m, 1 H, 29-H), 4.52-4.72 (sh, 1 H, 23-H),  4.93-5.11 (m, 
3 H, 16-H, 23’-H), 5.77 (bs, 1 H, NHa), 6.13-6.15 (m, 2 H, 6-H, 8-H), 6.32 
(bs, 1 H, NHb), 6.42-6.44 (m, 1 H, 3-H), 6.56-6.59 (m, 1 H, 1-H), 6.86-7.43 
(m, 9 H, HAr), 7.46 (d, 
3J6,1 = 9.0 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 14.2 (q, C-17), 17.1 (q, C-30), 28.3 (q, C-33), 41.6 
(t, C-20), 44.8 (t, C-12/C-10), 50.1 (t, C-23), 50.8 (d, C-29), 56.5 (t, C-16), 
61.5 (t, C-18), 80.3 (s, C-32), 81.7 (s, C-14), 94.6 (s, C-15), 97.4 (d, C-3), 
107.6 (d, C-1), 108.9 (s, C-5), 112.0 (d, C-8), 115.3 (d, C-36), 126.5-128.5 
(d, C-6/C-25/C-26/C-27/C-34/C-35), 136.3 (s, C-24/C-9), 151.1 (s, C-2), 
156.2 (s, C-4/C-37), 157.8 (s, C-31), 161.3 (s, C-28/C-7), 169.5 (s, C-21/C-
19). 
Elemental Analysis:  
C43H50N4O9 Calculated C 67.35 H 6.57 N 7.31 
(766.8785) Found  C 67.15 H 6.46 N 6.52 
HRMS (CI):   Calculated Found 
C43H51N4O9 [M+H]
+: 767.3651 767.3660  
Absorption max.:  400 nm 
Exitation max.: 411 nm 
Emission max.:  489 nm 
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Lifetime: 5.85 ns 
Melting point:   95-100 °C 
2-((S)-N-Benzyl-2-((tert-butoxycarbonyl)amino)-3-phenylpropanamido)-2-(4-
((3-(7-(diethylamino)-2-oxo-2H-chromen-4-yl)prop-2-yn-1-yl)oxy)phenyl)ace-
tyl)glycine ester (38) 
According to the GP 2 to the solution of 6 mg (5 µmol, 2 mol%) Pd(PPh3)4, 1.9 mg 
(10 µmol, 4 mol%) CuI and 91 mg (0.25 mmol, 1.3 eq.) enol triflate 12 in 1.25 ml abs. 
THF 45 µl (32.9 mg, 0.325 mmol, 1.3 eq.) Et3N and 119 mg (0.19 mmol, 1 eq.) 
tripeptide 35 were added at rt and the reaction mixture was stirred at rt for 2 h. 
Work-up and column chromatography (silica gel, DCM:MeOH 98:2) furnished 161.1 
mg (0.19 mmol, quant.) of the compound 38 as a yellow solid compound. 
Rf(38) = 0.15 (DCM:EA 95:5) 
 
38 
1H-NMR (400 MHz, CDCl3):  
 = 1.19 (t, 3J11,10 =  
3J13,12 = 7.1 Hz, 6 H, 11-H, 13-H), 1.25-1.31 (m, 3 H, 
17-H), 1.35-1.36 (s, 9 H, 33-H), 2.54-2.67 (m, 2 H, 30-H), 3.40 (q, 3J10,11 = 
3J12,13 = 7.0 Hz, 4 H, 10-H, 12-H), 3.79-4.30 (m, 4 H, 20-H, 18-H), 4.34-4.77 
(m, 2 H, 29-H, 23-H), 4.93-5.27 (m, 3 H, 16-H, 23’-H), 5.58 (bs, 1 H, NHa), 
6.12-6.16 (m, 2 H, 6-H, 8-H), 6.27 (bs, 1 H, NHb), 6.42-6.44 (m, 1 H, 3-H), 
6.55-6.62 (m, 1 H, 1-H), 6.88-7.47 (m, 15 H, HAr, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 14.2 (q, C-17), 28.2 (q, C-37), 37.8 (q, C-30), 41.5 
(t, C-20), 44.8 (t, C-12/C-10), 50.0 (t, C-23), 56.4 (d, C-29), 57.1 (t, C-16), 
61.4 (t, C-18), 79.7 (s, C-36), 81.7 (s, C-14), 94.6 (s, C-15), 97.4 (d, C-3), 
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107.6 (d, C-1), 108.9 (s, C-5), 111.9 (d, C-8), 115.4 (d, C-40), 126.5-128.9 
(d, C-6/C-25/C-26/C-27/C-38/C-39/C-32/C-33/C-34), 136.3 (s, C-24/C-9/C-
31), 151.1 (s, C-2), 156.2 (s, C-4/C-41), 157.8 (s, C-35), 161.4 (s, C-7), 
169.5 (s, C-21/C-19). 
Elemental Analysis:  
C49H54N4O9 Calculated C 69.82 H 6.46 N 6.65 
(842.9745) Found  C 68.67 H 6.41 N 6.15 
HRMS (CI):   Calculated Found 
C49H55N4O9 [M+H]
+: 843.3964 843.3980  
Absorption max.:  404 nm 
Exitation max.: 411 nm 
Emission max.:  486 nm 
Lifetime: 5.78 ns 
Melting point:  86-88 °C 
Methyl 7-(diethylamino)-2-oxo-2H-chromene-4-carboxylate (39) 
To the solution of 44 mg (0.12 mmol, 1 eq.) enol triflate 12 in 1.6 ml dry toluone 
and 0.2 ml MeOH 8.4 mg (12 µmol, 10 mol%.) Pd(PPh3)2Cl2 and 33 µl (24.3 mg, 0.24 
mmol, 2 eq.) Et3N were added. The reaction mixture was stirred under CO 
atmosphere (15 bar) at rt overnight. Afterwards the reaction was quenched with 1N 
KHSO4-solution, extracted 3x with EA. The combined organic phase was filtered 
through a celite and dried over anhydrous Na2SO4, The solvent was removed in 
vacuo and the crude product purified by column chromatography (silica gel, DCM) to 
furnish 31.7 mg (0.115 mmol, 97%) of the product 39 as a yellow solid compound. 
Rf(39) = 0.33 (PE:EA 7:3) 
 
39 
1H-NMR (400 MHz, CDCl3):  
 = 1.21 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.42 (q, 
3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 3.96 (s, 3 H, 15-H), 6.51 (d, 
4J3,1  = 2.6 Hz, 
1 H, 3-H), 6.52 (s, 1 H, 8-H), 6.60 (dd, 3J1,6 = 9.2 Hz, 
4J1,3 = 2.6 Hz, 1 H, 1-
H), 8.00 (d, 3J6,1 = 9.2 Hz, 1 H, 6-H). 
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13C-NMR (100 MHz, CDCl3): 
 = 12.6 (q, C-11/C13), 44.7 (t, C-12/C-10), 52.8 (q, C-15), 97.6 (d, C-3), 
104.1 (d, C-1), 109.1 (s, C-5), 111.3 (d, C-8) 127.7 (d, C-6), 150.8 (s, C-4/C-
2), 157.2 (s, C-9), 165.1 (s, C-7), 168.2 (s, C-14). 
Elemental Analysis:  
C15H17NO4 Calculated C 65.44 H 6.22 N 5.09  
(275.2998) Found  C 65.49 H 6.11 N 4.92  
HRMS (CI):   Calculated Found 
C15H17NO4 [M]
+: 275.1158 275.1171 
Absorption max.:  396 nm 
Exitation max.: 410 nm 
Emission max.:  536 nm 
Lifetime: 5.89 ns 
7-(Diethylamino)-2-oxo-2H-chromene-4-carbonyl)glycine methyl ester (40) 
According to the GP-4 to the solution of 73 mg (0.2 mmol, 1 eq.) enol triflate 12 
and 30 mg (0.24 mmol, 1.2 eq.) glycine methyl ester hydrochloride in 2 ml dry 
toluone 14 mg (20 µmol, 10 mol%.) Pd(PPh3)2Cl2 and 55 µl (0.4 mmol, 2 eq.) Et3N 
were added. The reaction mixture was stirred under CO atmosphere (15 bar) at rt 
overnight. After work-up and column chromatography (silica gel, DCM:EA 95:5, 9:1) 
57.1 mg (0.17 mmol, 86%) of 40 was isolated as a yellow solid compound. 
Rf(40) = 0.19 (DCM:EA 8:2) 
 
40 
1H-NMR (400 MHz, CDCl3):  
 = 1.20 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.41 (q, 
3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 3.81 (s, 3 H, 17-H), 4.24 (d, 
3J15,NH = 5.5 
Hz, 2 H, 15-H), 6.13 (s, 1 H, 8-H), 6.47 (d, 4J3,1 = 2.3 Hz, 1 H, 3-H), 6.58 
(dd, 3J1,6 = 9.1 Hz, 
4J1,3 = 2.6 Hz, 1 H, 1-H), 6.69 (sh, 1 H, NH), 7.64 (d, 
3J6,1 
= 9.1 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
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 = 12.4 (q, C-11/C13), 41.4 (t, C-15), 44.8 (t, C-12/C-10), 52.6 (q, C-17), 
97.7 (d, C-3), 104.9 (d, C-1), 106.7 (s, C-5), 109.2 (d, C-8) 127.5 (d, C-6), 
148.7 (s, C-2), 151.2 (s, C-4), 157.1 (s, C-9), 161.7 (s, C-7), 165.6 (s, C-16), 
169.7 (s, C-14). 
Elemental Analysis:  
C17H20N2O5 Calculated C 61.44 H 6.07 N 8.43 
(332.3560) Found  C 61.72 H 6.32 N 8.12 
HRMS (CI):   Calculated   Found 
C17H20N2O5 [M]
+: 332.1367 332.1361 
Absorption max.:  386 nm 
Exitation max.: 387 nm 
Emission max.:  425 nm 
Lifetime: 3.03 ns 
Melting point:  141 °C 
7-(Diethylamino)-2-oxo-2H-chromene-4-carbonyl)-L-alanine methyl ester 
(41) 
According to the GP-4 to the solution of 73 mg (0.2 mmol, 1 eq.) enol triflate 12 
and 33.5 mg (0.24 mmol, 1.2 eq.) L-alanine methyl ester hydrochloride in 2 ml dry 
toluone 14 mg (20 µmol, 10 mol%.) Pd(PPh3)2Cl2 and 55 µl (0.4 mmol, 2 eq.) Et3N 
were added. The reaction mixture was stirred under CO atmosphere (15 bar) at rt 
overnight. After work-up and column chromatography (silica gel, DCM:EA 95:5) 48.9 
mg (0.14 mmol, 71%) of 41 was isolated as a yellow solid compound. 
Rf(41) = 0.19 (DCM:EA 9:1) 
 
41 
1H-NMR (400 MHz, CDCl3):  
 = 1.18 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 1.53 (d, 
3J16,15 = 7.2 
Hz, 3 H, 16-H), 3.38 (q, 3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 3.78 (s, 3 
H, 18-H), 4.74 (q, 3J15,16 = 7.2 Hz, 1 H, 15-H), 6.09 (s, 1 H, 8-H), 6.43 (d, 
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4J3,1 = 2.3 Hz, 1 H, 3-H), 6.55 (dd, 
3J1,6 = 9.1 Hz, 
4J1,3 = 2.4 Hz, 1 H, 1-H), 
6.93 (d, 3JNH,15 = 7.2 Hz, 1 H, NH), 7.59 (d, 
3J6,1 = 9.1 Hz, 1 H, 6-H).
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 18.0 (q, C-16), 44.8 (t, C-12/C-10), 48.5 (q, C-18), 
52.7 (d, C-15), 97.6 (d, C-3), 105.0 (d, C-1), 106.6 (s, C-5), 109.2 (d, C-8) 
127.5 (d, C-6), 149.0 (s, C-2), 151.1 (s, C-4), 157.0 (s, C-9), 161.8 (s, C-7), 
165.1 (s, C-14), 172.8 (s, C-17). 
Elemental Analysis:  
C18H22N2O5 Calculated C 62.42 H 6.40 N 8.09  
(346.3820) Found  C 62.22 H 6.39 N 7.57 
HRMS (CI):   Calculated Found 
C18H22N2O5 [M]
+: 346.1523 346.1525 
Absorption max.:  386 nm 
Exitation max.: 388 nm 
Emission max.:  520 nm 
Lifetime: 6.57 ns 
Melting point:  144-146 °C 
7-(Diethylamino)-2-oxo-2H-chromene-4-carbonyl-L-phenylalanine methyl 
ester (42) 
According to the GP-4 to the solution of 73 mg (0.2 mmol, 1 eq.) enol triflate 12 
and 51.8 mg (0.24 mmol, 1.2 eq.) L-phenylalanine methyl ester hydrochloride in 2 ml 
dry toluone 14 mg (20 µmol, 10 mol%.) Pd(PPh3)2Cl2 and 55 µl (0.4 mmol, 2 eq.) Et3N 
were added. The reaction mixture was stirred under CO atmosphere (15 bar) at rt 
overnight. After work-up and column chromatography (silica gel, DCM:EA 95:5) 63.3 
mg (0.15 mmol, 75%) of 42 was isolated as a yellow solid compound. 
Rf(42) = 0.27 (DCM:EA 95:5) 
 
42 
1H-NMR (400 MHz, CDCl3):  
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 = 1.19 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.15 (dd, 
2J18,18’ = 
14.0 Hz, 3J18,16 =  6.9 Hz, 1 H, 18-H), 3.33 (dd, 
2J18’ ,18 = 14.0 Hz, 
3J18’ ,16 = 5.4 
Hz, 1 H, 18’-H),  3.39 (q, 3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 3.80 (s, 
3 H, 17-H), 5.06 (m, 1 H, 15-H), 5.96 (s, 1 H, 8-H), 6.44 (d, 4J3,1 = 2.5 Hz, 1 
H, 3-H), 6.51 (td, 3J1,6 = 9.1 Hz, 
4J1,3 = 2.5 Hz, 1 H, 1-H), 6.58 (d, 
3JNH,15 = 
8.0 Hz, 1 H, NH), 7.15 (d, 3J20,21 = 
3J24,23 =   6.6 Hz, 2 H, 20-H, 24-H), 7.29 
(m, 3 H, 23-H, 22-H, 21-H), 7.40 (d, 3J6,1 = 9.1 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 37.7 (t, C-18), 44.8 (t, C-12/C-10), 52.7 (d, C-15), 
53.4 (q, C-17), 97.6 (d, C-3), 104.9 (d, C-1), 106.6 (s, C-5), 109.1 (d, C-8) 
127.4 (d, C-6/C-22), 128.8 (d, C-24/C-20), 129.2 (d, C-21/C-23), 135.5 (s, 
C-19), 148.7 (s, C-2), 151.1 (s, C-4), 157.0 (s, C-9), 161.6 (s, C-7), 165.0 (s, 
C-16), 171.4 (s, C-14). 
Elemental Analysis:  
C24H26N2O5 Calculated C 68.23 H 6.20 N 6.63 
(422.4810) Found  C 67.74 H 6.28 N 6.18 
HRMS (CI):   Calculated Found 
C24H26N2O5 [M]
+: 422.1836 422.1842 
Absorption max.:  384 nm 
Exitation max.: 389 nm 
Emission max.:  524 nm 
Lifetime: 6.49 ns 
Melting point:  74-78 °C 
7-(Diethylamino)-2-oxo-2H-chromene-4-carbonyl-L-phenylalanylglycine 
methyl ester (43) 
According to the GP-4 to the solution of 73 mg (0.2 mmol, 1 eq.) enol triflate 12 
and 66 mg (0.24 mmol, 1.2 eq.) dipeptide in 2 ml dry toluone 14 mg (20 µmol, 10 
mol%.) Pd(PPh3)2Cl2 and 55 µl (0.4 mmol, 2 eq.) Et3N were added. The reaction 
mixture was stirred under CO atmosphere (15 bar) at rt overnight. After work-up and 
column chromatography (silica gel, DCM:EA 95:5) 67.3 mg (0.14 mmol, 70%) of 43 
was isolated as a yellow solid compound. 
Rf(43) = 0.15 (DCM:MeOH 95:5) 
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43 
1H-NMR (400 MHz, CDCl3):  
 = 1.13 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.13 (m, 2 H, 17 H), 
3.33 (q, 3J10,11 =  
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 3.68 (s, 3 H, 14-H), 3.96 
(dq, 3J22,NH = 5.3 Hz, 2 H, 22-H), 4.86 (q, 
3J15,17 = 7.3 Hz, 1 H, 15-H), 5.91 
(s, 1 H, 8-H), 6.32 (t, 3JNH,22 = 4.9 Hz, 1 H, NHGly), 6.39 (d, 
4J3,1 =  2.5 Hz, 1 
H, 3-H), 6.42 (dd, 3J1,6 = 9.1 Hz, 
4J1,3 = 2.5 Hz, 1 H, 1-H), 6.67 (d, 
3JNH,15 =  
7.8 Hz, 1 H, NHPhe), 7.19-7.27 (sh, 5 H, Phe). 
13C-NMR (100 MHz, CDCl3):  
 = 12.4 (q, C-11/C13), 38.2 (t, C-17), 41.3 (t, C-22), 44.8 (t, C-12/C-10), 
52.5 (q, C-24), 54.5 (d, C-15), 97.7 (d, C-3), 104.8 (d, C-1), 106.8 (s, C-5), 
109.1 (d, C-8), 127.7 (d, C-22), 127.3 (d, C-Ar), 129.2 (d, C-Ar), 136.6 (s, C-
18), 161.5 (s, C-7), 165.3 (s, C-23), 169.7 (s, C-14). 
HRMS (CI):   Calculated Found 
C26H30N3O6 [M+H]
+: 480.2129 480.2147 
Melting point:  139-141 °C 
 7-(Diethylamino)-2-oxo-2H-chromene-4-carbonyl)-L-leucine methyl ester 
(44) 
According to the GP-4 to the solution of 73 mg (0.2 mmol, 1 eq.) enol triflate 12 
and 43.6 mg (0.24 mmol, 1.2 eq.) leucine methyl ester hydrochloride in 2 ml dry 
toluone 14 mg (20 µmol, 10 mol%.) Pd(PPh3)2Cl2 and 55 µl (0.4 mmol, 2 eq.) Et3N 
were added. The reaction mixture was stirred under CO atmosphere (15 bar) at rt 
overnight. After work-up and column chromatography (silica gel, DCM:EA 95:5) 52.5 
mg (0.13 mmol, 65%) of 44 was isolated as a yellow solid compound. 
Rf(44) = 0.14 (DCM:EA 9:1) 
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44 
1H-NMR (400 MHz, CDCl3):  
 = 0.98 (2d, 3J21,19  = 
3J20,19 = 6.2 Hz, 6 H, 20-H, 21-H),  1.20 (t, 
3J11,10  =  
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H),  1.71 (m, 3 H, 19-H, 18-H), 3.41 (q, 
3J10,11  
= 3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 3.79 (s, 3 H, 17-H), 4.81 (m, 1 H, 15-H), 
6.11 (s, 1 H, 8-H), 6.47 (d, 4J3,1 = 2.6 Hz, 1 H, 3-H), 6.52 (d, 
3JNH,15 = 8.4 Hz, 
1 H, NH), 6.58 (dd, 3J1,6 = 9.1 Hz, 
4J1,3 = 2.6 Hz, 1 H, 1-H), 7.60 (d, 
3J6,1 = 9.1 
Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 21.9 (q, C-21/C-20), 22.9 (q, C-21/C-20), 25.1 (d, 
C-19), 41.3 (t, 18-C), 44.8 (t, C-12/C-10), 51.1 (d, C-15), 52.6 (q, C-17), 
97.7 (d, C-3), 105.0 (d, C-1), 106.6 (s, C-5), 109.2 (d, C-8) 127.4 (d, C-6), 
149.0 (s, C-2), 151.2 (s, C-9), 157. (s, C-4), 161.7 (s, C-7), 165.3 (s, C-14), 
172.8 (s, C-16). 
Elemental Analysis:  
C21H28N2O5 Calculated C 64.93 H 7.27 N 7.21 
(388.4574) Found  C 67.23 H 7.41 N 9.52 
HRMS (CI):   Calculated Found 
C21H28N2O5 [M]
+: 388.1993 388.1984  
Absorption max.:  386 nm 
Exitation max.: 388 nm 
Emission max.:  520 nm 
Lifetime: 6.38/3.43  ns  
Melting point:  146-148 °C 
N-Benzyl-7-(diethylamino)-2-oxo-2H-chromene-4-carboxamide (45) 
According to the GP-4 to the solution of 73 mg (0.2 mmol, 1 eq.) enol triflate 12 
and 26 µl (25.7 mg, 0.24 mmol, 1.2 eq.) benzylamine in 2 ml dry toluone 14 mg (20 
µmol, 10 mol%.) Pd(PPh3)2Cl2 and 55 µl (0.4 mmol, 2 eq.) Et3N were added. The 
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reaction mixture was stirred under CO atmosphere (15 bar) at rt overnight. After 
work-up and column chromatography (silica gel, DCM, DCM:EA 95:5) 67.3 mg (0.17 
mmol, 83%) of 45 was isolated as a yellow solid compound. 
Rf(45) = 0.45 (DCM:EA 95:5) 
 
45 
1H-NMR (400 MHz, CDCl3):  
 = 1.19 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.39 (q, 
3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 4.61 (d, 
3J15,NH = 5.9 Hz, 2 H, 15-H), 6.04 
(s, 1 H, 8-H), 6.41 (d, 4J3,1 = 2.5 Hz, 1 H, 3-H), 6.54 (dd, 
3J1,6 = 9.1 Hz, 
4J1,3 =  
2.5 Hz, 1 H, 1-H), 6.83 (t, 3JNH,15 = 5.4 Hz, 1 H, NH), 7.30-7.37 (sh, 5 H, 
Phe-H), 7.59 (d, 3J6,1 =  9.1 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.5 (q, C-11/C13), 43.8 (t, C-15), 44.8 (t, C-12/C-10), 97.6 (d, C-3), 
105.1 (d, C-1), 106.4 (s, C-5), 109.2 (d, C-8) 127.5-128.7 (d, C-17/C-18/C-
21/C-20), 137.5 (s, C-16), 149.4 (s, C-2), 151.1 (s, C-4), 157.0 (s, C-9), 
161.9 (s, C-7), 165.3 (s, C-14). 
Elemental Analysis:  
C21H22N2O3 Calculated C 71.98 H 6.33 N 7.99 
(350.4180) Found  C 72.01 H 6.41 N 7.89 
HRMS (CI):   Calculated   Found 
C21H22N2O3 [M]
+: 350.1625 350.1631 
Absorption max.:  384 nm 
Exitation max.: 388 nm 
Emission max.:  517 nm 
Lifetime: 6.64 ns 
Melting point: 169-170 °C  
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7-(Diethylamino)-2-oxo-N-phenyl-2H-chromene-4-carboxamide (46) 
According to the GP-4 to the solution of 73 mg (0.2 mmol, 1 eq.) enol triflate 12 
and 22 µl (22.4 mg, 0.24 mmol, 1.2 eq.) aniline in 2 ml dry toluone 14 mg (20 µmol, 
10 mol%.) Pd(PPh3)2Cl2 and 55 µl (0.4 mmol, 2 eq.) Et3N were added. The reaction 
mixture was stirred under CO atmosphere (15 bar) at rt overnight. After work-up and 
column chromatography (silica gel, DCM, DCM:EA 95:5) 52.4 mg (0.16 mmol, 78%) of 
46 was isolated as a yellow solid compound. 
Rf(46) = 0.16 (DCM:EA 95:5) 
 
46 
1H-NMR (400 MHz, CDCl3):  
 = 1.18 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.37 (q, 
3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 6.14 (s, 1 H, 8-H), 6.35 (d, 
4J3,1 = 2.5 Hz, 
1 H, 3-H), 6.55 (dd, 3J1,6 = 9.2 Hz, 
4J1,3 = 2.5 Hz, 1 H, 1-H), 7.19 (t, 
3J18,17 =  
3J18,19 = 7.4 Hz, 1 H, 18-H), 7.39 (dd, 
3J17,18 = 
3J17,16 = 
3J19,18 = 
3J19,20 = 7.9 
Hz, 2 H, 17 H, 19-H), 7.66 (d, 3J6,1 = 9.1 Hz, 1 H, 6-H), 7.78 (d, 
3J16,17 = 
3J20,19 = 7.7 Hz, 2 H, 16-H, 20-H), 8.80 (s, 1 H, NH). 
13C-NMR (100 MHz, CDCl3): 
 = 12.5 (q, C-11/C13), 44.8 (t, C-12/C-10), 97.5 (d, C-3), 105.1 (d, C-1), 
106.0 (s, C-5), 109.4 (d, C-8), 120.3 (d, C-16/C-20), 125.1 (d, C-18/C-6), 
127.7 (d, C-18/C-6), 137.7 (s, C-15), 149.9 (s, C-2), 151.2 (s, C-4), 157.0 (s, 
C-9), 162.5 (s, C-7), 163.5 (s, C-14). 
Elemental Analysis:  
C20H20N2O3 Calculated C 71.41 H 5.99 N 8.33 
(336.3910) Found  C 69.97 H 5.94 N 7.95 
HRMS (CI):   Calculated   Found 
C20H20N2O3 [M]
+: 336.1468 336.1473 
Absorption max.:  381 nm 
Exitation max.: 390 nm 
Emission max.:  528 nm 
Lifetime: 6.16 ns 
Melting point:  157-160 °C  
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N-Cyclohexyl-7-(diethylamino)-2-oxo-2H-chromene-4-carboxamide (47) 
According to the GP-4 to the solution of 73 mg (0.2 mmol, 1 eq.) enol triflate 12 
and 27.5 µl (23.8 mg, 0.24 mmol, 1.2 eq.) cyclohexylamine in 2 ml dry toluone 14 mg 
(20 µmol, 10 mol%.) Pd(PPh3)2Cl2 and 55 µl (0.4 mmol, 2 eq.) Et3N were added. The 
reaction mixture was stirred under CO atmosphere (15 bar) at rt overnight. After 
work-up and column chromatography (silica gel, DCM, DCM:EA 95:5) 63.3 mg (0.18 
mmol, 92%) of 47 was isolated as a yellow solid compound. 
Rf(47) = 0.18 (DCM:EA 95:5) 
 
47 
1H-NMR (400 MHz, CDCl3):  
 = 1.18 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 1.24-1.45 (sh, 5 H, 
17-H, 19-H, 18’-H), 1.62-1.65 (sh, 1 H, 18-H), 1.73-2.08 (sh, 4 H, 16-H, 20-
H), 3.37 (q, 3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 3.94 (m, 1 H, 15-H), 
5.98 (s, 1 H, 8-H), 6.39 (d, 4J3,1 = 2.3 Hz, 1 H, 3-H), 6.43 (d, 
3JNH,15 = 8.0 Hz, 
1 H, NH), 6.54 (dd, 3J1,6 = 9.1 Hz, 
4J1,3 = 2.4 Hz, 1 H, 1-H), 7.56 (d, 
3J6,1 = 9.1 
Hz, 1 H, 6-H).  
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 24.8 (t, C-17/C-19), 25.4 (t, C-18), 32.9 (t, C-16/C-
20), 44.8 (t, C-12/C-10), 48.9 (d, C-15), 97.5 (d, C-3), 105.2 (d, C-1), 106.1 
(s, C-5), 109.1 (d, C-8), 127.5 (d, C-6), 150.1 (s, C-2), 151.0 (s, C-4), 157.0 
6(s, C-9), 162.0 (s, C-7), 164. (s, C-14). 
Elemental Analysis:  
C20H26N2O3 Calculated C 70.15 H 7.65 N 8.18 
(342.4390) Found  C 69.91 H 7.95 N 7.99 
HRMS (CI):   Calculated   Found 
C20H26N2O3 [M]
+: 342.1938 342.1942 
Absorption max.:  383 nm 
Exitation max.: 385 nm 
Emission max.:  513 nm 
Lifetime: 6.50 ns 
Melting point:  158-161 °C 
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7-(Diethylamino)-N-(2-methoxyphenyl)-2-oxo-2H-chromene-4-carboxamide 
(48) 
According to the GP-4 to the solution of 73 mg (0.2 mmol, 1 eq.) enol triflate 12 
and 27.0 µl (29.6 mg, 0.24 mmol, 1.2 eq.) o-anisidine in 2 ml dry toluone 14 mg (20 
µmol, 10 mol%.) Pd(PPh3)2Cl2 and 55 µl (0.4 mmol, 2 eq.) Et3N were added. The 
reaction mixture was stirred under CO atmosphere (15 bar) at rt overnight. After 
work-up and column chromatography (silica gel, DCM, DCM:EA 95:5) 74.4 mg (0.2 
mmol, quant) of 48 was isolated as a yellow solid compound. 
Rf(48) = 0.2 (DCM:EA 95:5) 
 
48 
1H-NMR (400 MHz, CDCl3):  
 = 1.18 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.37 (q, 
3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 6.14 (s, 1 H, 8-H), 6.35 (d, 
4J3,1 = 2.5 Hz, 
1 H, 3-H), 6.55 (dd, 3J1,6 = 9.2 Hz, 
4J1,3 = 2.5 Hz, 1 H, 1-H), 7.19 (t, 
3J18,17 =  
3J18,19 = 7.4 Hz, 1 H, 18-H), 7.39 (dd, 
3J17,18 = 
3J17,16 = 
3J19,18 = 
3J19,20 = 7.9 
Hz, 2 H, 17 H, 19-H), 7.66 (d, 3J6,1 = 9.1 Hz, 1 H, 6-H), 7.78 (d, 
3J16,17 =  
3J20,19 = 7.7 Hz, 2 H, 16-H, 20-H), 8.80 (s, 1 H, NH). 
13C-NMR (100 MHz, CDCl3): 
 = 12.5 (q, C-11/C13), 44.8 (t, C-12/C-10), 97.5 (d, C-3), 105.1 (d, C-1), 
106.0 (s, C-5), 109.4 (d, C-8), 120.3 (d, C-16/C-20), 125.1 (d, C-18/C-6), 
127.7 (d, C-18/C-6), 137.7 (s, C-15), 149.9 (s, C-2), 151.2 (s, C-4), 157.0 (s, 
C-9), 162.5 (s, C-7), 163.5 (s, C-14). 
Elemental Analysis:  
C21H22N2O4 Calculated C 68.84 H 6.05 N 7.65 
(366.4170) Found  C 68.01 H 6.00 N 8.00 
HRMS (CI):   Calculated   Found 
C21H22N2O4 [M]
+: 366.1574 366.1579 
Absorption max.:  388 nm 
Exitation max.: 391 nm 
Emission max.:  531 nm 
Lifetime: 6.50 ns 
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Melting point:  155-156 °C   
7-(Diethylamino)-4-morpholino-2H-chromen-2-one (49) 
According to the GP-4 44 mg (0.12 mmol, 1 eq.) enol triflate 12 reacted with 12 µl 
(15.8 mg, 0.18 mmol, 1.5 eq.) morpholine. After work-up and column 
chromatography (silica gel, DCM:EA 95:5) 34.4 mg (0.114 mmol, 95%) of 49 was 
isolated as a yellow solid compound. 
Rf(49) = 0.32 (DCM:EA 9:1) 
 
49 
1H-NMR (400 MHz, CDCl3):  
 = 1.20 (t, 3J11,10 =  
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.22 (sh, 4 H, 17-H, 
15-H), 3.40 (q, 3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 3.89 (sh, 4 H, 16-
H, 14-H), 5.45 (s, 1 H, 8-H), 6.48 (d, 4J3,1 = 2.6 Hz, 1 H, 3-H), 6.54 (dd, 
3J1,6  
= 9.1 Hz, 4J1,3 = 2.6 Hz, 1 H, 1-H), 7.36 (d, 
3J6,1 = 9.1 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.5 (q, C-11/C13), 44.6 (t, C-12/C-10), 51.5 (t, C-16/C-14), 66.5 (t, C-
17/C-15), C-8 under CDCl3, 98.0 (d, C-3), 104.3 (d, C-1), 107.9 (s, C-1), 
125.6 (d, C-6), 150.3 (s, C-4/C-2), 156.7 (s, C-9), 162.0 (s, C-7). 
Elemental Analysis:  
C17H22N2O3 Calculated C 67.53 H 7.33 N 9.26 
(302.3682) Found  C 67.23 H 7.41 N 9.52 
HRMS (CI):   Calculated Found 
C17H22N2O3 [M]
+: 302.1625 302.1626  
Absorption max.:  356 nm 
Exitation max.: 358 nm 
Emission max.: 412 nm 
Lifetime: 2.46 ns 
Melting point:  132-133 °C  
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7-(Diethylamino)-2-oxo-2H-chromen-4-yl-L-leucine methyl ester (50) 
According to the GP-5 73 mg (0. 2 mmol, 1 eq.) enol triflate 12 reacted with 43.6 
mg (0.24 mmol, 1.2 eq.) leucine methyl ester hydrochloride. After work-up and 
column chromatography (silica gel, DCM:EA 95:5) 45 mg (0.12 mmol, 62%) of 50 was 
isolated as a yellow solid compound. 
Rf(50) = 0.51 (DCM:EA 9:1) 
 
50 
1H-NMR (400 MHz, CDCl3):  
 = 0.94 (2d, 3J20,18  = 
3J19,18 = 6.2 Hz, 6 H, 20-H, 19-H), 1.17 (t, 
3J11,10 =  
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 1.69-1.82 (sh, 3-H, 17-H, 18-H), 3.31-
3.41(sh, 4 H, 10-H, 12-H), 3.79 (s, 3 H, 16-H), 4.18 (dd, 3J14,17 = 13.8 Hz, 
3J14,NH = 7.7 Hz, 1 H, 14-H), 4.98 (s, 1 H, 8-H), 5.82 (d, 
3JNH,14 = 7.9 Hz, 1 H, 
NH), 6.29 (d, 4J3,1 = 2.5 Hz, 1 H, 3-H), 6.42 (dd, 
3J1,6 = 9.0 Hz, 
4J1,3 = 2.5 Hz, 
1 H, 1-H), 7.23 (d, 3J6,1 = 9.1 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.5 (q, C-11/C13), 21.9 (q, C-21/C-20), 22.7 (q, C-20/C-19), 25.0 (d, 
C-18), 41.0 (t, C-17), 44.6 (t, C-12/C-10), 52.7 (q, C-16), 53.8 (d, C-14), 
80.9 (d, C-8), 97.8 (d, C-3), 102.2 (s, C-5), 107.8 (d, C-1), 121.5 (d, C-6), 
150.5 (s, C-2), 153.3 (s, C-4), 155.6 (s, C-9), 164.1 (s, C-7), 174.2 (s, C-15). 
Elemental Analysis:  
C20H28N2O4 Calculated C 66.64 H 7.83 N 7.77 
(360.4473) Found  C 66.54 H 8.18 N 7.47 
HRMS (CI):   Calculated Found 
C20H29N2O4 [M+H]
+: 361.2122 361.2120 
Absorption max.:  345 nm 
Exitation max.: 345 nm 
Emission max.:  390 nm 
Melting point:  198-200 °C 
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7-(Diethylamino)-4-(pyrrolidin-1-yl)-2H-chromen-2-one (51) 
According to the GP-5 to the solution of 91 mg (0.25 mmol, 1 eq.) enol triflate 12 
and 41 µl (35.6 mg, 0.5 mmol, 2 eq.) pyrrolidine in 3 ml dry toluene 68.8 µl (0.5 
mmol, 2 eq) Et3N was added. The reaction mixture was refluxed overnight. After 
work-up and column chromatography (silica gel, DCM:EA 95:5) 69.8 mg (0.24 mmol, 
97%) of 51 was isolated as a brown solid compound. 
Rf(51) = 0.21 (DCM:EA 9:1) 
 
51 
1H-NMR (400 MHz, CDCl3):  
 ppm 1.19 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 2.00 (sh, 4 H, 15-
H, 16-H), 3.38 (q, 3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 3.64 (sh, 4 H, 
14-H, 17-H), 5.05 (s, 1 H, 8-H), 6.48 (m, 2 H, 1 H, 3-H), 7.73 (d, 3J6,1 = 9.0 
Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.5 (q, C-11/C13), 25.8 (t, C-15/C-16), 44.5 (t, C-12/C-10), 51.6 (t, C-
14/C-17), 82.9 (d, C-8),  98.6 (d, C-3), 104.6 (d, C-1), 107.0 (s, C-5), 126.7 
(d, C-6), 149.7 (s, C-2), 156.0 (s, C-4), 156.8 (s, C-9), 163.8 (s, C-7). 
Elemental Analysis:  
C17H22N2O2  Calculated C 71.30 H 7.74 N 9.78 
(286.3750) Found  C 71.03 H 7.69 N 9.24 
HRMS (CI):   Calculated   Found 
C17H23N2O2 [M+H]
+: 287.1754 287.1746 
Absorption max.:  346 nm 
Exitation max.: 350 nm 
Emission max.:  405 nm 
Melting point:  119-122 °C   
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7-(Diethylamino)-4-(piperidin-1-yl)-2H-chromen-2-one (52) 
According to the GP-5 to the solution of 73 mg (0.2 mmol, 1 eq.) enol triflate 12 
and 23.7 µl (20.4 mg, 0.24 mmol, 2 eq.) piperidine in 2 ml dry toluene 55 µl (0.4 
mmol, 2 eq) Et3N was added. The reaction mixture was refluxed overnight. After 
work-up and column chromatography (silica gel, DCM:EA 98:2, 95:5, 9:1) 59.1 mg 
(0.197 mmol, 98%) of 52 was isolated as a yellow solid compound. 
Rf(52) = 0.19 (DCM:EA 9:1) 
 
52 
1H-NMR (400 MHz, CDCl3):  
 = 1.12 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 1.61-1.71 (sh, 6 H, 
15-H, 16-H, 17-H), 3.11-3.13 (sh, 4 H, 14-H, 18-H), 3.32 (q, 3J10,11 = 
3J12,13  
= 7.1 Hz, 4 H, 12-H, 10-H), 5.35 (s, 1 H, 8-H), 6.40 (d, 4J3,1 = 2.6 Hz, 1 H, 3-
H), 6.47 (dd, 3J1,6 = 9.1 Hz, 
4J1,3 = 2.6 Hz, 1 H, 1-H), 7.30 (d, 
3J6,1 = 9.1 Hz, 1 
H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.5 (q, C-11/C13), 24.5 (t, C-16), 25.8 (t, C-15/C-17), 44.7 (t, C-12/C-
10), 52.3 (t, C-14/C-18), 91.9 (d, C-8),  98.0 (d, C-3), 105.0 (s, C-5), 107.7 
(d, C-1), 126.0 (d, C-6), 150.1 (s, C-2), 156.6 (s, C-4), 162.8 (s, C-9), 164.0 
(s, C-7). 
Elemental Analysis:  
C18H24N2O2  Calculated C 71.97 H 8.05 N 9.33 
(300.4020) Found  C 71.99 H 8.27 N 9.04 
HRMS (CI):   Calculated   Found 
C18H24N2O2 [M]
+: 300.1832 300.1838 
Absorption max.:  355 nm 
Exitation max.: 356 nm 
Emission max.:  409 nm 
Melting point: 100-101 °C 
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4,7-Bis(diethylamino)-2H-chromen-2-one (53) 
According to the GP-5 to the solution of 73 mg (0.2 mmol, 1 eq.) enol triflate 12 
and 25 µl (17.6 mg, 0.24 mmol, 2 eq.) diethylamine in 2 ml dry toluene 55 µl (0.4 
mmol, 2 eq) Et3N was added. The reaction mixture was refluxed overnight. After 
work-up and column chromatography (silica gel, DCM:EA 9:1) 39.5 mg (0.14 mmol, 
68%) of 53 was isolated as a yellow oil. 
Rf(53) = 0.19 (DCM:EA 9:1) 
 
53 
1H-NMR (400 MHz, CDCl3):  
 = 1.22 (dt, 3J11,10  = 
3J13,12 = 
3J15,14  = 7.1 Hz, 12 H, 13-H, 11-H, 15-H), 3.38 
(dq, 3J10,11 = 
3J12,13 = 
3J14,15 = 7.1 Hz, 8 H, 12-H, 10-H, 14-H), 5.34 (s, 1 H, 8-
H), 6.45 (d, 4J3,1 = 2.6 Hz, 1 H, 3-H), 6.50 (dd, 
3J1,6 = 9.1 Hz, 
4J1,3 =  2.7 Hz, 1 
H, 1-H), 7.40 (d, 3J6,1  = 9.1 Hz, 1 H, 6-H).
13C-NMR (100 MHz, CDCl3): 
 = 12.3 (q, C-15), 12.5 (q, C-11/C13), 44.6 (t, C-12/C-10), 45.4 (t, C-14),  
90.7 (d, C-8),  98.2 (d, C-3), 105.1 (s, C-5), 107.7 (d, C-1), 126.1 (d, C-6), 
149.9 (s, C-2), 156.7 (s, C-4), 160.1 (s, C-9), 163.9 (s, C-7). 
Elemental Analysis:  
C17H24N2O2  Calculated C 70.80 H 8.39 N 9.71 
(288.3910) Found  C 70.94 H 7.64 N 9.47 
HRMS (CI):   Calculated   Found 
C17H24N2O2 [M]
+: 288.1832 288.1841 
Absorption max.:  352 nm 
Exitation max.: 416 nm 
Emission max.:  417 nm 
4-(Dibenzylamino)-7-(diethylamino)-2H-chromen-2-one (54) 
According to the GP-5 to the solution of 73 mg (0.2 mmol, 1 eq.) enol triflate 12 
and 46 µl (47 mg, 0.24 mmol, 2 eq.) dibenzylamine in 2 ml dry toluene 55 µl (0.4 
mmol, 2 eq) Et3N was added. The reaction mixture was refluxed overnight. After 
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work-up and column chromatography (silica gel, DCM:EA 9:1) 50 mg (0.12 mmol, 
60%) of 54 was isolated as a beige solid compound. 
Rf(54) = 0.1 (DCM:EA 9:1) 
 
54 
1H-NMR (400 MHz, CDCl3):  
 = 1.11 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.31 (q, 
3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 4.42 (s, 4 H, 14-H), 5.32 (s, 1 H, 8-H), 
6.43 (m, 2 H, 1-H, 3-H), 7.22 (m, 10 H, 2Phe), 7.51 (d, 3J6,1 = 8.8 Hz, 1 H, 6-
H).
13C-NMR (100 MHz, CDCl3): 
 = 12.5 (q, C-11/C13), 44.6 (t, C-12/C-10), 55.3 (t, C-14),  93.2 (d, C-8),  
98.3 (d, C-3), 104.7 (s, C-5), 107.9 (d, C-1), 125.8 (d, C-6), 127.5-128.8 (d, 
C-16, C-17, C-18), 136.4 (s, C-15), 150.2 (s, C-2), 156.8 (s, C-4), 160.6 (s, 
C-9), 163.5 (s, C-7). 
Elemental Analysis:  
C27H28N2O2  Calculated C 78.61 H 6.84 N 6.79 
(412.5330) Found  C 78.99 H 6.96 N 6.69 
HRMS (CI):   Calculated   Found 
C27H28N2O2 [M]
+: 412.2145 412.2161 
Absorption max.:  356 nm 
Exitation max.: 359 nm 
Emission max.:  418 nm 
7-(Diethylamino)-4-[1R,2S)-1-hydroxy-1-phenylpropan-2-yl)(methyl)amino]-
2H-chromen-2-one (55) 
According to the GP-5 to the solution of 73 mg (0.2 mmol, 1 eq.) enol triflate 12 
and 40 mg (0.24 mmol, 2 eq.) ephedrine in 2 ml dry toluene 55 µl (0.4 mmol, 2 eq) 
Et3N was added. The reaction mixture was refluxed overnight. After work-up and 
4 Experimental section 
133 
 
column chromatography (silica gel, DCM:EA 9:1) 42.3 mg (0.11 mmol, 56%) of 55 was 
isolated as a beige solid compound. 
Rf(55) = 0.1 (DCM:MeOH 95:5) 
 
55 
1H-NMR (400 MHz, CDCl3):  
 = 1.19 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 1.51 (d, 
3J17,15 = 6.7 
Hz, 3 H, 17-H), 2.44 (bs, 1 H, OH), 2.82 (s, 3 H, 14-H), 3.38 (q, 3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 4.26 (dt, 
3J15,17 = 
3J15,16 = 6.7 Hz, 1 H, 15-
H), 4.75 (d, 3J16,15 = 6.9 Hz, 1 H, 16-H), 4.91 (s, 1 H, 8-H), 6.40 (d, 
4J3,1 = 
2.6 Hz, 1 H, 3-H), 6.44 (dd, 3J1,6 = 9.1 Hz, 
4J1,3 = 2.68 Hz, 1 H, 1-H), 7.18 (m, 
6 H, 6-H, Phe). 
13C-NMR (100 MHz, CDCl3): 
 = 12.5 (q, C-11/C13), 13.5 (q, C-17), 33.4 (q, C-14), 44.6 (t, C-12/C-10), 
62.0 (d, C-15), 76.5 (d, C-16), 90.5 (d, C-8),  98.1 (d, C-3), 104.6 (s, C-5), 
107.4 (d, C-1), 126.1 (d, C-21), 126.4 (d, C-19), 128.5 (d, C-20), 141.8 (s, 
C-18), 149.8 (s, C-2), 156.4 (s, C-4), 161.5 (s, C-9), 163.8 (s, C-7). 
Elemental Analysis:  
C23H28N2O3  Calculated C 72.60 H 7.42 N 7.36 
(380.4880) Found  C 72.02 H 7.78 N 6.85 
HRMS (CI):   Calculated   Found 
C23H29N2O3 [M+H]
+: 381.2173 381.2146 
Absorption max.:  351 nm 
Exitation max.: 361nm 
Emission max.:  410 nm 
Melting point:  100-102 °C  
7-(Diethylamino)-2-oxo-2H-chromene-4-carbaldehyde (56) [161] 
To the solution of 300 mg (1.2 mmol, 1 eq.) fluorescenting alken 58 solution in 1.5 
ml water and 1.6 ml of dioxane 6 µl (2.5 wt% solution in n-hexan, 1.68 mg, 6.6 µmol, 
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0.55 mol%) OsO4 was added. The reaction mixture was stirred for 5 minutes during 
which time the mixture became dark orange (due to osmate ester formation). While 
the temperature of the stirred mixture was maintained at 24-26 °C, a total of 513 mg 
(2.4 mmol, 2 eq.) of finely powdered sodium metaperiodate was added in portions 
over a period of 30 minutes. The tan-coloured slurry then was stirred for an 
additional 1.5 h. The mixture (now pale yellow) was extracted thoroughly with 
diethylether and the combined organic layers were filtered through celite, dried over 
Na2SO4 and the solvent was evaporated in vacuo. The crude product was purified by 
column chromatography (silica gel, PE:EA 7:3) to furnish 190 mg (0.78 mmol, 65%) of 
product 56 as a red solid compound. 
Rf(56) = 0.20 (PE:EA 6:4) 
 
56 
1H-NMR (400 MHz, CDCl3):  
 = 1.22 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.43 (q, 
3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 6.45 (s, 1 H, 8-H), 6.52 (d, 
4J3,1 = 2.6 Hz, 
1 H, 3-H), 6.63 (dd, 3J1,6 = 9.2 Hz, 
4J1,3 = 2.6 Hz, 1 H, 1-H), 8.30 (d, 
3J6,1  =  
9.2 Hz, 1 H, 6-H), 10.03 (s, 1 H, 14-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 44.8 (t, C-12/C-10), 97.6 (d, C-3), 109.5 (d, C-1), 
117.3 (s, C-5), 127.0 (d, C-6/C-8), 143.9 (d, C-2), 151.0 (s, C-4), 157.4 (s, 
C-7), 161.9 (s, C-9), 192.5 (s, C-14). 
HRMS (CI):   Calculated Found 
C14H15NO3 [M]
+: 245.1046 245.1050 
Absorption max.:  441 nm 
Exitation max.: 369 nm 
Emission max.:  432 nm 
Lifetime: 3.53 ns 
Melting point:  78-80 °C 
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7-(Diethylamino)-2H-chromen-2-one (57) [159] 
To the solution of 44 mg (0.12 mmol, 1 eq.) enol triflate 12 and 35 µl (38 mg, 
0.132 mmol, 1.1 eq.) Bu3SnH in 2 ml dry toluone 8.4 mg (12 µmol, 10 mol%.) 
Pd(PPh3)2Cl2 was added. The reaction mixture was stirred under CO atmosphere (15 
bar) at rt overnight. Afterwards it was diluted with EA and sat. KF-solution was 
added. The solution was stirred at rt for another 2 h.  The aqueous layer was 
extracted three times with DCM and combined organic layers were dried over 
Na2SO4. The solvent was removed in vacuo and the crude product was purified by 
column chromatography (silica gel, PE:EA 7:3) to furnish 24.8 mg (0.114 mmol, 95%) 
of coumarin 57 as a yellow solid compound. 
Rf(57) = 0.25 (PE:EA 6:4) 
 
57 
1H-NMR (400 MHz, CDCl3):  
 = 1.19 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.40 (q, 
3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 6.01 (d, 
3J8,9 = 9.3 Hz, 1 H, 8-H), 6.47 (d, 
4J3,1 = 2.4 Hz, 1 H, 3-H), 6.55 (dd, 
3J1,6 = 8.8 Hz, 
4J1,3 = 2.5 Hz, 1 H, 1-H), 
7.23 (d, 3J6,1 = 8.8 Hz, 1 H, 6-H), 7.52 (d, 
3J9,8 = 9.3 Hz, 1 H, 9-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 44.8 (t, C-12/C-10), 97.5 (d, C-3), 108.3 (d, C-
1/C8), 108.7 (d, C-1/C-8), 109.2 (s, C-5), 128.8 (d, C-6), 143.7 (d, C-9), 
150.7 (s, C-2), 156.7 (s, C-4), 162.3 (s, C-7). 
Elemental Analysis:  
C13H15NO2 Calculated C 71.87 H 6.96 N 6.45 
(217.2680) Found  C 71.68 H 6.99 N 6.34 
HRMS (CI):   Calculated Found 
C13H15NO2 [M]
+: 217.1097 217.1101  
Absorption max.:  365 nm 
Exitation max.: 373 nm 
Emission max.:  425 nm 
Lifetime: 3.03 ns 
Melting point:  84-85 °C  
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7-(Diethylamino)-4-vinyl-2H-chromen-2-one (58) [160] 
5.4 mg (15 µmol, 0.5 mol%) [AllylPdCl]2 and 7.9 mg (30 µmol, 1 mol%) were 
dissolved in 10 ml abs. THF and stirred for 15 minutes at rt. This mixture was added 
to solution of Bu3SnH 0.9 ml (813 mg, 2.5 mmol, 1 eq.) and 1 g (3 mmol, 1.2 eq.) enol 
triflate 12 dissolved in 20 ml abs. THF at 60 °C. The reaction mixture was refluxed for 
2 h, cooled down to rt, diluted with EA. After addition of sat. KF-solution the mixture 
was stirred overnight at rt. The aqueous layer was extracted with DCM, the organic 
layer was washed with H2O and dried over Na2SO4. The solvent was removed in 
vacuo and the crude product was purified by column chromatography (silica gel, 
DCM:Et2O 95:5) to furnish 579 mg (2.38 mmol, 95%) of 58 as a yellow solid 
compound. 
Rf(58) = 0.33 (DCM:Et2O 95:5) 
 
58 
The compound is sensitive to light.   
1H-NMR (400 MHz, CDCl3):  
 = 1.21 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.41 (q, 
3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 5.63 (dd, 
3J15trans,14 = 11.0 Hz,   
2J15trans,  
15cis = 1.0 Hz, 1 H, 15 trans-H), 5.94 (dd, 
3J15cis ,14 = 17.3 Hz, 
2J15cis,  15trans = 1.0 
Hz, 1 H, 15c is-H), 6.12 (s, 1 H, 8-H), 6.52 (d, 
4J3,1 = 2.6 Hz, 1 H, 3-H), 6.58 
(dd, 3J1,6 = 9.0 Hz, 
4J1,3 = 2.6 Hz, 1 H, 1-H), 6.93 (dd, 
3J14,15cis = 17.4 Hz, 
3J14,15trans = 11.0 Hz,   2 H, 14-H), 7.45 (d, 
3J6,1 = 9.0 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.5 (q, C-11/C13), 44.8 (t, C-12/C-10), 97.2 (d, C-3), 104.7 (d, C-8), 
108.5 (d, C-1), 110.0 (s, C-5),  115.8 (t, C-15), 130.8 (d, C-6), 150.6 (d, C-
14), 151.1 (s, C-2), 153.2 (s, C-4), 156.5 (s, C-7), 162.5 (s, C-9). 
Elemental Analysis:  
C15H17NO2 Calculated C 74.05 H 7.04 N 5.76 
(243.3060) Found  C 73.50 H 6.99 N 5.68 
HRMS (CI):   Calculated Found 
C15H17NO2 [M]
+: 243.1254 243.1263  
Absorption max.:  372 nm 
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Exitation max.: 372 nm 
Emission max.:  422 nm 
Lifetime: 4.19/2.39 ns  
Melting point:  50-53 °C  
7-(Diethylamino)-4-(3-hydroxypropyl)-2H-chromen-2-one (59) 
3.8 g (14 mmol, 1 eq.) of fluorescenting alcohol 21 was dissolved in MeOH (40 ml), 
and 380 mg (10 wt%) Pd/C was added. The mixture was stirred under H2 atmosphere 
overnight (until complete conversion of the starting material) and filtered through 
celite. The solvent was removed in vacuo and the crude product purified by column 
chromatography (silica gel, DCM:MeOH 98:2) to furnish 3.7 g (13.5 mmol, 96%) of 
the product 59 as a yellow oil.  
Rf(59) = 0.25 (DCM:MeOH 8:2) 
 
 
 
 
59 
1H-NMR (400 MHz, CDCl3):  
 = 1.19 (t, 3J11.10 = 
3J13.12 = 7.1 Hz, 6 H, 13-H, 11-H), 1.88-1.95 (sh, 2 H, 
14-H), 2.77-2.81 (sh, 2 H, 15-H), 3.39 (q, 3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-
H, 10-H), 3.75 (t, 3J16,15 = 6.1 Hz, 2 H, 16-H), 5.95 (s, 1 H, 8-H), 6.48 (d, 
4J3,1 = 2.6 Hz, 1 H, 3-H), 6.56 (dd, 
3J1,6 = 9.0 Hz, 
4J1,3 = 2.6 Hz, 1 H, 1-H), 
7.44 (d, 3J6,1 = 9.0 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.5 (q, C-11/C13), 28.0 (t, C-13/C-12), 31.4 (t, C-13/C-12), 44.7 (t, C-
12/C-10), 61.8 (t, C-16), 97.8 (d, C-3), 107.6 (d, C-1), 108.2 (d, C-8), 108.5 
(s, C-6) 125.4 (s, C-6), 150.5 (s, C-2), 156.3 (s, C-4/C9), 156.7 (s, C-4/C-9) 
162.5 (s, C-7). 
Elemental Analysis:  
C16H21NO3 Calculated C 69.79 H 7.69 N. 5.09 
(275.3480) Found  C 70.33 H 7.10 N 4.96 
HRMS (CI):   Calculated Found 
C16H22NO3 [M]
+: 275.1516 275.1542  
Absorption max.:  363 nm 
Exitation max.: 377 nm 
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Emission max.:  418 nm 
Lifetime: 5.47/2.78 ns 
  
3-(7-(Diethylamino)-2-oxo-2H-chromen-4-yl)propionaldehyde (60) 
Lemieux-Johnson Oxidation [161] 
A mixture of 7 ml ml water, 8 ml of dioxane, 1.63 g (6 mmol, 1 eq.) of 
fluorescenting alken 2 and 8.25 mg (33µmol, 0.55 mol%, 0.3 ml 2.5 wt% solution in 
n-hexan) OsO4 was stirred for 5 minutes during which time the mixture became dark 
orange (due to osmate ester formation). While the temperature of the stirred 
mixture was maintained at 24-26 °C, a total of 2.6 g (12 mmol, 2 eq.) of finely 
powdered sodium metaperiodate was added in portions over a period of 30 
minutes. The tan-coloured slurry then was stirred for an additional 1.5 h. The 
mixture (now pale yellow) was extracted thoroughly with diethylether and the 
combined organic layers were filtered through celite, dried over Na2SO4 and the 
solvent was evaporated in vacuo. The crude product was purified by column 
chromatography (silica gel, DCM:EA 98:5) to furnish 950 mg (3.5 mmol, 56%) 60 as a 
yellow oil. 
Dess-Martin 
According to the GP 6 to 1.3 g (4.7 mmol, 1 eq) fluorescenting alcohol 59 in 94 ml 
abs. DCM 2.4 g (5.64 mmo, 1.2 eq.) Dess-Martin periodinane was added at rt. The 
reaction mixture was stirred for 2 h. After work-up and column purification (silica 
gel, DCM:EA 95:5) 1.079 g (3.72 mmol, 79 %) of 60 was isolated as a yellow oil. 
Rf(60) = 0.29 (DCM:EA 95:5) 
 
60 
1H-NMR (400 MHz, CDCl3):  
 = 1.20 (t, 3J11,10 = 
3J13,12 = 7.0 Hz, 6 H, 11-H, 13-H), 2.86 (t, 
3J15,14 = 7.6 
Hz,  2 H, 15-H), 3.01 (t, 3J14,15 = 7.4 Hz, 2 H, 14-H), 3.40 (q, 
3J10,11 = 
3J12,13 = 
7.1 Hz, 4 H, 10-H, 12-H), 5.92 (s, 1 H, 8-H), 6.49 (d, 4J3,1 = 2.5 Hz, 1 H, 3-
H), 6.58 (dd, 4J1,3 = 2.6, 
3J1,6 = 9.0 Hz, 1 H, 1-H), 7.37 (d, 
3J6,1 = 9.0 Hz, 1 H, 
6-H), 9.87 (s, 1 H, 16-H). 
13C-NMR (100 MHz, CDCl3):  
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 = 12.4 (q, C-11/C-13), 23.5 (t, C-14), 42.0 (t, C-15), 44.7 (t, C-10/C-12), 
97.8 (d, C-3), 107.5 (d, C-1), 107.7 (s, C-5), 108.6 (d, C-8), 124.9 (d, C-6), 
150.6 (s, C-2), 154.7 (s, C-4), 156.2 (s, C-9), 162.0 (s, C-7), 199.8 (d, C-16). 
Elemental Analysis:  
C16H19NO3  Calculated C 70.31 H 7.01 N 5.12 
(273.33)   Found  C 69.01 H 7.04 N 4.83 
HRMS (CI):    Calculated   Found 
C16H19NO3[M+]:  273.1359   273.1353  
Absorption max.:  364 nm 
Exitation max.: 370 nm 
Emission max.:  419 nm 
Lifetime: 3.05 ns 
7-(Diethylamino)-4-(3-hydroxypent-4-en-1-yl)-2H-chromen-2-one (61) 
According to the GP-7 2.5 g (9.4 mmol, 1 eq) fluorescenting aldehyde 60 was 
dissolved in 113 ml abs. THF. 12.2 ml (12.2 mmol, 1.3 eq) 1M 
Vinylmagnesiumbromide-solution in THF was added slowly at –20 °C. The reaction 
mixture was stirred for 3 h. After column chromatography 2.029 mg (6.7 mmol, 71%) 
of the alcohol 61 was isolated as yellow oil. 
Rf(61) = 0.29 (DCM:EA 95:5) 
 
61 
1H-NMR (400 MHz, CDCl3):  
 = 1.21 (t, 3J13,12 =  
3J11,10 = 7.1 Hz, 6 H, 11-H, 13-H), 1.88 (m, 2 H, 15-H), 
2.80 (m, 2 H, 14-H), 3.41 (q, 3J12,13 = 
3J10,11 = 7.1 Hz, 4 H, 12-H, 10-H), 4.23 
(m, 1 H, 16-H), 5.19 (ddd, 3J18cis,17 = 17.2 Hz, 
2J18cis,  18trans = 
4J18cis,16  = 1.3 
Hz, 1 H, 18cis-H), 5.30 (ddd, 
3J18trans,17 = 10.4 Hz, 
2J18trans,18cis = 
4J18trans,16 =  
1.2 Hz, 1 H, 18trans-H), 5.91 (m, 1 H, 17-H), 5.96 (s, 1 H, 8-H), 6.50 (d, 
4J3,1  
= 2.6 Hz, 1 H, 3-H), 6.58 (dd, 3J1,6 = 9.0 Hz, 
4J1,3 = 2.6 Hz, 1 H, 1-H), 7.45 (d, 
3J6,1 = 9.0 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C-13), 25.4 (t, C-14), 38.0 (t, C-15), 44.7 (t, C-10/C-12), 
58.1 (d, C-16), 97.6 (d, C-3), 104.3 (d, C-1), 107.8 (s, C-5), 108.4 (d, C-8), 
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122.0 (t, C-18), 125.4 (d, C-6), 130.7 (d, C-17), 150.5 (s, C-2), 154.5 (s, C-
4), 156.2 (s, C-9), 162.2 (s, C-7). 
Elemental Analysis:  
C18H23NO3 Calculated C 71.71 H 7.69 N 4.65 
(301.39) Found  C 71.81 H 7.71 N 4.42 
HRMS (CI):   Calculated   Found 
C18H24NO3 [M+H]
+: 302.1751 302.1754  
Absorption max.:  370 nm 
Exitation max.: 368 nm 
Emission max.:  423 nm 
Lifetime: 3.13 ns 
5-(7-(Diethylamino)-2-oxo-2H-chromen-4-yl)pent-1-en-3-yl ethyl carbonate 
(62) 
According to the GP-8 253 mg (0.8 mmol, 1 eq.) allylalcohol 61 was dissolved in 
0.8 ml dry pyridine. 0.2 ml (174 mg, 1.6 mmol, 2 eq.) ethyl chloroformate was added 
at 0 °C. The reaction mixture was allowed to warm to rt overnight. After work-up and 
column chromatography (silica gel, PE:EA 7:3) 238 mg (0.62 mmol, 78%) of 
allylcarbonate 62 was isolated as a yellow oil. 
Rf(62) = 0.36 (PE:EA 7:3) 
 
62 
1H-NMR (400 MHz, CDCl3):  
 = 1.21 (t, 3J13,12 = 
3J11,10 = 7.1 Hz, 6 H, 11-H, 13-H), 1.33 (t, 
3J21,20 = 7.1 
Hz, 3 H, 21-H), 1.96-2.1 (sh, 2 H, 15-H, 15’-H), 2.71-2.77 (sh, 2 H, 14-H), 
3.41 (q, 3J12,13 = 
3J10,11 = 7.1 Hz, 4 H, 12-H, 10-H), 4.21 (q, 
3J20,21 = 7.2 Hz, 2 
H, 20-H), 5.17 (dd 3J16,15 = 12.7 Hz, 
3J16,17 = 6.5 Hz, 1 H, 16-H), 5.29 (ddd, 
3J18trans,17 = 10.5 Hz, 
2J18trans,c is = 
4J18trans,16  = 1.0 Hz, 1 H, 18 trans-H), 5.38 
(ddd, 3J18cis,17 = 17.2 Hz, 
2J18cis,18trans = 
4J18cis,16 = 1.1 Hz, 1 H, 18c is-H) 5.85 
(ddd, 3J17,18cis = 17.2 Hz, 
3J17,18trans = 10.5 Hz, 
3J17,16 =  6.6 Hz, 1 H, 17-H), 
5.93 (s, 1 H, 8-H), 6.50 (d, 4J3,1 = 2.6 Hz, 1 H, 3-H), 6.58 (dd, 
3J1,6 = 9.0 Hz , 
4J1,3 = 2.6 Hz, 1 H, 1-H), 7.37 (d, 
3J6,1  = 9.0 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
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 = 12.4 (q, C-11, C-13), 14.2 (q, C-21) 27.1 (t, C-14), 33.0 (t, C-15), 44.7 
(t, C-10, C-12), 60.4 (t, C-20), 64.1 (d, C-16), 97.8 (d, C-3), 107.7 (d, C-1), 
107.9 (s, C-5), 108.4 (d, C-8), 118.3 (t, C-18), 125.1 (d, C-6), 135.2 (d, C-
17), 150.5 (s, C-2), 154.5 (s, C-4/C-19), 155.5 (s, C-4/C-19), 156.2 (s, C-9), 
162.2 (s, C-7). 
Elemental Analysis:  
C21H27NO5 Calculated C 67.54 H 7.29 N 3.75 
(373.45) Found  C 68.39 H 6.84 N 3.43 
HRMS (CI):   Calculated   Found 
C21H27NO5 [M+5H]
+: 378.2253 378.1353  
Absorption max.:  371 nm 
Exitation max.: 380 nm 
Emission max.:  420 nm 
Lifetime: 3.06 ns 
 (E)-7-(Diethylamino)-4-(5-oxohex-3-en-1-yl)-2H-chromen-2-one (63) 
To a suspension of 1.2 g (3.9 mmol, 1.03 eq.) 1-triphenylphosphoranylidene-2-
propanone[162] in 21 ml THF 1 g (3.8 mmol, 1 eq.) fluorescenting aldehyde 60 was 
added. The reaction mixture was refluxed overnight. After solvent was removed in 
vacuo and column chromatography (silica gel, DCM:EA 95:5) 1.1 g (3.5 mmol, 92%) of 
63 was isolated as a red solid compound. 
Rf(63) = 0.18 (DCM:EA 9:1) 
 
63 
1H-NMR (400 MHz, CDCl3):  
 = 1.18 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 11-H, 13-H), 2.22 (s, 3 H, 19-H), 
2.58 (td, 3J15,14 = 14.3 Hz, 
3J15,16 = 6.8 Hz, 2 H, 15-H), 2.81 (m, 2 H, 14-H), 
3.38 (t, 3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 10-H, 12-H), 5.89 (s, 1 H, 8-H), 6.11 
(d, 3J17,16 = 16.0 Hz, 
4J17,15 = 1.5 Hz, 1 H, 17-H), 6.47 (d, 
4J3,1 = 2.5 Hz, 1 H, 
3-H), 6.56 (dd, 4J1,3 = 2.6, 
3J1,6 =  9.0 Hz, 1 H, 1-H), 6.81 (dt, 
3J16,17 = 15.9 
Hz, 3J16,15 = 6.7 Hz, 1 H, 16-H), 7.34 (d, 
3J6,1  =  9.0 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3):  
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 = 12.4 (q, C-11/C-13), 27.1 (q, C-19), 30.0 (t, C-14), 30.9 (t, C-15), 44.7 
(t, C-10/C-12), 97.9 (d, C-3), 107.6 (d, C-1), 107.8 (s, C-5), 108.6 (d, C-8), 
125.0 (d, C-6), 132.1 (d, C-17), 145.3 (d, C-16), 150.6 (s, C-2), 154.8 (s, C-
4), 156.3 (s, C-9), 162.1 (s, C-7), 198.2 (s, C-18). 
Elemental Analysis:  
C19H23NO3   Calculated C 72.82 H 7.40 N 4.47 
(313.3970)   Found  C 72.95 H 7.42 N 4.42 
HRMS (CI):    Calculated   Found 
C19H24NO3 [M+H]
+:  314.1751  314.1759 
Absorption max.:  361 nm 
Exitation max.: 369 nm 
Emission max.:  422 nm 
Melting point:   84-85 °C   
(E)-7-(Diethylamino)-4-(5-hydroxyhex-3-en-1-yl)-2H-chromen-2-one (64) 
To the solution of 627 mg (2 mmol, 1.0 eq.) fluorescenting ketone 63 and 768 mg 
(2.06 mmol, 1.03 eq.) CeCl3*7H2O in 5 ml MeOH 83 mg (2.2 mmol, 1.1 eq.) sodium 
borohydride was added slowly. The reaction mixture was stirred for 5 minutes. 
Afterwards it was hydrolysed with 1M KHSO4 at rt and extracted three times with 
DCM. The organic phase was washed with water and brine solution, and dried over 
Na2SO4. The solvent was removed in vacuo and the crude product purified on 
column (silica gel, DCM:MeOH 98:2) to furnish 555 mg (1.76 mmol, 88%) of 64 was 
isolated as a yellow oil. 
Rf(64) = 0.17 (DCM:MeOH 95:5) 
 
64 
1H-NMR (400 MHz, CDCl3):  
 = 1.19 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 11-H, 13-H), 1.24 (d, 
3J19,18 = 6.4 
Hz, 3 H, 19-H), 1.84 (bs, 1 H, OH), 2.37 (td, 3J15,14 = 14.9 Hz, 
3J15,16 = 6.9 
Hz, 2 H, 15-H), 2.73 (m, 2 H, 14-H), 3.39 (q, 3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 
10-H, 12-H), 4.26 (qd, 3J18,19 = 
3J18,17 = 6.2 Hz, 1 H, 18-H), 5.58 (dd, 
3J17,16 = 
15.4 Hz, 3J19,18 = 6.1 Hz, 1 H, 17-H), 5.68 (dt, 
3J16,17 = 15.3 Hz, 6.29, 
3J16,15 = 
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6.3 Hz, 1 H, 16-H), 5.9 (s, 1 H, 8-H), 6.48 (d, 4J3,1 = 2.6 Hz, 1 H, 3-H), 6.56 
(dd, 4J1,3 = 2.6, 
3J1,6 =  9.0 Hz, 1 H, 1-), 7.37 (d, 
3J6,1 =  9.0 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.5 (q, C-11/C-13), 23.5 (q, C-19), 30.9 (t, C-15), 31.3 (t, C-14), 44.7 
(t, C-10/C-12), 68.6 (d, C-18), 97.9 (d, C-3), 107.8 (d, C-1), 108.2 (s, C-5), 
108.1 (d, C-8), 125.2 (d, C-6), 132.5 (d, C-16), 135.8 (d, C-17), 150.5 (s, C-
2), 155.8 (s, C-4), 156.3 (s, C-9), 162.3 (s, C-7). 
Elemental Analysis:  
C19H25NO3   Calculated C 72.35 H 7.99 N 4.44 
(315.4130)   Found  C 72.65 H 7.51 N 3.60 
HRMS (CI):    Calculated   Found 
C19H25NO3 [M+]:  315.1834  315.1834  
Absorption max.:  363 nm 
Exitation max.: 370 nm 
Emission max.:  420 nm 
(E)-6-(7-(Diethylamino)-2-oxo-2H-chromen-4-yl)hex-3-en-2-yl ethyl 
carbonate (65) 
According to the GP-8 252 mg (0.8 mmol, 1 eq.) allylalcohol 64 was dissolved in 
0.8 ml dry pyridine. 0.15 ml (174 mg, 1.6 mmol, 2 eq.) ethyl chloroformate was 
added at 0 °C. The reaction mixture was allowed to warm to rt overnight. After work-
up and column chromatography (silica gel, PE:EA 7:3) 279 mg (0.72 mmol, 90%) of 
allylcarbonate 65 was isolated as a yellow oil. 
Rf(65) = 0.52 (PE:EA 6:4) 
 
65 
1H-NMR (400 MHz, CDCl3):  
 = 1.20 (t, 3J13,12  = 
3J11,10 = 7.1 Hz, 6 H, 11-H, 13-H), 1.32 (m, 6 H, 19-H, 
22-H), 2.41 (dd, 3J15,14 = 15.3 Hz, 
3J15,16 = 6.9 Hz, 2 H, 15-H), 2.75 (m, 2 H, 
14-H), 3.41 (q, 3J12,13  = 
3J10,11 = 7.1 Hz, 4 H, 12-H, 10-H), 4.18 (q, 
3J20,21 = 
7.2 Hz, 2 H, 20-H), 5.16 (qd, 3J18,19 = 
3J18,17 = 6.6 Hz, 1 H, 18-H), 5.56 (ddt, 
3J17,16 = 15.4 Hz, 
3J17,28 = 6.9 Hz, 
4J17,15 = 1.3 Hz, 1 H, 17-H), 5.81 (m, 1 H, 
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16-H), 5.91 (s, 1 H, 8-H), 6.50 (d, 4J3,1 = 2.6 Hz, 1 H, 3-H), 6.57 (dd, 
3J1,6 = 
9.0 Hz, 4J1,3 = 2.6 Hz, 1 H, 1-H), 7.37 (d, 
3J6,1 = 9.0 Hz, 1 H, 6-H).
13C-NMR (100 MHz, CDCl3): 
 = 12.5 (q, C-11/C-13), 14.3 (q, C-22) 20.4 (q, C-19), 30.9 (t, C-15/C-14), 
31.0 (t, C-14/C-15), 44.7 (t, C-10/C-12), 63.8 (t, C-21), 74.7 (d, C-18), 97.9 
(d, C-3), 107.8 (d, C-1), 108.1 (s, C-5), 108.4 (d, C-8), 125.2 (d, C-6), 130.6 
(d, C-16/C-17), 131.6 (d, C-16/C-17), 150.5 (s, C-2), 154.5 (s, C-4/C-20), 
155.6 (s, C-4/C-20), 156.3 (s, C-9), 162.2 (s, C-7). 
Elemental Analysis:  
C22H29NO5 Calculated C 68.20 H 7.54 N 3.61 
(387.4760) Found  C 67.95 H 7.61 N 3.37 
HRMS (CI):   Calculated   Found 
C22H29NO5 [M]
+: 387.2046  387.2044  
Absorption max.:  364 nm 
Exitation max.: 367 nm 
Emission max.:  420 nm 
tert-Butyl (E)-7-(7-(diethylamino)-2-oxo-2H-chromen-4-yl)-2-(2,2,2-trifluoro-
acetamido)hept-4-enoate (66) 
According to the GP 9 134 mg (0.59 mmol, 1 eq.) of TFA-Glycin-tert-butylester 
reacted with 154 mg (0.41 mmol, 0.7 eq.) 7-Aminocoumarin-carbonate 62. After 
work-up and column chromatography (silica gel, PE:EA 7:3) 146.2 mg (0.28 mmol, 
68%) of 66 was isolated as a yellow oil. 
Rf(66) = 0.23 (PE:EA 7:3) 
 
66 
1H-NMR (400 MHz, CDCl3):  
 = 1.17 (t, 3J13,12  = 
3J11,10 = 7.1 Hz, 6 H, 11-H, 13-H), 1.45 (s, 9 H, 24-H), 
2.28-2.40 (m, 2 H, 15-H), 2.52 (td,  3J18,17 = 14.9 Hz, 
3J18,19 = 6.0 Hz,  1 H, 18-
H), 2.61-2.74 (sh, 3 H, 14 H, 18’-H), 3.38 (q, 3J12,13 = 
3J10,11 = 7.1 Hz, 4 H, 
12-H, 10-H), 4.50 (m, 1 H, 19-H), 5.34 (m, 2 H, 17-H), 5.61 (m, 2 H, 16-H), 
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5.87 (s, 1 H, 8-H), 6.46 (d, 4J3,1 = 2.4 Hz, 1 H, 3-H), 6.52-6.58 (sh, 1 H, 1-
H), 7.03 (d, 3JNH,19 = 7.3 Hz, 1 H, NH), 7.33 (d, 
3J6,1 = 9.0 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11, C-13), 27.9 (q, C-24), 31.2 (2t, C-15/C-14), 34.9 (t, C-18), 
44.7 (t, C-12, C-10), 52.7 (d, C-19), 83.4 (s, C-23),  97.8 (d, C-3), 107.5 (d, 
C-1/C-5), C-23 not seen, 108.5 (d, C-8), 125.1 (d, C-17/C-6), 132.5 (d, C-
16), 155.7 (s, C-4/C-2), 156.3 (s, C-9/C-20), 162.3 (s, C-7), 169.3 (s, C-22). 
HRMS (CI):   Calculated   Found 
C26H33N2O5 [M]
+: 510.2342 510.2336  
Absorption max.:  364 nm 
Exitation max.: 367 nm 
Emission max.:  420 nm 
Lifetime: 3.06 ns 
tert-Butyl-3-(2-(7-(diethylamino)-2-oxo-2H-chromen-4-yl)ethyl)-2-(2,2,2-tri-
fluoroacetamido)pent-4-enoate (67) 
According to the GP 9 134 mg (0.59 mmol, 1 eq.) of TFA-Glycin-tert-butylester 
reacted with 154 mg (0.41 mmol, 0.7 eq.) 7-Aminocoumarin-carbonate 62. After 
work-up and column chromatography (silica gel, PE:EA 7:3) 23.8 mg (0.05 mmol, 
12%) of 67 was isolated as a yellow oil. 
Rf(67) = 0.23 (PE:EA 7:3) 
 
67 
1H-NMR (400 MHz, CDCl3):  
 = 1.17 (t, 3J13,12  = 
3J11,10 = 7.1 Hz, 6 H, 11-H, 13-H), 1.45 (s, 9 H, 24-H), 
2.28-2.40 (m, 2 H, 15-H), 2.61-2.74 (sh, 2 H, 14 H), 3.38 (q, 3J12,13 = 
3J10,11 
= 7.1 Hz, 4 H, 12-H, 10-H), 4.50 (m, 1 H, 19-H), 4.64 (m, 1 H, 16-H), 5.23 
(d, 3J18cis,17  = 17.1 Hz, 1 H, 18c is-H), 5.30 (sh, 1H, 18 trans-H), 5.60 (sh, 1H, 
17-H), 5.87 (s, 1 H, 8-H), 6.46 (d, 4J3,1 = 2.4 Hz, 1 H, 3-H), 6.52-6.58 (sh, 1 
H, 1-H), 7.03 (d, 3JNH,19 = 7.3 Hz, 1 H, NH), 7.33 (d, 
3J6,1 = 9.0 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
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 = 12.4 (q, C-11, C-13), 27.9 (q, C-24), 31.2 (2t, C-15/C-14), 44.7 (t, C-12, 
C-10), 52.7 (d, C-16), 60.4 (d, C-19), 83.4 (s, C-23),  97.8 (d, C-3), 107.5 (d, 
C-1/C-5), C-23 not seen, 108.5 (d, C-8), 114.3 (d, C-18), 125.1 (d, C-6), C-
17 not seen, 155.7 (s , C-4/C-2), 156.3 (s, C-9/C-20), 162.3 (s, C-7), 169.3 
(s, C-22). 
HRMS (CI):   Calculated   Found 
C26H33F3N2O5 [M]
+: 510.2342 510.2338  
Absorption max.:  364 nm 
Exitation max.: 367 nm 
Emission max.:  420 nm 
Lifetime: 3.06 ns 
tert-Butyl (E)-7-(7-(diethylamino)-2-oxo-2H-chromen-4-yl)-3-methyl-2-(2,2,2-
trifluoroacetamido)hept-4-enoate (68) 
According to the GP 9 81 mg (0.36 mmol, 1 eq.) of TFA-Glycin-tert-butylester 
reacted with 95 mg (0.25 mmol, 0.7 eq.) 7-Aminocoumarin-carbonate 65. After 
work-up and column chromatography (silica gel, PE:EA 7:3) 81.8 mg (0.16 mmol, 
63%, dr 91:9) of regioisomer 68 was isolated as a yellow oil. 
Rf(68) = 0.24 (PE:EA 7:3) 
 
68 
Major diastereomer anti (72 %): 
1H-NMR (400 MHz, CDCl3):  
 = 1.05 (d, 3J19,18 = 6.9 Hz,  3-H, 19-H), 1,19 (t, 
3J13,12 = 
3J11,10 = 7.1 Hz, 6 H, 
11-H, 13-H), 1.46 (s, 9 H, 25-H), 2.34-2.42 (sh, 2 H, 15-H), 2.68-2.75 (sh,  3 
H, 14-H, 18-H), 3.39 (q, 3J12,13 =  
3J10,11 =  7.1 Hz, 4 H, 12-H, 10-H), 4.43 (dd, 
3J20,NH = 8.5 Hz, 
3J20,18 = 5.1 Hz, 1 H, 20-H), 5.37 (dt, 
3J17,16 = 15.4 Hz, 
3J17,18 = 7.8 Hz, 1 H, 17-H), 5.60 (m, 1 H, 16-H), 5.89 (s, 1 H, 8-H), 6.48 (d, 
4J3,1 = 2.5 Hz, 1 H, 3-H), 6.55-6.58 (sh, 1 H, 1-H), 6.77 (d, 
3JNH,20 = 8.2 Hz, 1 
H, NH), 7.35 (d, 3J6,1  = 9.0 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
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 = 12.4 (q, C-11, C-13), 16.6 (q, C-19), 28.0 (q, C-25), 31.3 (t, C-15), 39.9 
(t, C-14), 44.7 (t, C-12, C-10), 63.8 (d, C-20), 83.4 (s, C-24),  97.8 (d, C-3), 
107.6 (d, C-1/C-8/s, C-5), 108.5 (d, C-8/C-1/s, C-5), C-22 not seen, 125.1 
(d, C-16/C-6), 131.6 (d, C-17), 150.5 (s, C-2), 155.6 (s, C-4), 156.3 (s, C-
9/C-21), 162.3 (s, C-7), 169.0 (s, C-23). 
Minor diastereomer syn (28 %): 
1H-NMR (400 MHz, CDCl3):  
 = 1.05 (d, 3J19,18 = 6.9 Hz,  3-H, 19-H), 1,19 (t, 
3J13,12 = 
3J11,10 = 7.1 Hz, 6 H, 
11-H, 13-H), 1.46 (s, 9 H, 25-H), 2.34-2.42 (sh, 2 H, 15-H), 2.68-2.75 (sh,  3 
H, 14-H, 18-H), 3.39 (q, 3J12,13 =  
3J10,11 =  7.1 Hz, 4 H, 12-H, 10-H), 4.57 (dd, 
3J20,NH = 8.7 Hz Hz, 
3J20,18 = 4.4 Hz, 1 H, 20-H), 5.37 (dt, 
3J17,16 = 15.4 Hz, 
3J17,18 = 7.8 Hz, 1 H, 17-H), 5.60 (m, 1 H, 16-H), 5.89 (s, 1 H, 8-H), 6.48 (d, 
4J3,1 = 2.5 Hz, 1 H, 3-H), 6.55-6.58 (sh, 1 H, 1-H), 6.77 (d, 
3JNH,20 = 8.2 Hz, 1 
H, NH), 7.35 (d, 3J6,1  =  9.0 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11, C-13), 15.5 (q, C-19), 28.0 (q, C-25), 30.9 (t, C-15), 39.6 
(t, C-14), 44.7 (t, C-12, C-10), 63.8 (d, C-20), 83.3 (s, C-24),  97.8 (d, C-3), 
107.6 (d, C-1/C-8/s, C-5), 108.5 (d, C-8/C-1/s, C-5), C-22 not seen, 125.1 
(d, C-16/C-6), 131.6 (d, C-17), 150.5 (s, C-2), 155.6 (s, C-4), 156.3 (s, C-
9/C-21), 162.3 (s, C-7), 168.8 (s, C-23). 
Elemental Analysis:  
C27H35F3N2O5 Calculated C 61.82 H 6.73 N 5.34  
(524.5812) Found  C 62.93 H 7.06 N 4.97 
HRMS (CI):   Calculated   Found 
C27H35F3N2O5 [M]
+: 524.2498  524.2500  
Absorption max.:  364 nm 
Exitation max.: 373 nm 
Emission max.:  419 nm 
Lifetime: 3.29 ns 
tert-Butyl-(E)-3-(2-(7-(diethylamino)-2-oxo-2H-chromen-4-yl)ethyl)-2-(2,2,2-
trifluoroacetamido)hex-4-enoate (69) 
According to the GP 9 81 mg (0.36 mmol, 1 eq.) TFA-Glycin-tert-butylester reacted 
with 95 mg (0.25 mmol, 0.7 eq.) 7-Aminocoumarin-carbonate 65. After work-up and 
column chromatography (silica gel, PE:EA 7:3) 31.5 mg (0.06 mmol, 24%) of 
regioisomer 69 was isolated as a yellow oil. 
Rf(69) = 0.23 (PE:EA 7:3) 
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69 
 1H-NMR (400 MHz, CDCl3):  
 = 1,19 (t, 3J13,12 = 
3J11,10 = 7.1 Hz, 6 H, 11-H, 13-H), 1.33 (d, 
3J19,18 = 6.5 
Hz, 3 H, 19-H), 1.46 (s, 9 H, 23-H), 2.34-2.42 (sh, 2 H, 15-H), 2.68-2.75 (sh,  
3 H, 14-H), 3.39 (q, 3J12,13 = 
3J10,11 = 7.1 Hz, 4 H, 12-H, 10-H), 4.48 (dd, 
3J20,NH = 8.4 Hz, 
3J20,16 = 4.5 Hz, 1 H, 20-H), 5.15 (m, 1 H, 16-H), 5.37 (m, 1 
H, 18-H), 5.60 (m, 1 H, 17-H), 5.89 (s, 1 H, 8-H), 6.48 (d, 4J3,1  = 2.5 Hz, 1 H, 
3-H), 6.55-6.58 (sh, 1 H, 1-H), 6.85 (d, 3JNH,20 = 8.2 Hz, 1 H, NH), 7.35 (d, 
3J6,1 = 9.0 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C-13), 16.6 (q, C-19), 28.0 (q, C-23), 31.3 (t, C-15), 39.9 
(t, C-14), 44.7 (t, C-12, C-10), 57.1 (d, C-16), 63.8 (d, C-20), 83.4 (s, C-22),  
97.8 (d, C-3), 107.6 (d, C-1/C-8/s, C-5), 108.5 (d, C-8/C-1/s, C-5), C-22 not 
seen, 125.1 (d, C-18/C-6), 131.6 (d, C-17), 150.5 (s, C-2), 155.6 (s, C-4), 
156.3 (s, C-9/C-24), 162.3 (s, C-7), 169.0 (s, C-21). 
Elemental Analysis:  
C27H35F3N2O5 Calculated C 61.82 H 6.73 N 5.34  
(524.5812) Found  C 62.93 H 7.06 N 4.97 
HRMS (CI):   Calculated   Found 
C27H35F3N2O5 [M]
+: 524.2498  524.2500  
Absorption max.:  364 nm 
Exitation max.: 373 nm 
Emission max.:  419 nm 
Lifetime: 3.29 ns 
7-(Diethylamino)-4-(1-hydroxyallyl)-2H-chromen-2-one (70) 
According to the GP-7 1 g (4.3 mmol, 1 eq.) fluorescenting aldehyde 56 was 
dissolved in 45 ml abs. THF. 5.72 ml (5.72 mmol, 1.3 eq) 1M Vinylmagnesium-
bromide-solution in THF was added slowly at –20 °C. The reaction mixture was 
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stirred for 3 h. After work-up solvent was removed in vacuo. The crude product was 
used raw without further purification. 
 Rf(70) = 0.16 (DCM:EA 9:1) 
 
70 
1H-NMR (400 MHz, CDCl3):  
 = 1.20 (t, 3J13,12 = 
3J11,10 = 7.1 Hz, 6 H, 11-H, 13-H), 3.40 (q, 
3J12,13 = 
3J10,11  
= 7.1 Hz, 4 H, 12-H, 10-H), 5.32 (d, 3J16trans,15 = 10.3 Hz, 1 H, 16 trans-H), 
5.42 (m, 1 H, 14-H), 5.49 (d, 3J16cis,15 = 17.2 Hz, 1 H, 16c is-H), 6.06 (ddd, 
3J15,16cis  = 16.6 Hz,  
3J15,16trans = 10.3 Hz, 
3J15,14 = 5.9 Hz, 1 H, 15-H), 6.26 (s, 
1 H, 8-H), 6.50 (d, 4J3,1 = 2.5 Hz, 1 H, 3-H), 6.55 (dd, 
3J1,6 =  9.1 Hz, 
4J1,3 = 
2.5 Hz, 1 H, 1-H), 7.48 (d, 3J6,1 = 9.1 Hz, 1 H, 6-H).  
13C-NMR (100 MHz, CDCl3): 
 = 12.5 (q, C-11/C-13), 44.7 (t, C-10/C-12), 71.1 (d, C-14), 97.8 (d, C-3), 
105.9 (d, C-1), 106.2 (s, C-5), 108.4 (d, C-8), 117.9 (t, C-16), 125.7 (d, C-
6), 137.4 (d, C-15), 150.4 (s, C-2), 155.7 (s, C-4), 156.6 (s, C-9), 162.6 (s, 
C-7/C-20). 
HRMS (CI):   Calculated   Found 
C16H23NO3 [M]
+: 273.1365 273.1399  
Absorption max.:  366 nm 
Exitation max.: 369 nm 
Emission max.:  432 nm 
Lifetime: 3.46 ns 
1-(7-(Diethylamino)-2-oxo-2H-chromen-4-yl)allyl ethyl carbonate (71) 
According to the GP-8 allylalcohol 70 in 10 ml abs. DCM was dissolved in 5 ml dry 
pyridine. 1 ml (8.6 mmol, 2 eq.) ethyl chloroformate was added at 0 °C. The reaction 
mixture was allowed to warm to rt overnight. After work-up and column 
chromatography (silica gel, PE:EA 7:3) 848 mg (2.5 mmol, 57% over two steps) of 
allylcarbonate 71 was isolated as a yellow oil. 
Rf(71) = 0.38 (PE:EA 7:3) 
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71 
1H-NMR (400 MHz, CDCl3):  
 = 1.13 (t, 3J13,12 = 
3J11,10 = 7.1 Hz, 6 H, 11-H, 13-H), 1.26 (t, 
3J19,18 = 7.1 
Hz, 3 H, 19-H), 3.34 (q, 3J12,13 = 
3J10,11 = 7.1 Hz, 4 H, 12-H, 10-H), 4.16 (q, 
3J18,19 = 7.1 Hz, 2 H, 18-H), 5.32 (d, 
3J16trans,15 = 10.4 Hz, 1 H, 16 trans-H), 
5.42 (d, 3J16cis,15 = 17.2 Hz, 1 H, 16c is-H), 5.95 (ddd, 
3J15,16cis  =  16.7 Hz,  
3J15,16trans = 10.4 Hz, 
3J15,14 = 6.1 Hz, 1 H, 15-H), 6.12 (s, 1 H, 8-H), 6.18 (d, 
3J14,15 = 6.1 Hz, 1 H), 6.44 (d, 
4J3,1 = 2.5 Hz, 1 H, 3-H), 6.50 (dd, 
3J1,6 = 9.1 
Hz, 4J1,3 = 2.6 Hz, 1 H, 1-H), 7.36 (d, 
3J6,1 = 9.1 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C-13), 14.2 (q, C-19), 44.7 (t, C-10/C-12), 64.7 (t, C-18), 
75.1 (d, C-14), 97.9 (d, C-3), 105.8 (d, C-1), 106.4 (s, C-5), 108.6 (d, C-8), 
120.2 (t, C-16), 125.5 (d, C-6), 133.2 (d, C-15), 150.6 (s, C-2), 154.1 (s, C-
4), 156.6 (s, C-17), 162.0 (s, C-7/C-9). 
HRMS (CI):   Calculated   Found 
C19H23NO5 [M]
+: 345.1576 345.1575  
Absorption max.:  377 nm 
Exitation max.: 372 nm 
Emission max.:  436 nm 
Lifetime: 4.62 ns 
tert-Butyl-(E)-5-(7-(diethylamino)-2-oxo-2H-chromen-4-yl)-2-(2,2,2-trifluoro-
acetamido)pent-4-enoate (72) 
According to the GP 9 81 mg (0.36 mmol, 1 eq.) TFA-Glycin-tert-butylester reacted 
with 95 mg (0.25 mmol, 0.7 eq.) 7-Aminocoumarin-carbonate 71. After work-up and 
column chromatography (silica gel, PE:EA 7:3) 86.9 mg (0.18 mmol, 72%) of 72 was 
isolated as a yellow oil. 
Rf(72) = 0.25 (PE:EA 7:3) 
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72 
1H-NMR (400 MHz, CDCl3):  
 = 1.20 (t, 3J13,12  = 
3J11,10 = 7.1 Hz, 6 H, 11-H, 13-H), 1.49 (s, 9 H, 22-H), 
2.82 (m, 1 H, 16-H), 2.95 (m, 1 H, 16’-H), 3.40 (q, 3J12,13 = 
3J10,11 = 7.1 Hz, 
4 H, 12-H, 10-H), 4.64 (dd, 3J17,16 = 12.4 Hz, 
3J17,NH = 5.7 Hz, 1 H, 17-H), 
6.03 (s, 1 H, 8-H), 6.24 (dt, 3J15,14 = 15.1 Hz, 
3J15,16 = 7.4 Hz, 1 H, 15-H), 
6.49 (d, 4J3,1 = 2.5 Hz, 1 H, 3-H), 6.55 (dd, 
3J1,6 = 9.0 Hz, 
4J1,3 = 2.6 Hz, 1 H, 
1-H), 6.68 (d, 3J14,15 =  15.6 Hz, 1 H, 14-H), 7.14 (d, 
3JNH,17 = 6.7 Hz, 1 H, 
NH), 7.37 (d, 3J6,1 = 9.0 Hz, 1 H, 6-H).
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C-13), 27.8 (q, C-22), 35.5 (t, C-16), 44.7 (t, C-12/C-10), 
52.7 (d, C-17), 84.1 (s, C-21),  97.9 (d, C-3), 104.6 (d, C-8), 107.2 (d, C-1), 
108.5 (s, C-5), 114.2 (s, C-19), 125.3 (d, C-6), 128.1 (d, C-14), 131.5 (d, C-
15), 149.9 (s, C-9), 150.7 (s, C-4), 156.5 (s, C-18), 162.4 (s, C-7/C-9), 168.9 
(s, C-20). 
HRMS (CI):   Calculated   Found 
C24H29F3N2O5 [M+H]
+: 483.2101 483.2101  
Absorption max.:  380 nm 
Exitation max.: 375 nm 
Emission max.:  443 nm 
Lifetime: 4.71 ns 
 (Z)-4-(Prop-2-yn-1-yloxy)but-2-en-1-ol (73) 
To solution of 2.67 ml (30 mmol, 3 eq.) cis-2-Butene-1,4-diol in 10 ml abs. THF 400 
mg (10 mmol, 1 eq., 60% suspension in mineral oil) NaH suspension in 5 ml abs. THF 
was added at 0 °C. The reaction mixture was stirred at rt for 30 minutes and 1.11 ml 
(10 mmol, 1 eq., 80% w/v in toluene) propargylic bromide was added quickly. After 
refluxing overnight the solution was diluted with water and washed with 
diethylether. The organic layer was dried over Na2SO4. The solvent was removed in 
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vacuo and the crude product purified by column chromatography (silica gel, 
DCM:Et2O 9:1) to furnish 980 mg (7.77 mmol, 78%) of 73 as a colourless liquid. 
Rf(73) = 0.16 (DCM:Et2O 9:1)
  
 
73 
1H-NMR (400 MHz, CDCl3):  
 ppm 2.44 (t, 4J7,5 = 2.4 Hz, 1 H, 7-H), 2.98 (bs, 1 H, OH), 4.07 (m, 4 H, 3-
H, 4-H), 4.12 (m, 2 H, 5-H), 5.59 (m, 1 H, 2-H), 5.74 (m, 1 H, 1-H). 
13C-NMR (100 MHz, CDCl3): 
 = 57.2 (t, C-3), 58.2 (t, C-5), 64.9 (t, C-4), 74.9 (d, C-7), 79.4 (s, C-6), 
126.9 (d, C-1), 133.2 (d, C-2).  
(Z)-7-(Diethylamino)-4-(3-((4-hydroxybut-2-en-1-yl)oxy)prop-1-yn-1-yl)-2H-
chromen-2-one (74) 
According to the GP 4 to the solution of 311 mg (248 µmol, 2 mol%) Pd(PPh3)4, 
94.5 mg (496 µmol, 4 mol%) CuI and 4.5 g (12.4 mmol, 1eq.) enol triflate 12 in 62 ml 
abs. THF 1.7 ml (1.3 g, 12.4 mmol, 1 eq.) Et3N and 3 g (24.8 mmol, 2 eq.) propargylic 
diol 73 were added at rt and the reaction mixture was stirred at rt for 2 h. Work-up 
and column chromatography (silicagel, DCM:MeOH 95:5) furnished 3.3 g (9.8 mmol, 
79%) of the product 74 as a yellow oil. 
Rf(74) = 0.23 (DCM:MeOH 95:5)
  
 
74 
1H-NMR (400 MHz, CDCl3):  
 = 1.19 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.39 (q, 
3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 4.25 (t, 
3J17,18 = 
3J20,19 = 6.6 Hz, 4 H, 17-
H, 20-H), 4.45 (s, 2 H, 16-H), 5.71 (m, 1 H, 18-H), 5.89 (m, 1 H, 19-H), 6.13 
(s, 1 H, 8-H), 6.43 (d, 4J3,1 = 2.5 Hz, 1 H, 3-H), 6.58 (dd, 
3J1,6 = 9.0 Hz, 
4J1,3 =  
2.5 Hz, 1 H, 1-H), 7.54 (d, 3J6,1 = 9.0 Hz, 1 H, 6-H). 
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13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 44.9 (t, C-12/C-10), 57.2 (t, C-16/C-20), 58.7 (t, C-
16/C-20),  64.9 (t, C-17), 80.8 (s, C-14), 96.2 (s, C-15), 97.4 (d, C-3), 107.7 
(d, C-1), 108.8 (s, C-5), 111.8 (d, C-8) 127.2 (d, C-6/C-19), 127.5(d, C-6/C-
19), 133.4 (d, C-18) 136.7 (s, C-9), 151.1 (s, C-2), 156.2 (s, C-4), 161.5 (s, 
C-7). 
HRMS (CI):   Calculated Found 
C20H23NO4 [M-OH]
+: 326.1751 326.1770  
Absorption max.:  393 nm 
Emission max.:  484 nm 
Lifetime: 5.53 ns 
Melting point:  68 °C 
(Z)-4-((3-(7-(Diethylamino)-2-oxo-2H-chromen-4-yl)prop-2-yn-1-yl)oxy)but-2-
en-1-yl ethyl carbonate (75) 
According to the GP 8 to 3.3 g (9.8 mmol, 1 eq.) fluorescenting allylalcohol 74 in 
3.2 ml dry pyridine 4.5 ml (19.6 mmol, 2 eq.) ethyl chloroformate was added 
dropwise at 0 °C. After work-up and column chromatography (silicagel, DCM:EA 
95:5) 4.4 g (10.7 mmol, 87%) of 75 was isolated as a yellow oil. 
Rf(75) = 0.42 (DCM:EA 95:5) 
 
75 
1H-NMR (400 MHz, CDCl3):  
 = 1.21 (t, 3J11,10  = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 1.30 (t, 
3J23,22 = 7.1 
Hz, 3 H, 23-H), 3.41 (q, 3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 4.19 (q, 
3J22,23 = 7.1 Hz, 2 H, 22-H), 4.28 (d, 
3J17,18 = 5.0 Hz, 2 H, 17-H), 4.47 (s, 2 H, 
16-H), 4.75 (d, 3J20,19 = 5.3 Hz, 2 H, 20-H), 5.86 (dtt, 
3J18,19 = 
3J19,18 = 11.3 
Hz, 3J18,17 = 
3J19,20 = 5.3 Hz,  
4J19,17 =  
4J18,20 = 2.5 Hz, 2 H, 18-H, 19-H), 6.17 
(s, 1 H, 8-H), 6.46 (d, 4J3,1 = 2.5 Hz, 1 H, 3-H), 6.60 (dd, 
3J1,6 = 9.0 Hz, 
4J1,3 =  
2.5 Hz, 1 H, 1-H), 7.57 (d, 3J6,1 = 9.0 Hz, 1 H, 6-H). 
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13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 14.3 (q, C-23), 44.8 (t, C-12/C-10), 58.1 (t, C-16), 
63.2 (t, C-22/C-10/C-17), 64.2 (t, C-22/C-10/C-17), 65.6 (t, C-22/C-10/C-
17), 80.8 (s, C-14), 96.1 (s, C-15), 97.4 (d, C-3), 107.8 (d, C-1), 108.8 (s, C-
5), 111.9 (d, C-8) 127.3 (d, C-6/C-19), 127.5 (d, C-6/C-19), 130.1 (d, C-18)  
136.6 (s, C-9), 151.0 (s, C-2), 155.0 (s, C-4), 156.2 (s, C-21), 161.4 (s, C-7). 
Elemental Analysis:  
C23H27NO6 Calculated C 66.81 H 6.58 N 3.39 
(413.4636) Found  C 67.11 H 6.61 N 3.13 
HRMS (CI):   Calculated Found 
C23H27NO6 [M]
+: 413.1824 413.1847  
Absorption max.:  396 nm 
Emission max.:  478 nm 
Lifetime: 5.57 ns 
Melting point:   55-56 °C 
tert-Butyl-(E)-6-((3-(7-(diethylamino)-2-oxo-2H-chromen-4-yl)prop-2-yn-1-
yl)oxy)-2-(2,2,2-trifluoroacetamido)hex-4-enoate (76) 
According to the GP 9 227 mg (1 mmol, 1 eq.) TFA-glycin-tert-butylester reacted 
with 206 mg (0.5 mmol, 0.5 eq.) 7-Aminocoumarin-carbonate 75. After work-up and 
column chromatography (silica gel, DCM:EA 95:5, 9:1) 189.5 mg (0.34 mmol, 69%) of 
76 was isolated as a yellow oil. 
Rf(76) = 0.41 (DCM:EA 95:5) 
 
76 
1H-NMR (400 MHz, CDCl3):  
 = 1.17 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 1.45 (s, 9 H, 26-H), 
2.51 (m, 1 H, 20-H), 2.67 (m, 1 H, 20’-H), 3.37 (q, 3J10,11 = 
3J12,13 = 7.1 Hz, 
4 H, 12-H, 10-H), 4.07 (d, 3J17,18 =  6.1 Hz, 2 H, 17-H), 4.52 (m, 1 H, 21-H), 
5.26 (s, 2 H, 16-H), 5.59 (m, 2 H, 18-H, 19-H), 5.95 (s, 1 H, 8-H), 6.46 (d, 
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4J3,1 = 2.6 Hz, 1 H, 3-H), 6.53 (dd, 
3J1,6 = 9.0 Hz, 
4J1,3 = 2.6 Hz, 1 H, 1-H), 
7.06 (d, 3JNH,21 = 7.2 Hz, 1 H, NH), 7.25 (d, 
3J6,1 = 9.0 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 27.9 (q, C-26), 34.7 (t, C-20), 44.8 (t, C-12/C-10), 
52.3 (t, C-16), 53.4 (d, C-21), 71.4 (t, C-17), C-25 not seen, 83.7 (s, C-14), 
C-15 not seen, 97.5 (d, C-3), 108.0 (d, C-1), 108.7 (s, C-5), 108.8 (d, C-8), 
125.7 (d, C-19), 129.2 (d, C-18), 148.3 (s, C-9), 148.2 (s, C-2), 150.8 (s, C-
27/C-4), 161.8 (s, C-7), 169.1 (s, C-24). 
HRMS (CI):   Calculated Found 
C28H36F3N2O6 [M+3H]
+: 553.2509 553.1800  
Absorption max.:  372 nm 
Exitation max.: 381 nm 
Emission max.:  446 nm 
Lifetime: 3.98 ns 
(E)-N-(tert-Butoxycarbonyl)-O-(4-((3-(7-(diethylamino)-2-oxo-2H-chromen-4-
yl)prop-2-yn-1-yl)oxy)but-2-en-1-yl)-L-serine (77) 
To the solution of 1 mg (2.5 µmol, 1 mol%) [AllylPdCl]2 and 3 mg (11.3 µmol, 4.5 
mol%) PPh3 in 0.5 ml abs. THF 103 mg (0.25 mmol, 0.5 eq.) fluorescenting carbonate 
75 was added. The mixture was stirred for 15 minutes at rt and 110 mg (0.5 mmol, 1 
eq.) Boc-serine was added. The reaction mixture was stirred overnight at rt. 
Afterwards the solvent was removed in vacuo and the crude product purified by 
column chromatography (silica gel, DCM:MeOH 95:5) to furnish 90 mg (0.17 mmol, 
68%) of 77 as a yellow oil. 
Rf(77) = 0.27 (DCM:MeOH 95:5) 
 
77 
1H-NMR (400 MHz, CDCl3):  
 = 1.21 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 1.44 (s, 9 H, 26-H), 
3.41 (q, 3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 3.95 (m, 2 H, 21-H), 
4.16-4.17 (sh, 2 H, 17-H), 4.39 (m, 1 H, 22-H), 4.46 (s, 2 H, 16-H), 4.70-
4.71 (sh, 2 H, 20-H), 5.91 (m, 2 H, 18-H, 19-H), 6.16 (s, 1 H, 8-H), 6.46 (d, 
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4J3,1 = 2.5 Hz, 1 H, 3-H), 6.60 (dd, 
3J1,6 = 9.0 Hz, 
4J1,3 = 2.5 Hz, 1 H, 1-H), 
7.56 (d, 3J6,1 = 9.0 Hz, 1 H, 6-H), 8.01 (s, 1 H, OH). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 28.3 (q, C-26), 44.9 (t, C-12/C-10), 58.0 (t, C-16/d, 
C-22), 69.7 (t, C-21/C-20), 77.2 (d, C-17), 80.8 (s, C-14/C-25), 96.1 (s, C-
15), 97.4 (d, C-3), 107.7 (d, C-1), 108.8 (s, C-5), 111.8 (d, C-8) 127.5 (d, C-
6), 130.3 (d, C-18), 132.1 (d, C-19), 136.7 (s, C-9), 151.0 (s, C-2/C-4), 
156.2 (s, C-24), 161.6 (s, C-7), 170.5 (s, C-23). 
HRMS (CI):   Calculated Found 
C28H37N2O8 [M+H]
+:  528.2472 528.2462  
Absorption max.:  396 nm 
Exitation max.: 404 nm 
Emission max.:  484 nm 
Lifetime: 5.66 ns 
(E)-7-(Diethylamino)-4-(3-((4-phenoxybut-2-en-1-yl)oxy)prop-1-yn-1-yl)-2H-
chromen-2-one (78) 
To the solution of 6 mg (5 µmol, 5 mol%) Pd(PPh3)4 and 41 mg (0.1 mmol, 1 eq.) 
fluorescenting carbonate 75 in 0.6 ml THF 10.4 mg (0.11 mmol, 1.1 eq.) phenol was 
added. The reaction mixture was refluxed overnight. Afterwards the solvent was 
removed in vacuo and the crude product purified by column chromatography (silica 
gel, DCM:EA 95:5) to furnish 24.2 mg (0.058 mmol, 58%) of 78 as a yellow oil. 
Rf(78) = 0.3 (DCM:EA 95:5) 
 
78 
1H-NMR (400 MHz, CDCl3):  
 = 1.13 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.34 (q, 
3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 4.14 (d, 
3J17,18 = 4.8 Hz, 2 H, 17-H), 4.40 
(s, 2 H, 16-H), 4.50 (d, 3J20,19 = 4.2 Hz, 2 H, 20-H), 5.94 (m, 2 H, 18-H, 19-
H), 6.10 (s, 1 H, 8-H), 6.39 (d, 4J3,1  = 2.5 Hz, 1 H, 3-H), 6.51 (dd, 
3J1,6 = 9.0 
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Hz, 4J1,3 = 2.5 Hz, 1 H, 1-H), 6.85 (m, 3 H, Phe), 7.19 (m, 2 H, Phe), 7.50 (d, 
3J6,1 = 9.0 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 44.8 (t, C-12/C-10), 57.9 (t, C-16), 67.6 (t, C-20), 
70.0 (t, C-17), 80.8 (s, C-14), 96.4 (s, C-15), 97.5(d, C-3), 107.7 (d, C-1), 
108.8 (d, C-22), 111.9 (d, C-8), 114.7 (s, C-5), 116,1 (d, C-24), 127.5 (d, C-
6), 128.6 (d, C-18), 129.2 (d, C-23), 129.5 (d, C-19), 136.7 (s, C-9), 151.1 
(s, C-2), 156.2 (s, C-4), 158.5 (s, C-21), 161.4 (s, C-7). 
HRMS (CI):   Calculated Found 
C26H27NO4 [M]
+: 417.1940 417.1947  
Absorption max.:  397 nm 
Exitation max.: 408 nm 
Emission max.:  482 nm 
Lifetime: 5.65 ns 
7-(Diethylamino)-4-(3-((2-phenoxybut-3-en-1-yl)oxy)prop-1-yn-1-yl)-2H-
chromen-2-one (79) 
To the solution of 6 mg (5 µmol, 5 mol%) Pd(PPh3)4 and 41 mg (0.1 mmol, 1 eq.) 
fluorescenting carbonate 75 in 0.6 ml THF 10.4 mg (0.11 mmol, 1.1 eq.) phenol was 
added. The reaction mixture was refluxed overnight. Afterwards the solvent was 
removed in vacuo and the crude product purified by column chromatography (silica 
gel, DCM:EA 95:5) to furnish 5 mg (0.012 mmol, 12%) of 79 as a yellow oil. 
Rf(79) = 0.3 (DCM:EA 95:5) 
 
79 
1H-NMR (400 MHz, CDCl3):  
 = 1.13 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.34 (q, 
3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 3.79 (dd, 
3J17,18 = 5.2 Hz, 
2J17,17’ = 4.0 Hz, 
1 H, 17-H), 4.41 (s, 2 H, 16-H), 4.84 (m, 1 H, 18-H), 5.25 (dt, 3J20trans,19 = 
10.6 Hz,  2J20trans,20cis  = 1.0 Hz, 1 H, 20 trans-H), 5.35 (dt, 
3J20cis,19 = 17.4 Hz,  
2J20cis,20trans = 1.2 Hz, 1 H, 20c is-H), 5.83 (m, 1 H, 19-H), 6.10 (s, 1 H, 8-H), 
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6.39 (d, 4J3,1 = 2.5 Hz, 1 H, 3-H), 6.51 (dd, 
3J1,6 = 9.0 Hz, 
4J1,3 = 2.5 Hz, 1 H, 
1-H), 6.85 (m, 3 H, Phe), 7.19 (m, 2 H, Phe), 7.50 (d, 3J6,1  = 9.0 Hz, 1 H, 6-
H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 44.8 (t, C-12/C-10), 59.4 (t, C-16), 72.6 (t, C-17), 
78.1 (d, C-18), 80.8 (s, C-14), 96.4 (s, C-15), 97.5 (d, C-3), 107.7 (d, C-1), 
108.8 (d, C-22), 111.9 (d, C-8), 114.7 (s, C-5), 116,1 (d, C-24), 127.5 (d, C-
6), 118.4 (t, C-20), 129.2 (d, C-23), 134.3 (d, C-19), 136.7 (s, C-9), 151.1 
(s, C-2), 156.2 (s, C-4), 158.5 (s, C-21), 161.4 (s, C-7). 
HRMS (CI):   Calculated Found 
C26H27NO4 [M]
+: 417.1940 417.1947  
Absorption max.:  397 nm 
Exitation max.: 408 nm 
Emission max.:  482 nm 
Lifetime: 5.65 ns 
(E)-7-(diethylamino)-4-(3-((4-(piperidin-1-yl)but-2-en-1-yl)oxy)prop-1-yn-1-
yl)-2H-chromen-2-one (80) 
To the solution of 4.8 mg (5 µmol, 5 mol%) [AllylPdCl]2 and 5.2 mg (20 µmol, 20 
mol%) PPh3 in 2 ml DMF 41 mg (0.1 mmol, 1 eq.) fluorescenting carbonate 75 was 
added and the mixture was stirred at rt for 15 minutes before it was cooled down to 
–20 °C and 15 µl (0.15 mmol, 1.5 eq.) piperidine was added dropwise. The reaction 
mixture was allowed to warm up to rt overnight. Afterwards it was dissolved with EA 
and washed with water. The aqueous layer was extracted three times with EA and 
combined organic layers were dried over Na2SO4. The solvent was removed in vacuo 
and the crude product purified by column chromatography (silica gel, DCM:MeOH, 
95:5) to furnish 35.9 mg (0.088 mmol, 88%) of 80 as a brown oil.  
Rf(80) = 0.19 (DCM:MeOH 9:1)
  
 
80 
1H-NMR (400 MHz, CDCl3):  
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 = 1.19 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 1.49 (sh, 2 H, 23-H), 
1.71 (m, 4 H, 22-H, 24-H), 2.63 (sh, 4 H, 21-H, 25-H), 3.21 (d, 3J20,19 = 6.6 
Hz, 2 H, 20-H), 3.40 (q, 3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 4.15 (d, 
3J17,18 = 5.2 Hz, 2 H, 17-H), 4.45 (s, 2 H, 16-H), 5.92 (dtt, 
3J18,19 = 
3J19,18 = 
16.8 Hz, 3J19,20 =  6.6 Hz, 
3J18,17 =  5.6 Hz, 2 H, 18-H, 19-H), 6.14 (s, 1 H, 8-
H), 6.44 (d, 4J3,1 = 2.5 Hz, 1 H, 3-H), 6.60 (dd, 
3J1,6 = 9.0 Hz, 
4J1,3 =  2.5 Hz, 1 
H, 1-H), 7.55 (d, 3J6,1  = 9.0 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 23.4 (t, C-23), 24.5 (t, C-22/C-24), 44.8 (t, C-12/C-
10), 53.7 (t, C-21/C-25), 58.0 (t, C-16), 60.0 (t, C-20), 70.0 (t, C-17), 80.8 
(s, C-14), 96.3 (s, C-15), 97.4 (d, C-3), 107.7 (d, C-1), 108.8 (s, C-5), 
111.8(d, C-8) 127.4 (d, C-6), 131.91 (d, C-18)  136.7 (d, C-19), C-9 not 
seen, 151.1 (s, C-2), 156.2 (s, C-4), 161.5 (s, C-7). 
HRMS (CI):   Calculated Found 
C25H33N2O3 [M+H]
+: 409.2486 409.2497  
Absorption max.:  374 nm 
Exitation max.: 380 nm 
Emission max.:  435 nm 
Lifetime: 4.50/1.37 ns  
(E)-7-(diethylamino)-4-(3-((4-morpholinobut-2-en-1-yl)oxy)prop-1-yn-1-yl)-
2H-chromen-2-one (81) 
To the solution of 3.7 mg (10 µmol, 5 mol%) [AllylPdCl]2 and 10.5 mg (40 µmol, 20 
mol%) PPh3 in 2 ml DMF 83 mg (0.2 mmol, 1 eq.) fluorescenting carbonate 75 was 
added and the mixture was stirred at rt for 15 minutes before it was cooled down to 
–20 °C and 22.4 µl (22.6 mg, 0.26 mmol, 1.3 eq.) morpholine was added dropwise. 
The reaction mixture was allowed to warm up to rt overnight. Afterwards it was 
dissolved with EA and washed with water. The aqueous layer was extracted three 
times with EA and combined organic layers were dried over Na2SO4. The solvent was 
removed in vacuo and the crude product purified by column chromatography (silica 
gel, DCM:MeOH 95:5) to furnish 68.7 mg (0.168 mmol, 84%) of 81 as a brown solid 
compound. 
Rf(81) = 0.28 (DCM:MeOH 9:1)
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81 
1H-NMR (400 MHz, CDCl3):  
 = 1.19 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 1.89 (sh, 4 H, 21-
H,24-H), 2.76 (sh, 4 H, 22-H, 23-H), 3.32 (d, 3J20,19 = 6.4 Hz, 2 H, 20-H), 
3.39 (q, 3J10,11 =  
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 4.14 (dd, 
3J17,18 = 5.6 Hz, 
4J17,16 = 0.7 Hz, 2 H, 17-H), 4.44 (s, 2 H, 16-H), 5.94 (dtt, 
3J18,19  = 
3J19,18 = 
15.6 Hz, 3J19,20 =  6.5 Hz, 
3J18,17 =  5.6 Hz, 2 H, 18-H, 19-H), 6.13 (s, 1 H, 8-
H), 6.43 (d, 4J3,1 = 2.5 Hz, 1 H, 3-H), 6.59 (dd, 
3J1,6 = 9.0 Hz, 
4J1,3 =  2.5 Hz, 1 
H, 1-H), 7.54 (d, 3J6,1  = 9.0 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 23.4 (t, C-21/C24), 44.8 (t, C-12/C-10), 53.5 (t, C-
22/C-23), 57.0 (t, C-16/C-20), 57.9 (t, C-16/C-20), 70.0 (t, C-17), 80.7 (s, 
C-14), 96.4 (s, C-15), 97.4 (d, C-3), 107.7 (d, C-1), 108.9 (s, C-5), 111.7 (d, 
C-8) 127.5 (d, C-6), 128.6 (d, C-18)  130.9 (d, C-19), 136.7 (s, C-9), 151.1 
(s, C-2), 156.2 (s, C-4), 161.4 (s, C-7). 
HRMS (CI):   Calculated Found 
C24H30N2O4 [M+3H]
+: 413.2435 413.2446  
Absorption max.:  370 nm 
Exitation max.: 373 nm 
Emission max.:  432 nm 
Lifetime: 3.68/1.25 ns  
Melting point:  73-75 °C 
(E)-7-(diethylamino)-4-(3-((4-(phenylamino)but-2-en-1-yl)oxy)prop-1-yn-1-
yl)-2H-chromen-2-one (82) 
To the solution of 5.8 mg (5 µmol, 5 mol%) Pd(PPh3)4 and 41 mg (0.1 mmol, 1 eq.) 
fluorescenting carbonate 75 in 0.6 ml THF 10 µl (10.2 mg,  0.11 mmol, 1.1 eq.) aniline 
was added. The reaction mixture was stirred at rt overnight. Afterwards the solvent 
was removed in vacuo and the crude product purified by column chromatography 
(silica gel, DCM:EA 95:5) to furnish 25.9 mg (0.062 mmol, 62%) of 82 as a yellow oil. 
Rf(82) = 0.28 (DCM:EA 9:1) 
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82 
1H-NMR (400 MHz, CDCl3):  
 = 1.20 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.41 (q, 
3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 3.82 (d, 
3J17,18 = 4.8 Hz, 2 H, 17-H), 4.16 
(d, 3J20,19 = 5.7 Hz, 2 H, 20-H), 4.45 (s, 2 H, 16-H), 5.91 (m, 2 H, 18-H, 19-
H), 6.16 (s, 1 H, 8-H), 6.46 (d, 4J3,1  = 2.5 Hz, 1 H, 3-H), 6.58 (dd, 
3J1,6 = 9.0 
Hz, 4J1,3 = 2.5 Hz, 1 H, 1-H), ), 6.85 (m, 3 H, Phe), 7.19 (m, 2 H, Phe), 7.41 
(d, 3JNH,20 = 7.9 Hz, 1 H, NH7.56 (d, 
3J6,1 = 8.9 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 44.8 (t, C-12/C-10), 45.4 (t, C-20), 57.7 (t, C-16), 
70.0 (t, C-17), 80.7(s, C-14), 96.5 (s, C-15), 97.5(d, C-3), 107.8 (d, C-1), 
108.8 (d, C-8, s, C-5), 111.8 (d, C-22), 117.7 (d, C-24), 127.5 (d, C-6), 
129.3 (d, C-23/C-18), 131.9 (d, C-19), 136.7 (s, C-9), 147.9 (s, C-21), 151.1 
(s, C-2), 156.2 (s, C-4), 161.4 (s, C-7). 
HRMS (CI):   Calculated Found 
C26H28N2O3 [M]
+: 416.2100 416.2095  
Absorption max.:  377 nm 
Exitation max.: 373 nm 
Emission max.:  436 nm 
Lifetime: 4.60/1.82 ns  
7-(Diethylamino)-4-(3-((2-(phenylamino)but-3-en-1-yl)oxy)prop-1-yn-1-yl)-
2H-chromen-2-one (83) 
To the solution of 5.8 mg (5 µmol, 5 mol%) Pd(PPh3)4 and 41 mg (0.1 mmol, 1 eq.) 
fluorescenting carbonate 75 in 0.6 ml THF 10 µl (10.2 mg,  0.11 mmol, 1.1 eq.) aniline 
was added. The reaction mixture was stirred at rt overnight. Afterwards the solvent 
was removed in vacuo and the crude product purified by column chromatography 
(silica gel, DCM:EA 95:5) to furnish 3.7 mg (0.009 mmol, 9%) of 83 as a yellow oil. 
Rf(83) = 0.33 (DCM:EA 9:1) 
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83 
 
1H-NMR (400 MHz, CDCl3):  
 = 1.20 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.41 (q, 
3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 3.77 (m, 2 H, 17-H), 4.14 (dd, 
3J18,17 = 
10.2 Hz,  3J18,19 =  5.7 Hz, 1 H, 18-H), 4.52 (s, 2 H, 16-H), 5.25 (dt, 
3J20trans,19  
= 10.5 Hz,  2J20trans,20cis  = 1.2 Hz, 1 H, 20 trans-H), 5.38 (dt, 
3J20cis ,19 = 17.3 
Hz, 2J20cis,20trans = 1.4 Hz, 1 H, 20cis-H), 5.89 (ddd, 
3J19,20cis =  17.2 Hz, 
3J19,20trans = 10.4 Hz, 
3J19,18 = 5.7 Hz, 1 H, 19-H), 6.14 (s, 1 H, 8-H), 6.46 (d, 
4J3,1 = 2.5 Hz, 1 H, 3-H), 6.53 (dd, 
3J1,6 = 9.0 Hz, 
4J1,3 = 2.5 Hz, 1 H, 1-H), 
6.69 (m, 3 H, Phe), 7.16 (m, 2 H, Phe), 7.55 (d, 3J6,1 = 8.9 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 44.8 (t, C-12/C-10), 59.4 (t, C-16), 64.4 (d, C-18), 
70.2 (t, C-17), 80.9 (s, C-14), 96.5 (s, C-15), 97.5 (d, C-3), 107.7 (d, C-1), 
108.0 (d, C-22), 111.9 (d, C-8), 114.7 (s, C-5), 116,1 (d, C-24), 127.5 (d, C-
6), 118.4 (t, C-20), 129.2 (d, C-23), 131.9 (d, C-19), 136.7 (s, C-9), 151.1 
(s, C-2), 156.2 (s, C-4), 158.5 (s, C-21), 161.4 (s, C-7). 
HRMS (CI):   Calculated Found 
C26H28N2O3 [M]
+: 416.2100 416.2099  
Absorption max.:  387 nm 
Exitation max.: 382 nm 
Emission max.:  449 nm 
Lifetime: 5.72/2.66 ns  
(E)-7-(Diethylamino)-4-(3-((4-(methyl(phenyl)amino)but-2-en-1-yl)oxy)prop-
1-yn-1-yl)-2H-chromen-2-one (84) 
To the solution of 5.8 mg (5 µmol, 5 mol%) Pd(PPh3)4 and 41 mg (0.1 mmol, 1 eq.) 
fluorescenting carbonate 75 in 0.6 ml THF 11 µl (10.2 mg,  0.11 mmol, 1.1 eq.) N-
methylanilin was added. The reaction mixture was stirred at rt overnight. Afterwards 
the solvent was removed in vacuo and the crude product purified by column 
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chromatography (silica gel, DCM:EA 95:5) to furnish 32.4 mg (0.075 mmol, 75%) of 
84 as a brown oil. 
Rf(84) = 0.38 (DCM:EA 9:1)
  
 
84 
1H-NMR (400 MHz, CDCl3):  
 = 1.19 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 1.89 (sh, 4 H, 21-
H,24-H), 2.76 (sh, 4 H, 22-H, 23-H), 3.32 (d, 3J20,19 = 6.4 Hz, 2 H, 20-H), 
3.39 (q, 3J10,11 =  
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 4.14 (dd, 
3J17,18 = 5.6 Hz, 
4J17,16 = 0.7 Hz, 2 H, 17-H), 4.44 (s, 2 H, 16-H), 5.94 (dtt, 
3J18,19  = 
3J19,18 = 
15.6 Hz, 3J19,20 =  6.5 Hz, 
3J18,17 =  5.6 Hz, 2 H, 18-H, 19-H), 6.13 (s, 1 H, 8-
H), 6.43 (d, 4J3,1 = 2.5 Hz, 1 H, 3-H), 6.59 (dd, 
3J1,6 = 9.0 Hz, 
4J1,3 =  2.5 Hz, 1 
H, 1-H), 7.54 (d, 3J6,1  = 9.0 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 23.4 (t, C-21/C24), 44.8 (t, C-12/C-10), 53.5 (t, C-
22/C-23), 57.0 (t, C-16/C-20), 57.9 (t, C-16/C-20), 70.0 (t, C-17), 80.7 (s, 
C-14), 96.4 (s, C-15), 97.4 (d, C-3), 107.7 (d, C-1), 108.9 (s, C-5), 111.7 (d, 
C-8) 127.5 (d, C-6), 128.6 (d, C-18)  130.9 (d, C-19), 136.7 (s, C-9), 151.1 
(s, C-2), 156.2 (s, C-4), 161.4 (s, C-7). 
Elemental Analysis:  
C27H30N2O3  Calculated C 75.32 H 7.02 N 6.51 
(430.5480) Found  C 75.02 H 7.20 N 5.90 
HRMS (CI):   Calculated Found 
C27H31N2O3 [M+H]
+: 431.2329 431.2343  
3-(7-(Diethylamino)-2-oxo-2H-chromen-4-yl)prop-2-yn-1-yl ethyl carbonate 
(85). 
According to the GP-4 to the solution of 2.8 mg (240 µmol, 2 mol%) Pd(PPh3)4, 90 
mg (480 µmol, 4 mol%) CuI and 4.4 g (12 mmol, 1eq.) enol triflate 12  in 60 ml abs. 
THF under nitrogen atmosphere at rt 2 ml (12 mmol, 1 eq) Et3N  and 3.1 g (24 mmol, 
2 eq.) ethyl propargyl carbonate were added. The reaction mixture was stirred for 2 
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h. After work-up and column chromatography (silica gel, DCM:EA 95:5) 4.049 g (11.8 
mmol, 98%) of 85 was isolated as a yellow solid compound. 
Rf(85) = 0.13 (DCM:EA 95:5) 
 
85 
1H-NMR (400 MHz, CDCl3):  
 = 1.21 (t, 3J11.10  = 
3J13.12 = 7.1 Hz, 6 H, 13-H, 11-H), 1.35 (t, 
3J19.18 = 7.1 
Hz, 3 H, 19-H), 3.41 (q, 3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 4.28 (q, 
3J18.19 = 7.1 Hz, 2 H, 18-H), 5.03 (s, 2 H, 16-H), 6.17 (s, 1 H, 8-H), 6.46 (d, 
4J3,1 = 2.5 Hz, 1 H, 3-H), 6.59 (dd, 
3J1,6 = 9.0 Hz, 
4J1,3 = 2.5 Hz, 1 H, 1-H), 
7.55 (d, 3J6,1 = 9.0 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 14.3 (q, C-19), 44.9 (t, C-12/C-10), 55.4 (t, C-16), 
64.9 (t, C-18), 81.3 (s, C-14), 93.2 (s, C-15), 97.4 (d, C-3), 107.6 (d, C-1), 
108.8 (s, C-5), 112.1 (d, C-8) 127.5 (d, C-6), 136.1 (s, C-9), 151.1 (s, C-2), 
154.5 (s, C-4), 156.2 (s, C-17), 161.3 (s, C-7). 
Elemental Analysis:  
C19H21NO5 Calculated C 66.46 H 6.16 N 4.08 
(343.3790) Found  C 66.91 H 5.48 N 4.21 
HRMS (CI):   Calculated Found 
C19H22NO5 [M]
+: 343.1414 343.1422  
Absorption max.:  405 nm 
Exitation max.: 410 nm 
Emission max.:  502 nm 
Lifetime: 6.05 ns 
Melting point:  135-138 °C 
(Z)-3-(7-(Diethylamino)-2-oxo-2H-chromen-4-yl)allyl ethyl carbonate (86) [163] 
162 mg (0.49 mmol, 1 eq.) fluorescenting ester 85 was dissolved in EA (4 ml), and 
25 mg (40 wt%) Lindlar catalyst was added. The mixture was stirred under H2 
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atmosphere for 2 h until the complete conversion of the starting material, filtered 
through celite. The solvent was removed in vacuo and the crude product purified by 
column chromatography (silica gel, DCM:EA 95:5) to furnish 140 mg (0.4 mmol, 83%) 
of 86 as a yellow oil. 
Rf(86) = 0.39 (DCM:EA 9:1) 
 
86 
1H-NMR (400 MHz, CDCl3):  
 = 1.20 (t, 3J11.10  = 
3J13.12 = 7.1 Hz, 6 H, 13-H, 11-H), 1.29 (t, 
3J19.18 = 7.1 
Hz, 3 H, 19-H), 3.41 (q, 3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 4.19 (q, 
3J18.19 = 7.2 Hz, 2 H, 18-H), 4.76 (dd, 
3J16,15 = 6.6 Hz, 
4J16.14 = 1.2 Hz, 2 H, 
16-H), 5.9 (sh, 1 H, 8-H), 6.15 (dt, 3J15.14 =  11.9 Hz, 
3J15,16 =  6.6 Hz, 1 H, 
15-H), 6.50 (d, 4J3,1 =  2.5 Hz, 1 H, 3-H), 6.55 (dd, 
3J1,6 = 9.0 Hz, 
4J1,3 = 2.6 
Hz, 1 H, 1-H), 6.65 (ddd, 3J14.15 = 11.8 Hz, 
4J14.16 = 1.5 Hz, 1 H, 14-H), 7.29 
(d, 3J6,1 = 9.0 Hz, 1 H, 6-H) 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 14.2 (q, C-19), 44.8 (t, C-12/C-10), 64.0 (t, C-18/C-
16), 64.2 (t, C-18/C-16), 97.8 (d, C-3), 107.4 (d, C-1/C-8), 108.2 (d, C-1/C-
8),  108.4 (s, C-5), 126.3 (d, C-15/C14), 127.3 (d, C-15/C14), 131.0 (d, C-
6), 149.4 (s, C-2), 150.8 (s, C-4), 154.8 (s, C-17), 156.3 (s, C-7), 161.7 (s, C-
9). 
Elemental Analysis:  
C19H23NO5 Calculated C 66.07 H 6.71 N 4.06 
(345.3896) Found  C 66.72 H 6.94 N 4.57 
HRMS (CI):   Calculated Found 
C19H24NO5 [M+H]
+: 346.1649 346.1659  
Absorption max.:  379 nm 
Exitation max.: 378 nm 
Emission max.:  516 nm 
Lifetime: 4.83/3.2 ns  
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tert-Butyl-4-(7-(diethylamino)-2-oxo-2H-chromen-4-yl)-3-[ethoxycarbonyl)-
oxy)methyl)-2-(2,2,2-trifluoroacetamido]butanoate (88) [99] 
In a Schlenk flask 228 mg (1 mmol, 1 eq.)  TFA-glycine-tert-butylester was 
dissolved in abs. THF (5 ml), 2.5 ml (1M solution in THF, 2.5 mmol, 2.5 eq) LHMDS 
was added dropwise at –78 °C. The mixture was stirred for another 15 minutes. In 
the second Schlenk flask 158 mg (1.1 mmol, 1.1 eq) ZnCl2 was heated carefully in 
vacuo, and after cooling down to room temperature dissolved in 2 ml abs. THF. The 
ZnCl2-solution was added dropwise at –78 °C to Li-enolate solution and the resulting 
mixture was stirred for additional 45 minutes for the complete transmetallation. 
Meanwhile 4 mg (10 µmol, 1 mol%) allylpalldium(II) chloride dimer and 15 mg (46 
µmol, 4.5 mol%)  triphenylphosphine were dissolved in THF (2 ml) stirred for 10 
minutes at rt before 242 mg (0.7 mmol, 0.7 eq.) fluorescenting allylcarbonate 86 was 
added. 
The catalyst-substrate solution was added dropwise to Zink-enolat solution at –78 
°C. The reaction mixture was warmed up to –50 °C over 4 h, after monitoring by TLC, 
the reaction mixture was diluted with EA and quenched with 1N KHSO4-solution. The 
aqueous layer was extracted three times with EA and combined organic layers were 
dried over Na2SO4. The solvent was removed in vacuo and the crude product purified 
by column chromatography (silica gel, DCM:EA 95:5) to furnish 237 mg (0.41 mmol, 
59%) of 88 as a yellow solid compound. 
Rf(88) = 0.41 (DCM:EA 9:1)
  
 
88 
1H-NMR (400 MHz, CDCl3):  
 = 1.20 (t, 3J11,10  = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 1.28 (t, 
3J19,18 = 7.1 
Hz, 3 H, 19-H), 1.54 (s, 9 H, 23-H), 2.71-2.79 (sh, 1 H, 15-H), 2.84 (dd, 
2J14,14’ = 13.7 Hz, 
3J14,15 = 9.6 Hz, 1 H, 14-H), 2.94 (dd, 
2J14 ’ ,14 = 13.7 Hz, 
3J14’,15 = 5.4 Hz, 1 H, 14’-H), 3.40 (q, 
3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-
H), 4.02 (dd, 2J16,16’ = 11.5 Hz, 
3J16,15 = 6.4 Hz, 1 H, 16-H), 4.17 (m, 3 H, 
16’-H, 18-H), 4.71 (dd, 3J20,NH = 7.5 Hz, 
3J20,15 = 3.4 Hz, 1 H, 20-H), 5.97 (s, 
1 H, 8-H), 6.49 (d, 4J3,1 = 2.5 Hz, 1 H, 3-H), 6.59 (dd, 
3J1,6 =  9.0 Hz, 
4J1,3 =  
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2.6 Hz, 1 H, 1-H), 7.30 (d, 3JNH,20 = 6.9 Hz, 1 H, NH), 7.40 (d, 
3J6,1 = 9.1 Hz, 
1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 14.1 (q, C-19), 28.0 (q, C-23), 30.4 (d, C-15), 39.9 
(t, C-14), 44.7 (t, C-12/C-10), 54.4 (d, C-20), 64.4 (t, C-18/C-16), 65.5 (t, C-
18/C-16), 84.8 (s, C-22), 98.0 (d, C-3), 107.5 (d, C-1), 108.8 (s, C-5), 109.3 
(d, C-8), 114.2 (s, C-25), 125 (d, C-6), 150.8 (s, C-2), 152.4 (s, C-4), 154.5 
(s, C-17/C-24), 156.6 (s, C-9), 161.7 (s, C-7), 168.1 (s, C-21). 
Elemental Analysis:  
C27H35F3N2O8 Calculated C 56.64 H 6.16 N 4.89 
(572.5782) Found  C 55.67 H 5.99 N 4.69 
HRMS (CI):   Calculated Found 
C27H34F3N2O8 [M-H]
+: 571.2340 571.2258  
Absorption max.:  363 nm 
Exitation max.: 370 nm 
Emission max.:  442 nm 
Lifetime: 3.24 ns 
Melting poing: 67-69 °C 
tert-Butyl-2-(4-(7-(diethylamino)-2-oxo-2H-chromen-4-yl)-5-oxotetrahydro-
furan-3-yl)-2-(2,2,2-trifluoroacetamido)acetate (89) [99] 
In a Schlenk flask 228 mg (1 mmol, 1 eq.)  TFA-glycine-tert-butylester was 
dissolved in abs. THF (5 ml), 2.5 ml (1M solution in THF, 2.5 mmol, 2.5 eq) LHMDS 
was added dropwise at –78 °C. The mixture was stirred for another 15 minutes. In 
the second Schlenk flask 158 mg (1.1 mmol, 1.1 eq) ZnCl2 was heated carefully in 
vacuo, and after cooling down to room temperature dissolved in 2 ml abs. THF. The 
ZnCl2 solution was added dropwise at –78 °C to Li-enolate solution and the resulting 
mixture was stirred for additional 45 minutes for the complete transmetallation. 
Meanwhile 4 mg (10 µmol, 1 mol%) allylpalldium(II) chloride dimer and 15 mg (46 
µmol, 4.5 mol%) triphenylphosphine were dissolved in THF (2 ml) stirred for 10 
minutes at rt before 242 mg (0.7 mmol, 0.7 eq.) fluorescenting allylcarbonate 86 was 
added.  
The catalyst-substrate solution was added dropwise to Zink-enolate solution at –
78 °C. The reaction mixture was warmed up overnight to rt, after monitoring by TLC, 
the reaction mixture was diluted with EA and quenched with 1N KHSO4-solution. The 
aqueous layer was extracted three times with EA and combined organic layers were 
dried over Na2SO4. The solvent was removed in vacuo and the crude product purified 
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by column chromatography (silica gel, DCM:EA 95:5) to furnish 226 mg (0.43 mmol, 
60 %) of 89 as a yellow solid. 
Rf(89) = 0.16 (DCM:EA 9:1) 
 
89 
1H-NMR (400 MHz, CDCl3):  
 = 1.18 (t, 3J11.10 = 
3J13.12 = 7.1 Hz, 6 H, 13-H, 11-H), 1.43 (s, 9 H, 23-H), 
3.39 (q, 3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 3.55 (m, 1 H, 15-H), 4.16 
(d, 3J14,15 = 9.4 Hz, 1 H, 14-H), 4.35 (dd, 
3J16,16’  = 9.8 Hz, 
3J16,15 =  8.4 Hz,  1 
H, 16-H), 4.75 (m, 2 H, 18-H, 16’-H), 5.93 (s, 1 H, 8-H), 6.45 (d, , 4J3,1 = 2.5 
Hz, 1 H, 3-H), 6.61 (dd, 3J1,6 = 9.1 Hz, 
4J1,3 = 2.5 Hz, 1 H, 1-H), 7.30 (d, 
3J6,1 
= 9.2 Hz, 1 H, 6-H), 8.11 (d, 3JNH,18 = 8.2 Hz, 1 H, NH) 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 27.7 (q, C-23), 43.9 (d, C-15), 44.7 (t, C-12/C-10), 
53.4 (d, C-14), 54.6 (d, C-18), 69.1 (t, C-16), 85.0 (s, C-22), 97.7 (d, C-3), 
106.9 (d, C-1), 107.7 (s, C-5), 109.4 (d, C-8), 114.0 (s, C-20) 125.3 (d, C-6), 
150.5 (s, C-2), 156.5 (s, C-4), 157.4 (s, C-19/C-9), 157.8 (s, C-19/C-9), 
162.0 (s, C-7), 167.1 (s, C-17), 173.5 (s, C-21). 
HRMS (CI):   Calculated Found 
C25H29F3N2O7 [M]
+:  526.1927 526.1951  
Absorption max.:  375 nm 
Exitation max.: 386 nm 
Emission max.:  213 nm 
Lifetime: 4.78/2.27 ns  
2-(Prop-2-yn-1-yloxy)tetrahydro-2H-pyran (91) [164] 
0.8 ml (13.9 mmol, 1 eq.) propargylic alcohol and 352 mg (1.4 mmol, 0.1 eq.) PPTS 
were suspended in DCM (55 ml). 1.4 ml (15.3 mmol, 1.1 eq.) 3,4-dihydro-2H-pyran 
was added dropwise. The reaction was allowed to stir over night at rt and afterwards  
it was washed with sat. NaCl-solution. The organic layer was dried over Na2SO4 and 
the solvent was removed in vacuo. The resulted white liquid product 91 1.9 g (13.6 
mmol, 98%) was used raw without further purification. 
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Rf(91) = 0.63 (PE:EA 8:2) 
 
91 
1H-NMR (400 MHz, CDCl3):  
 = 1.44-1.81 (sh, 6 H, 4-H, 5-H, 6-H), 2.38 (t, 2J8.1 = 2.4 Hz, 1 H, 8-H), 4.20 
(m, 2 H, 3-H), 4.76 (m, 1 H, 2-H), 5.26 (s, 2 H, 1-H). 
13C-NMR (100 MHz, CDCl3):  
 = 20.4 (t, C-5), 25.4 (t, C-4), 30.2 (t, C-6), 54.6 (t, C-1), 62.1 (t, C-3), 80.1 
(s, C-14), 96.7 (s, C-15), 104.2 (d, C-2). 
7-(Diethylamino)-4-(3-((tetrahydro-2H-pyran-2-yl)oxy)prop-1-yn-1-yl)-2H-
chromen-2-one (92) 
According to the GP-4 to the solution of 17 mg (15 µmol, 2 mol%) Pd(PPh3)4, 5.7 
mg (30 µmol, 4 mol%) CuI and 271 mg (0.74 mmol, 1eq.) enol triflate 12 in 3.7 ml 
abs. THF under nitrogen atmosphere 0.1 ml (0.74 mmol, 1 eq) Et3N and 207 mg (1.48 
mmol, 2 eq.) propargyl ester 91 were added at rt. The reaction mixture was stirred 
for 2 h. After work-up and column chromatography (silica gel, DCM:EA 95:5) 278 mg 
(0.72 mmol, 97 %) of 92 was isolated as a yellow solid.  
Rf(92) = 0.16 (DCM:EA 95:5) 
 
92 
 
1H-NMR (400 MHz, CDCl3):  
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 = 1.21 (t, 3J11.10 = 
3J13.12 = 7.1 Hz, 6 H, 13-H, 11-H), 1.54-1.8 (sh, 6 H, 19-
H, 20-H, 21-H), 3.41 (q,  3J10,11 = 
3J12,13  = 7.1 Hz, 4 H, 12-H, 10-H), 3.56-3.61 
(m, 1 H, 18’-H), 3.87-3.92 (m, 1 H, 18-H), 4.58 (d, 4J16.17 = 2.0 Hz, 2 H, 16-
H), 4.90 (t, 3J17.21 = 3.4 Hz, 17-H), 6.17 (s, 1 H, 8-H), 6.46 (d, 
4J3,1  = 2.5 Hz, 
1 H, 3-H), 6.59 (dd, 3J1,6 = 9.0 Hz, 
4J1,3 = 2.5 Hz, 1 H, 1-H), 7.58 (d, 
3J6,1 = 
9.0 Hz, 1 H, 6-H).  
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 19.0 (t, C-20), 25.3 (t, C-19), 30.2 (t, C-21), 44.8 (t, 
C-12/C-10), 54.6 (t, C-16), 62.1 (t, C-18), 80.1 (s, C-14), 96.7 (s, C-15), 
97.3 (d, C-3/C-17), 97.4 (d, C-3/C-17),  107.9 (d, C-1), 108.8 (s, C-5), 111.9 
(d, C-8) 127.6 (d, C-6), 136.9 (s, C-9), 151.0 (s, C-2), 156.2 (s, C-4), 161.5 
(s, C-7). 
Elemental Analysis:  
C21H25NO4 Calculated C 70.96 H 7.09 N 3.94 
(355.4275) Found  C 70.66 H 7.19 N 4.05 
HRMS (CI):   Calculated Found 
C21H26NO4 [M+H]
+: 356.1856 356.1872  
Absorption max.:  397 nm 
Exitation max.: 404 nm 
Emission max.:  481 nm 
Lifetime: 5.523 ns 
 (Z)-7-(Diethylamino)-4-(3-((tetrahydro-2H-pyran-2-yl)oxy)prop-1-en-1-yl)-
2H-chromen-2-one (93) [163] 
109.6 mg (0.3 mmol, 1 eq.) fluorescenting ester 92 was dissolved in EA (1 ml), and 
50 mg (45 wt%) Lindlar catalyst was added. The mixture was stirred under H2 
atmosphere for 2 h (until the complete conversion) and filtered through celite. The 
solvent was removed in vacuo and the crude product purified by column 
chromatography (silica gel, DCM:EA 95:5) to furnish 102.6 mg (0.29 mmol, 97%) of 
93 as a yellow oil.  
Rf(93) = 0.16 (DCM:EA 95:5) 
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93 
1H-NMR (400 MHz, CDCl3):  
 = 1.19 (t, 3J11.10 = 
3J13.12 = 7.1 Hz, 6 H, 13-H, 11-H), 1.47-1.84 (sh, 6 H, 
19-H, 20-H, 21-H), 3.39 (q, 3J10,11  = 
3J12,13  = 7.1 Hz, 4 H, 12-H, 10-H), 3.44-
3.48 (m, 1 H, 18’-H), 3.77-3.83 (m, 1 H, 18-H), 4.38 (ddd, 3J16,15 = 5.9 Hz, 
4J16.14 = 1.8 Hz, 2 H, 16-H), 4.56-4.58 (sh, 1 H, 17-H), 5.84 (s, 1 H, 8-H), 
6.20 (m, 1 H, 15-H), 6.48 (d, 4J3,1 =  2.6 Hz, 1 H, 3-H), 6.54 (dd, 
3J1,6 = 8.9 
Hz, 4J1,3 = 2.6 Hz, 1 H, 1-H), 6.58 (m, 1 H, 14-H), 7.33 (d, 
3J6,1 = 8.9 Hz, 1 H, 
6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 19.0 (t, C-20), 25.3 (t, C-19), 30.2 (t, C-21), 44.8 (t, 
C-12/C-10), 64.0 (t, C-16), 62.1 (t, C-18), 97.3 (d, C-3/C-17), 97.4 (d, C-
3/C-17),  107.9 (d, C-1), 108.8 (s, C-5), 111.9 (d, C-8), 126.3 (d, C-15/C14), 
127.3 (d, C-15/C14),  127.6 (d, C-6), 136.9 (s, C-9), 151.0 (s, C-2), 156.2 (s, 
C-4), 161.5 (s, C-7). 
HRMS (CI):   Calculated Found 
C17H21NO2 [M-OTHP]
+: 271.1572 271.1490  
Absorption max.:  397 nm 
Exitation max.: 402 nm 
Emission max.:  479 nm 
Lifetime: 5.41 ns 
tert-Butyl-4-(7-(diethylamino)-2-oxo-2H-chromen-4-yl)-3-[tetrahydro-2H-
pyran-2-yl)oxy)methyl)-2-(2,2,2-trifluoroacetamido]butanoate (94) [99] 
To the solution of 0.2 ml (132 mg, 0.82 mmol, 2.75 eq.) HMDS in 1 ml abs. THF 
was added dropwise 1.6M solution of 0.46 ml (0.74 mmol, 2.5 eq.) n-BuLi at –78 °C. 
The cooling bath was removed and the mixture was stirred for another 15 minutes at 
rt. In the second Schlenk flask 45 mg (0.33 mmol, 1.1 eq) ZnCl2 and 67 mg (0.297 
mmol, 1.0 eq.) TFA-glycine-tert-butylester were dissolved in 1 ml abs. THF. The 
freshly prepared LHMDS-solution was added dropwise to glycineester-metall salt-
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solution at –78 °C and the reaction mixture was stirred at this temperature for 30 
minutes for the complete transmetallation. 
97 mg (0.27 mmol, 0.9 eq.) fluorescing coumarin 93 was dissolved in 0.5 ml abs. 
THF and added dropwise to Zn-enolate solution at –78 °C. The reaction mixture was 
allowed to warm overnight to rt, diluted with EA and quenched with 1N KHSO4-
solution. The aqueous layer was extracted three times with EA and combined 
organic layers were dried over Na2SO4. The solvent was removed in vacuo and the 
crude product purified by column chromatography (silica gel, DCM:EA 95:5) to 
furnish 83.1 mg (0.14 mmol, 53 %) of 94 as a yellow oil. 
Rf(94) = 0.1 (DCM:MeOH 95:5)
  
 
94 
Isolated as a mixture of diastereomers.  
Selected signals:  
1H-NMR (400 MHz, CDCl3):  
 = 1.19 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 3.40 (q, 
3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 4.57 (m, 1 H, 16-H), 5.84 (s, 1 H, 8-H), 
6.49 (d, 4J3,1 = 2.6 Hz, 1 H, 3-H), 6.54 (dd, 
3J1,6 = 8.9 Hz, 
4J1,3 = 2.6 Hz, 1 H, 
1-H), 7.33 (d, 3J6,1 = 8.9 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 27.3 (q, C-19), 31.1 (t, C-14), 44.7 (t, C-12/C-10), 
53.0 (d, C-16), 84.2 (s, C-18), 97.9 (d, C-3), 107.6 (d, C-1/C-8), 107.7 (d, C-
1/C-8), 108.73 (s, C-5), 114.2 (s, C-21), 124.8 (d, C-6), 150.7 (s, C-2), 154.6 
(s, C-4), 156.4 (s, C-20), 162.0 (s, C-7), 169.4 (s, C-17). 
tert-Butyl-4-(7-(diethylamino)-2-oxo-2H-chromen-4-yl)-2-(2,2,2-trifluoroacet-
amido)butanoate (95) [99] 
To the solution of 0.15 ml (113 mg, 0.7 mmol, 2.31 eq.) HMDS in 1 ml abs. THF 0.4 
ml (0.63 mmol, 2.1 eq.) 1.6M solution of n-BuLi was added dropwise at –78 °C. The 
cooling bath was removed and the mixture was stirred for another 15 minutes at rt. 
In the second Schlenk flask 45 mg (0.33 mmol, 1.1 eq) ZnCl2 and 75 mg (0.33 mmol, 
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1.1 eq.) TFA-glycine-tert-butylester were dissolved in 1 ml abs. THF. The freshly 
prepared LHMDS-solution was added dropwise to glycineester-metallsalt-solution at 
–78 °C and the reaction mixture was stirred at this temperature for 30 minutes for 
the complete transmetallation. 
68 mg (0.3 mmol, 1 eq.) vinyl coumarin 58 was dissolved in 0.5 ml abs. THF and 
added dropwise to Zn-enolate solution at –78 °C. The reaction mixture was warmed 
up overnight to rt, after monitoring by TLC, the reaction mixture was diluted with EA 
and quenched with 1N KHSO4-solution. The aqueous layer was extracted three times 
with EA and combined organic layers were dried over Na2SO4. The solvent was 
removed in vacuo and the crude product purified by column chromatography (silica 
gel, DCM:EA 95:5) to furnish 60 mg (0.13 mmol, 60 %) of 95 as a yellow solid 
compound. 
Rf(95) = 0.18 (DCM:EA 95:5)
  
 
95 
1H-NMR (400 MHz, CDCl3):  
 = 1.20 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 1.53 (s, 9 H, 19-H), 
2.09 (s, 1 H), 2.06-2.14 (sh, 1 H), 2.29-2.38 (sh, 1 H), 2.59-2.67 (sh, 1 H), 
2.74-2.82 (sh, 1 H),  3.41 (q, 3J10,11 =  
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 4.60 
(dd, 3J16,15 = 12.3 Hz, 
3J16,NH =  6.5 Hz, 1 H, 16-H), 5.91 (s, 1 H, 8-H), 6.50 
(d, 4J3,1 = 2.6 Hz, 1 H, 3-H), 6.58 (dd, 
3J1,6 = 9.0 Hz, 
4J1,3 = 2.6 Hz, 1 H, 1-H), 
7.11 (d, 3JNH,16 = 6.90 Hz, 1 H, NH), 7.30 (d, 
3J6,1 = 9.1 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3): 
 = 12.4 (q, C-11/C13), 27.3 (q, C-19), 31.1 (t, C-14), 44.7 (t, C-12/C-10), 
53.0 (d, C-16), 84.2 (s, C-18), 97.9 (d, C-3), 107.6 (d, C-1/C-8), 107.7 (d, C-
1/C-8), 108.73 (s, C-5), 114.2 (s, C-21), 124.8 (d, C-6), 150.7 (s, C-2), 154.6 
(s, C-4), 156.4 (s, C-20), 162.0 (s, C-7), 169.4 (s, C-17). 
Elemental Analysis:  
C23H29F3N2O5 Calculated C 58.72 H 6.21 N 5.95 
(471.4967) Found  C 59.58 H 6.43 N 5.77 
HRMS (CI):   Calculated Found 
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C23H30F3N2O5 [M+H]
+: 471.2101 471.2076  
Absorption max.:  371 nm 
Exitation max.: 367 nm 
Emission max.:  421 nm 
Lifetime: 3.11 ns 
Melting poing: 135-138 °C 
4-(2-(Benzylamino)ethyl)-7-(diethylamino)-2H-chromen-2-one (96) 
According to the GP 10 to 27 µl (26.8 mg, 0.25 mmol, 2 eq) benzylamine in 0.3 ml 
1.4-dioxane 38 µl (0.25 mmol, 2 eq.) Et3N, 5.3 mg (0.125 mmol, 1 eq.) LiCl and 30 mg 
(0.125 mmol, 1 eq.) vinyl coumarin 58 in 0.3 ml 1.4-dioxane were added. The 
resulting mixture was refluxed overnight. After work-up and column 
chromatography (silicagel, DCM:EA 95:5, 9:1) 36.5 mg (0.1 mmol, 83%) of 96 was 
isolated as a yellow oil. 
Rf(96) = 0.07 (DCM:EA 9:1)
 
 
96 
1H-NMR (400 MHz, CDCl3):  
 = 1.15 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 1.64 (bs, 1 H, NH), 
2.83 (t, 3J14,15 = 7.0 Hz, 2 H, 14-H), 2.93 (t, 
3J15,14 = 6.7 Hz, 2 H, 15-H), 3.36 
(q, 3J10,11  = 
3J12,13  = 7.1 Hz, 4 H, 12-H, 10-H), 3.78 (s, 2 H, 16-H), 5.90 (s, 1 
H, 8-H), 6.44 (d, 4J3,1 = 2.6 Hz, 1 H, 3-H), 6.51 (dd, 
3J1,6 = 9.0 Hz, 
4J1,3 = 2.6 
Hz, 1 H, 1-H), 7.19-7.27 (m, 5 H, Phe), 7.35 (d, 3J6,1 = 9.0 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3):  
 = 12.5 (q, C-11/C13), 32.0 (t, C-14), 44.7 (t, C-12/C-10), 47.8 (t, C-15), 
53.7 (t, C-16), 97.8 (d, C-3), 108.1 (d, C-1), 108.2 (s, C-5), 108.5 (d, C-8), 
125.4 (d, C-6), 127.3-128.8 (d, C-18/C-19/C-20), 139.2 (s, C-17), 150.5 (s, 
C-2), 154.4 (s, C-4), 156.3 (s, C-9), 162.2 (s, C-7).  
Elemental Analysis:  
C22H26N2O2  Calculated C 75.40 H 7.48 N 7.99 
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(350.4620) Found  C 76.56 H 7.93 N 7.70 
HRMS (CI):   Calculated Found 
C22H27N2O2 [M+H]
+: 351.2067 351.2074  
Absorption max.:  364 nm 
Exitation max.: 370 nm 
Emission max.:  420 nm 
2-(7-(Diethylamino)-2-oxo-2H-chromen-4-yl)ethyl)-L-leucine methyl ester 
(97) 
According to the GP 10 to 54.5 mg (0.3 mmol, 1.2 eq) leucine methyl ester 
hydrochloride in 0.6 ml 1.4-dioxane 70 µl (0.5 mmol, 2 eq.) Et3N, 10.6 mg (0.25 
mmol, 1 eq.) LiCl and 60.8 mg (0.25 mmol, 1 eq.) vinyl coumarin 58 in 0.6 ml 1.4-
dioxane were added. The resulting mixture was refluxed overnight. After work-up 
and column chromatography (silicagel, DCM:MeOH 98:2) 58.2 mg (0.15 mmol, 60%) 
of 97 was isolated as a yellow solid compound. 
Rf(97) = 0.21 (DCM:MeOH 95:5) 
 
97 
1H-NMR (400 MHz, CDCl3):  
 = 0.92 (2d, 3J20,18 = 6.6 Hz, 6 H, 20-H, 19-H), 1.20 (t, 
3J11,10 = 
3J13,12 = 7.1 
Hz, 6 H, 13-H, 11-H), 1.46 (m, 2 H, 17-H, 18-H), 1.72 (m, 2 H, 17’-H, NH), 
2.86 (m, 4 H, 15-H, 14-H), 3.31 (t, 3J16,17  = 
3J16,NH7 = 7.3 Hz, 1 H, 16-H), 
3.40 (q, 3J10,11 =  
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 3.69 (s, 3 H, 22-H), 5.96 
(s, 1 H, 8-H), 6.49 (d, 4J3,1 = 2.5 Hz, 1 H, 3-H), 6.57 (dd, 
3J1,6 = 9.0 Hz, 
4J1,3 =  
2.6 Hz, 1 H, 1-H), 7.40 (d, 3J6,1 = 9.0 Hz, 1 H, 6-H).  
13C-NMR (100 MHz, CDCl3):  
 = 12.5 (q, C-11/C13), 22.4 (q, C-20/C-19), 22.7 (q, C-20/C-19), 24.9 (d, 
C-18), 32.5 (t, C-14), 42.7 (t, C-17), 44.7 (t, C-12/C-10), 46.8 (t, C-15), 
51.7 (q, C-22), 60.1 (d, C-16), 97.9 (d, C-3), 108.1 (d, C-1), 108.2 (s, C-5), 
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108.5 (d, C-8), 125.3 (d, C-6), 150.5 (s, C-2), 154.3 (s, C-4), 156.3 (s, C-9), 
162.2 (s, C-7), 171.5 (s, C-21).  
HRMS (CI):   Calculated Found 
C22H32N2O4 [M]
+: 388.2362 388.2369  
Absorption max.:  363 nm 
Exitation max.: 368 nm 
Emission max.:  421 nm 
Lifetime: 3.13 ns 
7-(Diethylamino)-4-(2-(hexylthio)ethyl)-2H-chromen-2-one (98) 
According to the GP 10 to 71 µl (59 mg, 0.5 mmol, 2 eq) 1-hexanthiol in 0.6 ml 
1.4-dioxane 70 µl (0.5 mmol, 2 eq.) Et3N and 60.8 mg (0.25 mmol, 1 eq.) vinyl 
coumarin 58 in 0.6 ml 1.4-Dioxane were added. The resulting mixture was stirred 
overnight at rt. After work-up and column chromatography (silicagel, PE:EA 7:3) 79.3 
mg (0.22 mmol, 88%) of 98 was isolated as a yellow solid compound. 
Rf(98) = 0.41 (DCM:EA 95:5) 
 
98 
1H-NMR (400 MHz, CDCl3):  
 = 0.88 (t, 3J21,20 = 6.9 Hz, 3 H, 21-H), 1.20 (t, 
3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 
13-H, 11-H), 1.24-1.31 (sh, 4 H, 19-H, 20-H), 1.33-1.41 (sh, 2 H, 18-H), 
1.59 (m, 2 H, 17-H), 2.56 (m, 2 H, 16-H), 2.78-2.82 (sh, 2 H, 14-H), 2.94 (t, 
3J15,14 = 7.3 Hz, 2 H, 15-H), 3.40 (q, 
3J10,11 =  
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-
H), 5.95 (s, 1 H, 8-H), 6.49 (d, 4J3,1  = 2.6 Hz, 1 H, 3-H), 6.57 (dd, 
3J1,6 = 9.0 
Hz, 4J1,3 = 2.6 Hz, 1 H, 1-H), 7.38 (d, 
3J6,1 = 9.0 Hz, 1 H, 6-H). 
 13C-NMR (100 MHz, CDCl3):  
 = 12.5 (q, C-11/C13), 14.0 (q, C-21), 22.5 (t, C-20), 28.6-32.5 (5t, C-14/ 
C-15/C-16/C-17/C-18/C-19), 44.7 (t, C-12/C-10), 97.9 (d, C-3), 107.9 (d, C-
1), 108.0 (s, C-5), 108.5 (d, C-8), 125.1 (d, C-6), 150.6 (s, C-2), 154.6 (s, C-
4), 156.4(s, C-9), 162.1 (s, C-7).  
 
4 Experimental section 
177 
 
Elemental Analysis:  
C21H31NO2S Calculated C 69.76 H 8.64 N 3.87 
(361.5440) Found  C 69.64 H 8.63 N 3.77   
HRMS (CI):   Calculated Found 
C21H31NO2S [M]
+: 361.2075 361.2078  
Absorption max.:  370 nm 
Exitation max.: 369 nm 
Emission max.:  423 nm 
Melting point:  62-63 °C 
4-(2-(Benzylthio)ethyl)-7-(diethylamino)-2H-chromen-2-one (99) 
According to the GP 10 to 67 µl (70.8 mg, 0.5 mmol, 2 eq) benzyl mercaptan in 0.6 
ml 1.4-dioxane 70 µl (0.5 mmol, 2 eq.) Et3N and 60.8 mg (0.25 mmol, 1 eq.) vinyl 
coumarin 58 in 0.6 ml 1.4-dioxane were added. The resulting mixture was stirred at 
rt overnight. After work-up and column chromatography (silicagel, PE:EA 7:3) 78 mg 
(0.21 mmol, 85%) of 99 was isolated as a yellow solid compound. 
Rf(99) = 0.24 (PE:EA 7:3) 
 
99 
1H-NMR (400 MHz, CDCl3):  
 = 1.11 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 2.60 (m, 2 H, 14-H), 
2.75 (m, 2 H, 15-H), 3.30 (q, 3J10,11 = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 3.68 
(s, 2 H, 16-H), 5.77 (s, 1 H, 8-H), 6.38 (d, 4J3,1 = 2.5 Hz, 1 H, 3-H), 6.43 (dd, 
3J1,6 = 9.0 Hz, 
4J1,3 = 2.6 Hz, 1 H, 1-H), 7.13 (d, 
3J6,1 = 9.0 Hz, 1 H, 6-H), 7.17 
(m, 1 H, 20-H), 7.23 (sh, 4 H, 18-H, 19-H). 
13C-NMR (100 MHz, CDCl3):  
 = 12.5 (q, C-11/C13), 30.0 (t, C-15), 32.0 (t, C-16), 36.6 (t, C-14), 44.7 (t, 
C-12/C-10), 97.8 (d, C-3), 107.8 (d, C-1), 108.0 (s, C-5), 108.5 (d, C-8), 
125.1 (d, C-6), 127.2 (d, C-20), 128.6 (d, C-18/C-19), 128.9 (d, C-18/C-19), 
138.0 (s, C-17), 150.5 (s, C-2), 154.5 (s, C-4), 156.3 (s, C-9), 162.1 (s, C-7).  
Elemental Analysis:  
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C22H25NO2S Calculated C 71.90 H 6.86 N 3.81 
(367.5070) Found  C 71.80 H 6.96 N 3.68 
HRMS (CI):   Calculated Found 
C21H31NO2S [M]
+: 367.1606 367.1614  
Absorption max.:  368 nm 
Exitation max.: 370 nm 
Emission max.:  424 nm 
Melting point:  65-67 °C 
N-tert-Butoxycarbonyl-L-cystein methyl ester (100) [165] 
1.49 g (3.18 mmol, 1 eq.) Boc-cystin was suspended in 12 ml MeOH, 5 ml H2O and 
0.1 ml glacial acetic acid. After 875 mg (3.34 mmol, 1.05 eq.) PPh3 and 98.5 mg (1.2 
mmol, 0.34 eq.) sodium acetate were added, the reaction mixture was refluxed for 
20 h. Subsequently it was diluted with DCM, the organic layer was separated and the 
aqueous phase was extracted 3x with DCM. The combined organic layers were 
washed with sat. NaCl-solution and dried over Na2SO4. The solvent was removed in 
vacuo. The crude product was purified by column chromatography (silica gel, PE:EA 
8:2) to furnish 1.2 mg (5.13 mmol, 81%) of 100 as a colourless oil. 
Rf(100) = 0.19 (PE:EA 8:2) 
 
100 
1H-NMR (400 MHz, CDCl3):  
 = 1.38 (t, 3JSH,5 = 8.9 Hz, 1 H, SH), 1.44 (s, 9 H, 1-H), 2.96 (m, 2 H, 5-H), 
3.77 (s, 3 H, 7-H), 4.59 (sh, 1 H, 4-H), 5.41 (bs, 1H, NH).  
13C-NMR (100 MHz, CDCl3): 
 = 27.3 (t, 5-C), 28.3 (q, C-1), 52.7 (q, C-7), 54.8 (d, C-4), 80.3 (s, C-2), 
155.1 (s, C-3), 170.8 (s, C-6). 
N-(tert-Butoxycarbonyl)-S-(2-(7-(diethylamino)-2-oxo-2H-chromen-4-yl)-
ethyl)-L-cysteine methyl ester (101). 
According to the GP 10 to 70.8 mg (0.3 mmol, 1.2 eq) methyl (tert-
butoxycarbonyl)-L-cysteinester 100 in 0.6 ml 1.4-dioxane 35 µl (25 mg, 0.25 mmol, 1 
eq.) Et3N and 60.8 mg (0.25 mmol, 1 eq.) vinyl coumarin 58 solution in 0.6 ml 1.4-
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dioxane were added at rt. The resulting solution was stirred for 3 h at rt. After work-
up and column chromatography (silicagel, PE:EA 7:3, 6:4) 107.9 mg (0.23 mmol, 92%) 
of 101 was isolated as a yellow oil. 
Rf(101) = 0.28 (PE:EA 6:4)
  
 
101 
1H-NMR (400 MHz, CDCl3):  
 = 1.17 (t, 3J11,10 = 
3J13,12 = 7.1 Hz, 6 H, 13-H, 11-H), 1.40 (s, 9 H, 22-H), 
2.78-2.83 (m, 2 H, 15-H), 2.88-2.92 (m, 2 H, 14-H), 2.98-3.02 (m, 2 H, 16-
H), 3.37 (q, 3J10,11  = 
3J12,13 = 7.1 Hz, 4 H, 12-H, 10-H), 3.73 (s, 3 H, 19-H), 
4.53 (m, 1 H, 17-H), 5.37 (d, 3JNH,17 = 7.3 Hz, 1 H, NH), 5.90 (s, 1 H, 8-H), 
6.46 (d, 4J3,1 = 2.5 Hz, 1 H, 3-H), 6.56 (dd, 
3J1,6 = 9.0 Hz, 
4J1,3 = 2.5 Hz, 1 H, 
1-H), 7.35 (d, 3J6,1 = 9.0 Hz, 1 H, 6-H). 
13C-NMR (100 MHz, CDCl3):  
 = 12.4 (q, C-11/C13), 28.3 (q, C-22), 28.3 (t, C-15), 29.7 (t, C-16), 34.9 
(t, C-14), 44.8 (t, C-12/C-10), 53.4 (q, C-19), 60.4 (s, C-17), 80.3 (s, C-21), 
97.9 (d, C-3), 107.6 (d, C-1), 108.0 (d, C-8), 108.6 (s, C-5), 125.0 (d, C-6), 
150.6 (s, C-2), 154.1 (s, C-4), 162.0 (s, C-7/C-20), 171.4 (s, C-18). 
Elemental Analysis:  
C24H34N2O6S Calculated C 60.23 H 7.16 N 5.85 
(478.6040) Found  C 59.70 H 7.13 N 5.90 
HRMS (CI):   Calculated Found 
C24H34N2O6S [M]
+: 478.2132 478.2134  
Absorption max.:  368 nm 
Exitation max.: 370 nm 
Emission max.:  523 nm 
Lifetime: 3.192 ns
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5  
 
Summary 
 
The aim of this thesis was the development of new fluorescent labels based on 7-
diethylamino-coumarin moiety and to stuty their application in biorthogonal 
labellining of amino acids and peptides. 
5.1 Synthesis of 7-diethylaminocoumarin 
Unfortunately the previously developed methodology[19] using Ti-catalyzed 
Pechmann condensation did not afford the target aminocoumarin in preparative 
ammount for further modifications because of the side reaction – transesterification 
of the keto-ester. Though 4-hydroxycoumarin could be isolated in 70% yield 
according to the reported procedure. Malonic acid was converted to the activated 
bisphenylester 6, which was subsequently condensed with commercially available 3-
diethylaminophenol to afford the desired compound 4 (Scheme 5.1). 
 
Scheme 5.1 Synthesis of 4-hydroxycoumarin 4. 
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Further studies towards the selective O- and C-allylation gave satisfying results as 
well. It was possible to isolate C-allylated coumarin 7 in 87% yield under Pd-catalyzed 
allylic alkylation conditions; Mitsunobu conditions afforded the selective O-allylation 
of coumarin 4 in 89% yield (Scheme 5.2). 
 
 
 
 
Scheme 5.2: Selective C- and O-allylation of hydroxycoumarin 4. 
5.2 Labelling through cross-coupling reactions 
Functionalization of 4-hydroxycoumarin 4 gave desired vinyl triflate 12 in high 
yield. This compound was found to be an excellend candidate for various transition 
metal-catalyzed cross-coupling reactions, such as Sonogashira-, Suzuki- and 
Buchwald-Hartwig coupling (Scheme 5.3). 
 
 
 
 
Scheme 5.3: Synthesis of 7-diethylamino-4-trifluoromethylsulfonyloxy-coumarin 12. 
It was possible to get access to molecules with coumarin fluorescent tag in good 
to excellent yields under Sonogashira and Suzuki-Miyaura, as well as Buchwald-
Hartwig coupling conditions (Scheme 5.4). Several amino acids, as well as peptides, 
were screened in transition metal-catalyzed couplings to afford labelled molecules in 
high yields. 
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Scheme 5.4: Transition metal-catalyzed cross-coupling reactions with coumarin 12. 
More nucleophilic amines (e.g. morpholine) provided enamines of type 49 
without CO-insertion under Buchwald-Hartwig coupling conditions (Scheme 5.5). The 
formation of 49 was also achieved under transition metal-free conditions. Therefore, 
in this case conjugate substitution (Michael addition and elimination of TfOH) 
leading to 49 must be significantly faster then cross-coupling reaction.  
  
Scheme 5.5: Buchwald-Hartwig amination. 
Various secondary amines were screened under substitution conditions affording 
the substitution products in good to excellent yield. 
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5.3 Labelling through Pd-catalyzed allylic alkylation 
In the scope of this thesis several allylic fluorescent dyes (Figure 5.1) were 
developed and applied in Palladium-catalyzed allylic alkylation as one of the possible 
labelling method of the backbone of a peptide. 
 
Figure 5.1: Fluorescent dyes with allylic residues. 
The synthesized allylcarbonate-labels 62 and 65 were subjected to palladium-
catalyzed allylic alkylation of TFA-glycine-tert-butyl ester as a nucleophile. Here, the 
allylic substitution reaction again proved to be an excellent method for fluorescent 
labeling of amino acid esters. Both allylic alkylations provided the fluorescence 
labeled amino acid esters 66, 67, 68 and 69 in good yields (around 80%). In the 
reaction with the carbonate 62 and 65 the formation of the both - linear and 
branched products was observed (Scheme 5.6). 
The fluorescent dye 75 with an expanded -system was screened in allylic 
alkylation reactions with various nucleophiles (C-, N- and O-nucleophiles), what 
provided the target compounds (Z- and E-regioisomers) with aminocoumarin 
fluorescent tags in good yields.  
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Scheme 5.6: Pd-catalyzed allylic alkylaitons. 
Fluorescent dye 71 with a shorter side chain gave rise to selective allylation 
furnishing only one regioisomer 72 (Scheme 5.7). In this case the branched position 
of monosubstituted -allyl complex is prevented by the coumarin ring for an attack 
of the nucleophile, which resulted in regioselective allylation of the aminoacid. 
 
Scheme 5.7: Pd-catalyzed allylic alkylation with fluorescent dye 71. 
5.4 Labelling through Michael addition reaction 
Dyes based on 7-aminocoumarin moiety turned out to be good Michael acceptors 
and were applied subsequently for various addition reactions (Scheme 5.8). Several 
dyes have been developed as possible Michael acceptors in fluorescent labelling. 
Amines and thiols were chosen as possible nucleophiles, as well as TFA-glycine-tert-
butyl ester. The Michael acceptor was synthesized according to the scheme 5.9. 
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Scheme 5.9: Synthesis of Michael acceptor 58. 
The obtained vinyl-coumarin 58 was succefully applied as a Michael acceptor in 
various labelling reaction of amines and thiols. The molecules with fluorescent tag 
were isolated in good yields. 
 
Scheme 5.8: Fluorescent labelling of peptide through Michael addition. 
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